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Abstract  
Worldwide, hundreds of thousands of healthcare acquired infections (HAIs) are reported 
each year.  HAIs are infections that occur whilst in hospital or as a result of hospital 
admittance, contamination of hospitals is a source of, and allows dissemination of HAIs.  In 
healthcare settings one of the major vectors of contamination is healthcare workers’ 
uniforms.  As surfaces become contaminated, bacteria can then be contacted by patients 
(direct transmission) or staff who may then indirectly spread those bacteria to patients.  Both 
direct and indirect spread of bacteria could result in infection of patients ultimately resulting 
in increased infection rates and associated costs.  A further consequence of such a scenario 
is the increased levels of antibiotic use, the survival of antibiotic resistant bacteria and 
increased prevalence of antimicrobial resistance.   
 
A pilot study was conducted at Antrim Area Hospital, Northern Health and Social Care Trust.  
100 pre-shift and 100 post-shift healthcare workers’ uniforms were assessed for 
Staphylococcus aureus and Enterococcus spp. isolates.  We found increased levels of 
antibiotic resistant S. aureus and antibiotic resistant Enterococcus spp. contamination on 
post-shift uniforms compared to zero to minimal contamination of pre-shift uniforms.  A 
biobank of isolates was created and subsequently characterised for antibiotic sensitivity 
using European Union Committee on Antimicrobial Susceptibility Testing (EUCAST) 
guidelines – 51% of S. aureus isolates were classed multi-drug resistant.  Genomic diversity 
was assessed using Random Amplification of Polymorphic DNA (RAPD) – high levels of 
similarity was found amongst isolates.  As one means of reducing uniform bioburden, we 
conducted analysis of a novel surface active organosilane disinfectant named Goldshield 
(GS).  GS was marketed as a long lasting antimicrobial with residual activity to prevent 
(re)contamination.  GS was tested against model HAI bacteria, spores and biofilms with a 
view to assessing its potential incorporation into infection control practices.  GS technology 
displayed bactericidal, sporicidal and anti-biofilm properties in laboratory testing providing 
rationale for an intervention where GS could be incorporated into hospital laundry and 
assessed for potential use in infection control.   
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Chapter 1 
General Introduction 
 
  
2 
1.1 Healthcare Acquired Infections  
Healthcare acquired infections are often referred to as hospital acquired infections, 
‘superbugs’ or nosocomial infections and are often abbreviated as HCAIs or HAIs [HAIs 
hereafter].  Cardoso et al. (2014) defined HAIs as “a localized or systemic condition: 1) that 
results from adverse reaction to the presence of an infectious agent(s) or its toxin(s) and 2) 
that was present 48 hours or more after hospital admission and not incubating at hospital 
admission time” –thus a HAI is an infection acquired from the healthcare environment as 
opposed to community/community associated infections (Cardoso et al., 2014).   
 
HAIs are categorised based on the nature of the infection, or the procedure under which the 
infection occurred.  Common terms used to describe HAI classifications include central line-
associated bloodstream infections (CLABSIs) (Pallotto et al., 2017), catheter-associated 
urinary tract infections (CAUTIs) (Rebmann and Greene, 2010), surgical site infections (SSIs) 
(Lee, 2000), hospital-acquired pneumonias (HAP) (Leu et al., 1989; Sprigings et al., 2017) and 
gastrointestinal infections (predominantly caused by Clostridium difficile (Schmier et al., 
2016).  A considerable diversity of microorganisms are responsible for HAIs, including 
Staphylococcus aureus, Enterococcus spp., Clostridium difficile, carbapenem-resistant 
Enterobacteriaceae (predominantly Escherichia coli, Klebsiella spp, Enterobacter spp.), 
Acinetobacter spp. and Pseudomonas spp (Dancer, 2014). 
3 
1.2 Implications of Healthcare Acquired Infections  
1.2.1  Healthcare Acquired Infection Incidence Rates 
HAIs are directly responsible for increased morbidity and mortality rates (Magill et al., 2014; 
Zingg et al., 2015).  Worldwide it is estimated that hundreds of millions of patients are 
affected by HAIs yearly (Pittet et al., 2017).  In Europe ‘The European Surveillance System’ 
(TESSy) collects, analyses and reports data on communicable diseases including HAIs.  
However, issues exist in standards of reporting of HAIs and compliance in reporting varies 
per hospital and per country, and therefore most reported numbers tend to be estimates 
based on large sample groups.  It is estimated that HAIs are the cause of 4.5 million infections 
each year in the European Union (EU) alone and that these result in approximately 37,000 
deaths per year (Lamarsalle et al., 2013; Zingg et al., 2015; European Centre for Disease 
Prevention and Control, 2018).  The most common type of HAI is a SSI (Al-Tawfiq and 
Tambyah, 2014), and the European Centre for Disease Prevention and Control (ECDC) 
reported that, within the EU in 2016, there were a total of 630,551 (14% of total HAI cases) 
surgical site HAIs (European Centre for Disease Prevention and Control, 2016).  In the UK 
198,138 (~4.5% of EU total) cases of HAI were reported from 365 hospitals; more locally in 
Northern Ireland a total of 10,288 HAI cases were reported from 10 hospitals (European 
Centre for Disease Prevention and Control, 2016).   
 
In the USA there is no standalone surveillance system for HAI incidence and infection 
numbers published are national estimates based on sub-population sample groups.  The ‘US 
Centers for Disease Control and Prevention’ (CDC) most recent estimation was ~1.7 million 
HAIs per year resulting in 35,967 deaths annually in the USA (Klevens et al., 2007; Magill et 
al., 2014; Scott, 2009).  In 2014 Magill et al. conducted a large scale surveillance of infection 
4 
data across 10 US states in which they investigated acute care hospitals only – they 
concluded that there were 721,800 HAIs per year for 648,000 patients (Magill et al., 2014).  
They also concluded “on any given day approximately 1 of every 25 inpatients in U.S. acute 
care hospitals has at least one health care–associated infection” (Magill et al., 2014) – this 
figure remains the most updated statistic reported by the CDC (Centers for Disease Control 
and Prevention, 2018).  The most common infections were pneumonias and SSIs, however 
the most common causative HAI organism was C. difficile (for all HAI infection types) (Magill 
et al., 2014).   
 
In regard to location within healthcare facilities, intensive care units (ICUs) are the most 
common place for HAIs to occur (Šuljagić et al., 2005; Sadatsafavi et al., 2016).  The ECDC 
reported that 8.4% of patients (12,735 patients) staying in ICUs for more than 2 days 
experienced a HAI – in their reports the most common infections were P. aeruginosa, S. 
aureus, Klebsiella spp. and E. coli (European Centre for Disease Prevention and Control, 
2016b).  Moreover, Custovic et al. (2014) stated that is it 5-10 times more likely that HAIs will 
occur in ICUs compared to other hospital departments, and indeed it has been reported that 
40-50% of ICU patients develop HAIs (Custovic et al., 2014).  Furthermore, a recent 
publication used molecular typing methods to robustly demonstrate transmission of HAIs 
around a hospital setting in Australia (Leong et al., 2018).   
 
Geography also influences HAI prevalence.  Allegranzi et al (2011) conducted a meta-analysis 
on HAI prevalence, comparing developing countries to developed countries.  In these 
countries from Africa, Americas, Europe, Southeast Asia, eastern Mediterranean and 
western pacific were included and classed developing or developed according to the WHO 
classification.  They concluded that increased incidence of HAIs in developing countries was 
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due to lower budgets for infection control and prevention.  They reported that 7.1% of all 
patients in Europe suffer a HAI and that 4.5% of USA patients suffer a HAI (Allegranzi et al., 
2011).  However, in developing countries, 15.5% of patients suffer a HAI based on pooled 
information from high quality studies (Allegranzi et al., 2011).  It is likely that the increased 
incidence of HAIs in developing countries compared to developed countries is as a result of 
poorer hygiene and less money available for infection prevention.   
 
1.2.2  Financial Burden of Healthcare Acquired Infections 
The costs associated with HAIs are substantial.  Associated expenses include costs 
attributable to increased length of stay in hospital (due to increased requirement of 
resources and staffing costs), increased diagnostic expenses to determine cause of infection 
and appropriate treatment, and increased treatment expenses once the HAI has been 
diagnosed.  For example, during an outbreak of K. pneumoniae in USA, it was reported that 
the total cost due to 486 infections was $341,751 (Stone et al. 2003).  These costs were 
broken down as healthcare workers time ($146,331 for additional staff time of 2489 h ($58 
per hour)), surveillance and infection control procedures ($66,794 for 1055 h staff time ($63 
per hour)), additional laboratory procedures ($56,716), and loss of bed space/lost revenue 
($109,680).  Additionally, the average increase for length of stay in hospital ranged from 25 
to 181 days (average increase in length of stay was 48.5 days) (Stone et al., 2003).   
 
WHO estimates that the incidence of HAIs leads to an additional 16 million extra patient days 
in hospital in the EU (World Health Organisation, 2011; Zingg et al., 2015), accumulating to 
an expenditure of €7 billion per year (World Health Organisation, 2011; Lamarsalle et al., 
2013).  In the UK it is estimated that HAIs cost €54 million (~£47 million as per conversion 
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rate October 2018) per year, while in France alone, expenditure is equal to €130 million 
(~£113 billion as per conversion rate October 2018) (World Health Organisation, 2011).  In 
the USA it is estimated that the overall cost of HAIs is $28 billion to $45 billion annually (Scott, 
2009; Stone, 2009) and a single HAI case could cost between $962 and $44,204 depending 
on the type of infection, with pneumonia cases being the most expensive HAI cases (Scott, 
2009; Eber et al., 2010; Anderson et al., 2013; Zimlichman et al., 2013; Schmier et al., 2016); 
shown in Table 1.1.  Table 1.2 summarises HAI costs based on infectious agent.   
 
Table 1.1 – Direct medical costs of different types of healthcare acquired infections (HAIs) in the USA.   
Type of Healthcare Acquired Infection Lowest estimated 
cost per case ($) 
Highest 
estimated cost 
per case ($) 
Catheter-associated urinary tract infection (CAUTI) $962 $1167 
Central line-associated bloodstream infection (CLABSI) $8379 $49201 
Gastrointestinal infection (GI) $8531 $12119 
Surgical site infection (SSI) $14572 $40688 
Ventilator-associated pneumonia (VAP)/Hospital-acquired 
pneumonia (HAP) 
$19475 $43112 
Figures representative of estimated cost of healthcare acquired infection types in the USA.  
Information collated from various sources (Scott, 2009; Eber et al., 2010; Anderson et al., 2013; 
Zimlichman et al., 2013; Schmier et al., 2016).   
 
Table 1.2 – Costs and length of hospital stay for outbreaks of individual healthcare acquired infections 
due to different bacterial pathogens.   
Bacteria  Number of 
infections  
Increased length 
of stay per case 
Overall 
Increased costs 
Source  
Klebsiella 
pnuemoniae  
486  48.5 days (mean) $341,751 (total) (Stone et al., 
2003) 
Acinetobacter 
baumannii 
34 11 days (mean) $98,575 (total) (Wilson et al., 
2004) 
Enterococcus spp 277 17 days (mean) $77,558 (mean 
per case) 
(Song et al., 
2003) 
Pseudomonas 
aeruginosa 
82 20 days (median) Not reported  (Carmeli et al., 
2006) 
Staphylococcus 
aureus 
348 8 days (mean) $22,818 (mean 
per case) 
(Cosgrove et al., 
2005) 
Clostridium difficile  40 3.6 days (mean) $3669 (mean per 
case) 
(Kyne et al., 
2002) 
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The costs discussed above are primarily limited to assessments of direct care cost, i.e. 
hospital/treatment based cost (Marchetti and Rossiter, 2013).  However a social impact is 
also observed as result of HAIs, with the main societal cost of HAIs being a loss of earnings 
due to increased length of stay in hospital.  Marchetti and Rossiter (2013) assessed the cost 
of HAIs in USA from both clinical and societal perspectives.  They concluded that when social 
costs are included, the ‘true’ total cost of HAIs per year in the USA rises from $28 billion to 
$45 billion (Scott, 2009) (when only direct costs are considered) to $96 billion to $147 billion 
(Marchetti and Rossiter, 2013).   
 
1.2.3 Healthcare Acquired Infections and Antimicrobial 
Resistance  
The development of antimicrobial resistance is a multifactorial problem that arises due to 
the overuse and misuse of antibiotics (O’Neill, 2016).  However, the prevalence of HAIs also 
contributes to the emergence of antimicrobial resistance in pathogenic bacteria associated 
with HAIs (Holmes et al., 2016; Swaminathan et al., 2017).  Thus antimicrobial resistance 
promotes the persistence and prevalence of HAIs (O’Neill, 2016).  The well-established 
relationship between HAIs and antimicrobial resistance is evidenced by the development of 
national surveillance programmes, and the publication of comprehensive government 
reports on the topic.  In the USA, the CDC and National Healthcare Safety Network (NHSH) 
publish the “Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated 
Infections: Summary of Data Reported to the National Healthcare Safety Network at the 
Centers for Disease Control and Prevention,” which every three years, reviews antimicrobial 
resistance patterns amongst HAIs, collating incidence data and antimicrobial resistance data 
together (Hidron et al., 2008; Sievert et al., 2013; Weiner et al., 2016).  In the UK Jim O’Neill 
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recently published a series of reports detailing the issue of antimicrobial resistance, included 
was a report dedicated to the role of HAIs entitled “Infection prevention, control and 
surveillance: limiting the development and spread of drug resistance” (O’Neill, 2016).  The 
overall message of this report was that by improving infection prevention practices, infection 
rates would be reduced which would ultimately reduce antimicrobial resistance.   
 
Antimicrobial resistance reduces the effectiveness of antibiotics against HAIs resulting in 
longer infections, leading to increased morbidity and mortality rates in hospitals (Cardoso et 
al, 2014; Al-Taani et al, 2018).  Antibiotic-resistant HAIs commonly occur in hospitals 
(Cardoso et al., 2014b; Ventola, 2015) and it is estimated that 30-40% of patients in European 
hospitals are receiving antibiotic therapy (European Centre for Disease Prevention and 
Control, 2013) – this combination results in a major driver of antimicrobial resistance 
(Holmes et al., 2016).  It is also estimated that 16% of the bacteria causing HAIs are 
antimicrobial resistant (Hidron et al., 2008).  In 2008 it was estimated that half of the deaths 
caused by HAIs in Europe were caused by multi-drug resistant bacteria (Watson, 2008; ter 
Meuken, 2009).  In summary HAIs are often antimicrobial resistant pathogens – making them 
more difficult to treat as certain antibiotics could be ineffective against them.  There is also 
a consequence of increased antibiotic use and subsequently increased antimicrobial 
resistance.   
 
Furthermore, extra expense is incurred when infections due to antimicrobial resistant 
bacteria occur.  This is due to the added expense/time to diagnose antimicrobial resistance 
and determine a suitable antibiotic for treatment (Stone, 2009; Cheng et al., 2015).  It is 
reported that antimicrobial resistance results in greater length of stay and higher costs for 
drug-resistant infections compared to non-resistant infections – evidence of this has been 
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reported for beta-lactam resistant K. pneumoniae (Stone et al., 2003), multi-drug resistant 
A. baumannii (Wilson et al., 2004), vancomycin resistant Enterococcus spp. (Song et al., 
2003), multi-drug resistant P. aeruginosa (Carmeli et al., 2006), methicillin resistant S. aureus 
(Cosgrove et al., 2005) and C. difficile (Kyne et al., 2002) – information regarding increased 
costs and length of stay is summarised in Table 1.2  It has also been reported that a drug 
resistant case of S. aureus costs twice as much to treat as a drug-sensitive infection ($16,000 
vs. $35,000) (Filice et al., 2010; O’Neill, 2016).  Similarly, treatment of penicillin-resistant 
Streptococcus pneumoniae was more expensive that a penicillin-susceptible S. pneumoniae 
(211 $CDN vs. 74 $CDN) (Quach et al., 2002; Cheng et al., 2015).   
 
In conclusion HAIs lead to increased infection rates leading to increased antibiotic use which 
contributes to increased antimicrobial resistance (O’Neill, 2016).  Struelens (1998) 
summarised the cycle – “Resistance (to antimicrobials) results from the interplay of micro-
organisms, patients, and the hospital environment, including antibiotic use and infection 
control practices” (Struelens, 1998) – i.e. this is a recurring cycle with an interplay of 
associated factors.  As these factors are intrinsically linked, reducing one could allow a 
reduction in others, for example reducing HAIs prevalence could lead to subsequent 
reduction in antimicrobial resistance (O’Neill, 2016). 
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1.3 Contamination of the Healthcare Environment 
It has been shown that many factors contribute to the prevalence of HAIs in hospitals, 
including increased antibiotic use (Holmes et al., 2016), the susceptibility of patients 
increasing their likelihood of catching an infection and critically, poor infection control 
compliance (Lee et al., 2018).  However, after much debate and conflicting reports (Malik et 
al., 2003) it is now accepted that microbial contamination of the healthcare environment is 
a significant contributing factor in the emergence, spread and prevalence of HAIs (Mitchell 
et al., 2013; Dancer, 2014; Doll et al., 2018; Lee et al., 2018).   
 
Microbial contamination of the hospital environment is responsible for direct and indirect 
transmission of microorganisms to patients (Martínez et al., 2003; French et al., 2004; 
Dancer, 2014; Cheng et al., 2015).  When the environment becomes contaminated with 
pathogenic organisms, those objects/surfaces/people act as a source of infectious agents 
(Kramer et al., 2006; Cheng et al, 2015).  High touch surfaces are the most problematic as 
they are the most likely to become contaminated with, and harbour, potentially pathogenic 
microorganisms, and to act as vectors for transmission to vulnerable patients (Dancer, 2014; 
Cheng et al., 2015).  Examples of high touch surfaces include bed rails, door handles 
(Muirhead et al., 2017), bed clothing (mattresses/sheets) (Tarrant et al., 2018), staff and staff 
equipment/uniforms.  The routes of environmental transmission of HAIs is presented in 
Figure 1.1 (Cheng et al., 2015).   
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Figure 1.1 – The routes of environmental transmission of HAIs.  When high-touch surfaces become 
contaminated they can contribute to the spread of healthcare acquired infections via direct (patient) 
and indirect transmission routes (others) – arrows represent transmission of environmental 
pathogens (Cheng et al., 2015).   
 
In the early 1990s cleaning was considered non-critical in infection prevention practices; 
resulting in a misguided a cost-saving scheme in the UK NHS in the 1990s in which financial 
support for cleaning was reduced (Dancer, 1999; Dharan et al., 1999).  This correlated with 
a subsequent rapid increase in HAIs prevalence in the late 1990s to early 2000s with resulting 
increased interest from health service providers, industry and researchers alike (Dancer, 
2014).  As of 2018, cleaning and decontamination for infection prevention purposes is 
considered vital and therefore interest in methods for decontamination of the healthcare 
environment has increased across a range of sectors and disciplines.   
 
The environmental contamination of high touch surfaces in healthcare settings by 
methicillin-resistant S. aureus (MRSA) was first described in 1997 by Boyce et al. (1997) – this 
study demonstrated that healthcare workers’ gloves became contaminated with MRSA due 
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to their touching contaminated sites/objects (including patient bedside furniture) (Boyce et 
al., 1997).  Evidence of hospital contamination by pathogenic bacteria can be found 
throughout the literature including by MRSA (Knelson et al., 2014; Lin et al., 2017), 
vancomycin-resistant Enterococcus (VRE) (Bonten et al., 1996; Knelson et al., 2014), 
carbapenem-resistant Enterobacteriaceae (CRE) (Lerner et al., 2013; Weber et al., 2015), C. 
difficile (Weber et al., 2010; Sitzlar et al., 2013) and Acinetobacter species (Weber et al., 
2010).  A recent publication (Deshpande et al., 2017) described contamination of hospital 
floors with C. difficile, MRSA and VRE – and the authors concluded that this contamination 
leads to further contamination of high touch objects/surfaces.  In addition, work by other 
researchers has determined the survival periods of known HAI agents on inanimate surfaces 
representative of surfaces found in healthcare settings where bacteria can survive for up to 
one and a half years (Table 1.3).   
 
Table 1.3 – Survival times of known healthcare acquired infection-causing organisms and infectious 
doses.   
Organism  Reported survival time Infectious dose 
Methicillin-resistant 
Staphylococcus aureus  
7 days to 7 months 4 CFU 
Acinetobacter 3 days to 5 months 250 CFU 
Clostridium difficile >5 months 5 spores 
Vancomycin-resistant 
Enterococcus 
5 days to 4 months <103 CFU 
Escherichia coli 2 hours to 16 months 102-105 CFU 
Klebsiella 2 hours to 30 months 102 CFU 
Norovirus  8 hours to 7 days  <20 virons 
*table taken directly from Dancer (2014) who extrapolated information from published materials as 
part of a review (Wandall, Arpi and Wandall, 1997; Kjerulf et al, 1998; Kramer, Schwebke and Kampf, 
2006; Makison and Swan, 2006; Eaton et al, 2008; Teunis et al, 2008; Chiang et al 2009; Lawley et al, 
2010; Dancer, 2014).   
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Studies have also demonstrated the role that contamination plays in increasing incidence 
rates of HAIs (this is often shown inversely, i.e. reducing the bioburden reduces incidence).  
In an intervention to reduce environmental and staff contamination, Simmons et al. (2013) 
implemented hand hygiene and novel disinfection systems over a 6 month period in a US 
hospital system and reported an average 56% reduction in infection rates of MRSA during 
the intervention period.  Another example from a Glasgow teaching hospital assessed 
bioburden levels in a surgical intensive care unit (SICU) correlating these levels with HAIs 
rates (White et al., 2008).  They found that 25% of their samples (hospital beds, cardiac 
monitor buttons, curtains, keyboards and chairs) were contaminated with greater than 2.5 
CFU/cm2 S. aureus, meaning that 25% of the samples were deemed hygiene failures.  They 
also reported that levels of contamination increased when occupation of the SICU increased 
and concluded overall that hygiene failures correlated with HAI levels, in that increased 
contamination resulted in increased HAI incidence rates (Figure 1.2) (White et al., 2008).   
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Figure 1.2 – Relationship between environmental contamination of a surgical intensive care unit and 
number of healthcare acquired infections during a 2 month sampling period (White et al., 2008; 
Dancer, 2014).   
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1.4 Decontamination  
Decontamination of the healthcare environment to remove pathogens is critical in reducing 
bioburden and thus the risk of HAIs (Han et al., 2015).  Appropriate decontamination will 
eradicate/prevent contamination of the healthcare environment and thus reduce spread of 
HAIs.  Decontamination may be defined as a multi-purpose process whereby items are made 
clear of dirt and microorganisms.  There are various levels of decontamination that may be 
employed depending on the purpose.  For example the Western Health and Social Care Trust 
(WHSCT) define decontamination as a “combination of cleaning, disinfection and 
sterilisation” (WHSCT, 2015).  Cleaning is defined as the process where a low grade detergent 
is applied to remove dust, oil and dirt from objects and eradicates a proportion of 
microorganisms.  Disinfection is considered an intermediate grade decontamination process; 
this can be heat or chemical application aimed to reduce the bio-burden to a non-harmful 
level but doesn’t eradicate all microorganisms and it does not destroy bacterial spores.  
Sterilisation however, is the complete removal of all microorganisms including bacterial 
spores, and is achieved mainly by the use of chemicals, and is common practice for surgical 
instruments (WHSCT, 2015).   
 
Current decontamination strategies have been shown to be ‘unsatisfactory’ throughout the 
published literature.  One such study in a London teaching hospital assessed 124 swab 
samples from high-touch points in surgical wards before and after cleaning (the cleaning 
process was not fully defined but detergent sanitizer and laundry processes were employed).  
They reported that 90% of the contaminated surfaces (before disinfection) remained 
contaminated (post disinfection) (French et al., 2004).  Many other examples of 
environmental contamination of pathogenic bacteria have been reported (Bonten et al., 
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1996; Boyce et al., 1997; Weber et al., 2010, 2015; Lerner et al., 2013; Sitzlar et al., 2013; 
Knelson et al., 2014; Deshpande et al., 2017; Lin et al., 2017). 
 
1.4.1  Prevention of Contamination  
Whilst reducing contamination of the healthcare environment is essential, prevention of 
contamination in the first place is the ideal scenario.  As discussed, there is supporting 
evidence for contamination of the healthcare environment which can be transmitted to 
susceptible patients.  Furthermore, there is evidence of re-contamination of the 
environment post decontamination.  For example, Aldeyab et al. (2009) reported the re-
contamination of successfully cleaned areas within 1 h of disinfection in Antrim Area 
Hospital.  Similarly Attaway et al. (2012) assessed bacterial bioburden of hospital surfaces 
pre-disinfection and post-disinfection in a South Carolina hospital.  They reported re-
contamination levels as high as 45% of the pre-disinfection bioburden levels (i.e. prior to 
cleaning) after 2.5 h (Attaway et al., 2012).   
 
Some current methods of decontamination claim to prevent (re)contamination of the 
environment by their mode of action (Dancer, 2014).  Examples of these include 
antimicrobial surfaces (for example antiadhesive surfaces) to prevent contamination and 
antimicrobial coatings (for example copper) which provide residual (long-lasting) 
antimicrobial activity (Baxa et al., 2011; Dancer, 2014; Perez et al., 2015).  Such methods are 
discussed further in chapter 2.   
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1.5 Overview of Thesis  
The main focus of this thesis is assessment of contamination of the healthcare environment 
and a novel approach to prevent (re)contamination of the healthcare environment.  Working 
alongside an industrial partner and clinical collaborators a surface-active, long-lasting 
disinfection product was assessed in vitro.  The main focus of this was to determine both 
antimicrobial activity and the residual activity of the product with a view to incorporating it 
in infection control practice in the Northern Health and Social Care Trust (NHSCT).  This was 
to be in the laundry of healthcare workers uniforms to prevent contamination.   
 
To demonstrate the need for such an intervention, the current bioburden status of 
healthcare workers uniforms was assessed in Antrim Area Hospital, Northern Health and 
Social Care Trust.  Working with the consultant microbiologist and domestic services team, 
healthcare workers’ uniforms were assessed for bacterial contamination pre-shift and post-
shift.  We hypothesised that this would demonstrate environment contamination and 
contamination of uniforms representing direct and indirect transmission routes of HAIs onto 
patients and provide rationale that steps are required to reduce the contamination of 
healthcare workers uniforms.   
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Chapter 2 
Evaluation of bactericidal, anti-biofilm and sporicidal 
properties of a novel, surface-active organosilane biocide 
 
 
Associated publication: 
Murray, J., Muruko, T., Gill, C.I.R., Kearney, M.P., Farren, D., Scott, M.G., McMullan, G., 
Ternan, N.G. (2017) Evaluation of bactericidal and anti-biofilm properties of a novel surface-
active organosilane biocide against healthcare associated pathogens and Pseudomonas 
aeruginosa biolfilm. PLoS One 12: e0182624. 
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2.1 Introduction  
There is a requirement for alternative technologies/compounds for decontamination of the 
healthcare environment.  One alternative approach to tackle microbial contamination and 
re-contamination is the creation and use of antimicrobial surfaces, either by use of 
antimicrobial coating materials or via antimicrobial impregnated surfaces (Boyce, 2016).   
 
2.1.1 Organosilanes 
Organosilanes are a group of chemicals which can be used to create these antimicrobial 
surfaces.  Silanes are chemicals containing a silicon-carbon bond.  Silanes are monomeric, 
meaning functional groups can be formed by covalent bonds of reactive components to 
silanes (Gkana et al., 2017).  Organosilanes are molecules where two different reactive 
groups are bond with silanes.  One of these reactive groups allows organosilanes to form 
strong covalent bonds to inorganic substrates which is effectively the coating system of these 
compounds (Gkana et al., 2017).  Organosilanes can then be coupled with an antimicrobial 
compound (often quaternary ammonium compounds).  This combination has risen to 
application in disinfectants to provide residual protection (Baxa et al., 2011; Boyce, 2016).  
Only a few studies have assessed the residual activity of these compounds with conflicting 
results and conclusions on the potential benefits of using these compounds in disinfection 
practices (Baxa et al, 2011; Boyce et al, 2014; Tamimi et al, 2014).   
 
2.1.2 Goldshield 
Goldshield (distributed by Goldshield technologies Ltd. [GS hereinafter]) is a patented, water 
soluble organosilane, coupled with a quaternary ammonium compound that is designed to 
20 
coat surfaces with a protective antimicrobial layer to prevent microbial contamination.  The 
product was originally designed at Emory University, USA and is the subject of three US 
patents (patent nos. US5,959,014, US6,221,944, and US6,632,805) (Baxa et al., 2011; Perez 
et al., 2015).   
 
GS products are marketed as water-based, non-toxic, non-leaching, environmentally-benign 
nano-molecular-assembly technology (Baxa et al., 2011; Perez et al., 2015).  GS technology 
utilises a chemical structure that is marketed as bactericidal, virucidal and fungicidal.  The 
sophisticated technology has a very specific mechanism for direct killing of microbes (Baxa 
et al., 2011; Perez et al., 2015).  The oxygen–organosilane carrier complex allows attachment 
to almost any surface and/or textile and affixation creating a semi-permanent covalent bond.  
Nitrogen creates a positive charge hence attracting negatively charged microbes.  The unique 
molecular assembly of a long carbon chain physically attacks the cell, penetrating the 
cytoplasmic membrane resulting, the company states, in proteins becoming denatured and 
bacterial cell lysis resulting in an outpour of intracellular materials.  The process, described 
as a “molecular bed of nails” results in the death of microorganisms as they contact the GS 
coated surfaces.  Figure 2.1 shows an outline of the chemical make-up of GS and Figure 2.2 
details GS mode of action.   
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Figure 2.1 – Core Goldshield technology structure consisting of an oxygen-silane complex (for coating 
of surfaces), a nitrogen component (for attraction of microorganisms) and a long carbon chain (for 
physical disruption of microorganisms).   
 
 
Figure 2.2 – Model for Goldshield mode of action.  The process of how Goldshield acts as a surface-
active protectant to kill any bacteria which contact the surface which could be an ideal solution in 
preventing contamination of hospital surfaces.  GS coats surfaces forming a covalent bond.  As 
microbes contact the surface they are attracted to GS via electrostatic charges.  The long carbon chain 
physically ruptures microbial cell membranes resulting in a compromised membrane and ultimately 
cell death.   
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In 2014, GS had a range of products on the market based on the original technology 
developed at Emory.  The products can potentially be used in a range of sectors, ranging from 
healthcare to schools, sport facilities, hospitality and military.  GS5 (surface disinfectant) is 
the core product containing 3-trihydroxysilyl propyldimethyloctadecyl ammonium chloride 
(5%); Alcohols C12-16, Ethoxylated (1-5%); 2-butoxyethanol (1-5%); Pentaerythritol (<2%); 
and d-Limonene (<0.25%).  Sporicidal products GS48 and GS48-55 are the same formulation 
as GS5, but with the addition of varying concentrations of hydrogen peroxide.   
 
Peer reviewed, robust scientific research on Goldshield is limited to only two papers (Baxa et 
al., 2011; Perez et al., 2015).  Baxa et al. (2011) assessed the effectiveness of the GS5 against 
S. aureus (MRSA), P. aeruginosa, and E. coli on fabrics, stainless steel and Formica surfaces.  
GS5 residual activity on fabrics was also tested over a 14 day period.  Microbial bioburden 
Log10 reductions on treated surfaces were observed for stainless steel and Formica with 0.6 
Log10 to 2.2 Log10 reduction dependent upon surface (Baxa et al., 2011).   
 
Perez et al. (2015) completed a hospital intervention study in which they used GS5 in 
University School of Medicine in Dearborn, Michigan.  They determined the quantitative 
microbial risk assessment (QMRA) (which is a method of estimating risk of infection by 
exposure to microorganisms) both before and after GS5 use in environmental cleaning of 
high-touch surfaces in patient rooms.  They documented reduction of bacterial bioburden of 
these surfaces and concluded that GS5 could prevent 5-10% of HAIs (Perez et al., 2015).   
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2.1.3 Aims and Hypothesis  
The aim of the work presented in this chapter was to assess the efficacy of GS 
technologies/products as disinfectant agents against a range of known HAIs.  GS5 was initially 
tested as a standard disinfectant using suspension assays to directly assess antibacterial 
properties.  The GS5 product was then tested as long-lasting disinfectant in comparison with 
competitor products to quantify residual antibacterial activity post application.  GS5 was 
then tested to determine its residual activity against 10 known HAIs.  Anti-biofilm activity 
was also assessed, by challenging P. aeruginosa DSM3227 biofilm formation with GS5.  
Finally, GS48 and GS48-55 products were tested against C. difficile spores.  We hypothesised 
that GS technologies would exhibit bactericidal, anti-biofilm and sporicidal properties.  It was 
also hypothesised that GS5 would exhibit residual antimicrobial activity.   
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2.2 Materials and Methods 
2.2.1 Chemicals, Glassware and Media 
All glassware was sterilised by soaking overnight in 1% Virkon (Antec, UK) and steam 
sterilised in an autoclave prior to use.  All culture media (Oxoid, UK) was prepared as per the 
manufacturer’s instructions.  Phosphate Buffered Saline (PBS) (Oxoid, UK) was prepared in 
deionised water and steam sterilised in an autoclave prior to use.  Two model surfaces were 
used.  316l Steel (Aalco, UK) and Formica.  Sample of these materials were cut into 2cm×2cm 
chips, autoclaved (121 °C for 15 mins) and stored in a sealed sterile container prior to use in 
experiments.   
 
2.2.2 Microorganisms 
Ten bacterial species were obtained from either the American Type Culture Collection (ATCC) 
or the Leibniz-Institute DSMZ German Collection of Microorganisms and Cell Cultures 
(DSMZ).  Bacteria included Escherichia coli ATCC25922, Klebsiella pneumoniae DSM16358, 
Mycobacterium smegmatis DSM43469, Pseudomonas aeruginosa DSM3227, Staphylococcus 
aureus (MRSA) ATCC43300, Staphylococcus aureus (non-MRSA) DSM20231, Staphylococcus 
epidermidis DSM28319 (all cultured at 37 °C using Nutrient broth/agar), Enterococcus 
faecalis DSM12956 (37 °C using Tryptone soya broth/agar), Burkholderia multivorans 
DSM13243 (28°C using Nutrient broth/agar) and Acinetobacter baumannii DSM30008 (30 °C 
using Nutrient broth and agar).  These were chosen as representative organisms of the type 
causing HAIs commonly seen in hospitals (U.S. Centers for Disease Control and Prevention, 
2014) and included Gram positive organisms, Gram negative organisms and Mycobacteria.  
Mycobacterium smegmatis was used as it is a fasting-growing model Mycobacterium species 
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(Altaf et al., 2010).  Organisms were stored on Cryobeads (Technical Service Consultants Ltd, 
UK) at -80 °C and recovered in suitable media when required.   
 
 2.2.3 Disinfectant Agents 
Five disinfectant agents were used (GS5, GS48, GS48-55, Actichlor and Distel).  The 
characteristics of these antimicrobial agents are summarised in Table 2.1.  Agents were 
acquired as full strength concentrate and working stock concentrations were prepared by 
dilution with deionised water as per the respective manufacturer’s instructions.   
 
Table 2.1 – Disinfectant products used in residual bactericidal testing.   
Agent Type Active ingredient(s) Concentration 
used* 
Goldshield5 
 
Organosilane 
coupled with 
Quaternary 
Ammonium 
Compound 
(siQAC) 
3-trihydroxysilyl 
propyldimethyloctadecyl 
ammonium chloride 
 
1:20 dilution 
(5%) 
Goldshield48 Organosilane 
coupled with 
Quaternary 
Ammonium 
Compound 
(siQAC) 
3-trihydroxysilyl 
propyldimethyloctadecyl 
ammonium chloride 
Hydrogen peroxide 
1:20 dilution 
(5%) 
Goldshield48-55 Organosilane 
coupled with 
Quaternary 
Ammonium 
Compound 
(siQAC) 
3-trihydroxysilyl 
propyldimethyloctadecyl 
ammonium chloride 
1:20 dilution 
(5%) 
Actichlor Chlorine-based 
disinfectant 
Sodium dichloroisocyanurate 1:10 dilution 
(10%) 
Distel Quaternary 
Ammonium 
Compound 
Tertiary amine and quaternary 
ammonium compounds 
1:100 dilution 
(1%) 
* as per manufacturer’s instructions.   
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2.2.4 Direct Bactericidal Assessment of GS5 
To determine the direct bactericidal activity of GS5, a suspension contact time assay was 
completed; varying concentrations of GS5 and S. aureus ATCC43300 were mixed followed by 
recovery and enumeration of viable cells to determine Log10 reduction.  0% (sterile water), 
0.25% (v/v), 0.5% (v/v) and 1% (v/v) GS5 dilutions were prepared using sterile water as 
diluent.  A 10 µL aliquot of mid-log phase S. aureus ATCC43300 was mixed with each of the 
GS5 concentrations and left to stand at room temperature for 5 min.  Bacteria were 
enumerated by plating onto Nutrient agar and incubating at 37 °C for 24 h followed by direct 
colony counts.   
 
2.2.5 Growth Calibration  
For accurate application of precise bacterial numbers onto test surfaces, growth calibration 
testing was completed to determine the D600nm to CFU/ml relationship for each organism.  
From an overnight culture a fresh culture was grown to a pre-defined D600nm (D600nm = 0.8-1).  
From this a range of serial dilutions (0% (broth reference), 20%, 40%, 60%, 80% and 100% of 
sample) were made using fresh broth.  For each dilution D600nm measurements were taken 
and CFU/mL determined by serial dilution and plated onto a suitable agar medium followed 
by incubation using appropriate incubation parameters.  Following incubation colonies were 
enumerated, and CFU/mL determined.  Data analysis (determination of y intercept (y=)) was 
conducted using Graphpad prism.   
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2.2.6 Residual Surface Activity of Disinfectants 
To investigate the residual activity of surface disinfectants a protocol was developed from 
the EN13697 standard and the work of Baxa et al. (2011).  S. aureus ATCC43300 (MRSA) and 
316l Steel were used.  The 316l Steel surface samples were sprayed with either GS5, 
Actichlor, Distel or sterile water (no treatment control) using a hand spray.  The test surfaces 
were left to dry in the sterile environment of a category 2 cabinet (Biomat).  S. aureus 
ATCC43300 was grown to mid-log phase of growth (D600nm = 0.49) and diluted 1/100 using 
sterile PBS (Oxoid, UK).  A total of 100 µL of this was added (in 10 µL droplets) to each surface.  
Bacteria were left on the surfaces for 45 min, and viable cells were then recovered in 10 mL 
of PBS by vortexing for 2 min.  Viable bacteria were enumerated by plating on Nutrient Agar 
and incubating at 37 °C for 24 h followed by direct colony counts (Baxa et al., 2011).  
Following recovery of bacteria from the surfaces, each surface was individually washed using 
sterile PBS, air dried and then stored in a sterile storage box.  The surfaces were subsequently 
re-challenged with S. aureus ATCC43300 as described.  This re-challenge was repeated at 3-
day intervals over 15 days.   
 
2.2.7 GS5 Bactericidal Surface Testing 
A selection of 10 different bacteria, representative of important HAI bacteria, were 
individually tested on 316l Steel and Formica.  Testing was performed to determine the 
maximum antimicrobial effect for a freshly treated surface.  The protocol was as described 
above, but without re-challenge and only the activity of GS5 was assessed.   
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2.2.8 Assessment of GS5 Anti-biofilm Efficacy 
P. aeruginosa DSM3227 biofilms were grown in 24-well microtiter plates and these were 
stained with 0.1% crystal violet to assess the extent of biofilm growth (Djordjevic et al., 2002; 
Welch et al., 2012; Shen et al., 2013).  To determine efficacy of GS5 against biofilm, microtiter 
plates (Thermo Scientific, UK) were pre-treated (prior to inoculation) with either 5% GS5 or 
sterile water (untreated): wells were soaked with 1 mL of agent for 10 min following which 
the treatment agents were aspirated and the plates left to dry in a sterile environment 
(Biomat category 2 cabinet).  An overnight culture of P. aeruginosa DSM3227 was diluted 
1/100 (using sterile nutrient broth) and microtitre plate wells were inoculated with a 1 mL 
aliquot of this, following which the plates were incubated aerobically at 37 °C.  At defined 
time points (8 h, 12 h, 24 h, 48 h, 72 h and 96 h) biofilm production was assessed.  The 
medium containing planktonic cells was removed and wells stained with 1.5 mL 0.1% Crystal 
Violet (Sigma-Aldrich, UK) for 10 min at room temperature.  Unbound crystal violet (Sigma-
Aldrich, UK) was removed and the stained wells were washed twice with 2 mL sterile PBS, 
following which the bound crystal violet was solubilised with 1.5 mL of 30% Acetic Acid 
(Thermo Scientific, UK) for 30 min at room temperature.  A 1 mL aliquot from each well was 
transferred to a fresh 24-well microtiter plate and the absorbance of the crystal violet 
measured at 570nm (A5700nm) using a FLUROstar Omega plate reader (BMG LABTECH, 
Europe).   
 
2.2.9 Assessment of GS5 Effects on Bacterial Viability in Biofilm 
Bacterial viability within biofilms was assessed using the BacLight Live/Dead bacterial 
viability kit (L-7007; Molecular Probes, Eugene, OR) (Webb et al., 2003; Bauer et al., 2013).  
With Baclight, live cells stain green and dead/damaged cells stain red.  A stock solution was 
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prepared by mixing 4 µL of component A (1.67 mM Syto9 plus 1.67 mM propidium iodide), 
6 µL of component B (1.67 mM syto9 plus 18.3 mM propidium iodide) and 1 mL of sterile 
water as described by (Webb et al., 2003).  P. aeruginosa DSM3227 biofilm was grown in 4-
well Nunc™ Lab-Tek™ II Chamber Slide™ Systems (Thermo Scientific, UK) pre-treated with 
either 5% GS5 or sterile deionised water. Slides were inoculated with 1 mL of a 1/100 dilution 
of overnight culture of P. aeruginosa as above and incubated aerobically for 24 h and 48 h at 
37 °C.  At each time point during the experiment, excess media and planktonic cells were 
removed and the wells washed with sterile PBS followed by staining with 200 µL BacLight 
mix and 100 µL of sterile water.  Stained slides were incubated in the dark at room 
temperature for 30 min following which the wells were then washed with sterile PBS and 
biofilm viewed using ×100 oil immersion on a Nikon ECLIPSE E400 (Nikon) microscope 
utilising a dual-band emission filter (450-490 nm/510-560 nm).  Images were generated using 
NIS-Elements BR (Nikon) software version 3.22.09.   
 
2.2.10 Preparation of Clostridium difficile strain 630 Spores 
For efficacy testing of sporicidal GS preparations, C. difficile spores were prepared from C. 
difficile strain 630.  BHI-S broth was inoculated with freshly grown C. difficile strain 630 and 
incubated at 37 °C for seven days in an anaerobic environment using a Whitley mg500 
anaerobic workstation (DW Scientific, UK).  Following the seven day incubation period 
cultures were transferred to 4 °C and incubated for a further 24 h (Sorg and Sonenshein, 
2008).  Aliquots (1 mL) were centrifuged at 10,000 rpm in an Eppendorf 5418R Centrifuge for 
15 min, the supernatant discarded and spore pellets re-suspended in 1 mL of sterile water; 
this wash was repeated 10 times for each 1 mL aliquot as per Lawley et al. (2009).  Spore 
suspensions were then heat treated to kill any remaining vegetative cells, by incubation at 
60 °C in a Grant micro tube.  Purification of spores was verified by plating onto both 0.1% 
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taurocholic acid-supplemented (Sigma-Aldrich, UK) and non-taurocholate supplemented 
BHI-S, and comparing colony counts after 24 h anaerobic incubation at 37 °C.  Growth on 
taurocholate supplemented agar plates combined with lack of growth on non-taurocholate 
supplemented media indicated spore purity.   
 
2.2.11 Assessment of GS48 and GS48-55 on Spores 
To determine the efficacy of GS48 and GS48-55 against C. difficile strain 630 spores, the 
method of sporicidal suspension testing described by Vohra and Poxton (2011) was used.  To 
a 1 mL aliquot of spore suspension, 0.1 mL of GS48, GS48-55 or sterile water (untreated 
control) was added.  Tubes were briefly vortexed and then incubated at room temperature 
for varying time periods (0 h, 1 h, 4 h, 8 h, 12 h and 24 h).  At each time point, samples were 
centrifuged at 13,000 rpm (using Eppendorf 5418R Centrifuge) for 5 min to recover spores, 
and the supernatant containing the disinfecting agent was removed.  Harvested spore pellets 
were re-suspended in 1 mL sterile deionised water and 0.1 mL was then plated onto BHI-S 
agar supplemented with 0.1% (w/v) taurocholic acid  to enhance germination (Burns et al., 
2010; Heeg et al., 2012).  Plates were incubated anaerobically at 37 °C and colony 
enumeration was performed every 24 h for a total of 5 days to allow complete germination 
as per the method of Heeg et al. (2012).   
 
2.2.12 Statistical Analysis 
For bactericidal testing, Log10 changes in viable bacterial numbers, compared to untreated 
controls was determined.  The equation Log Reduction LR = Log10 (Ncontrol) – Log10 (Ntreated) 
was used where Ncontrol is total recovery of untreated bacteria and Ntreated is total recovery of 
31 
treated bacteria.  Data was imported to Graphpad Prism 6.01 and charts constructed.  
Statistical analysis was completed using SPSS v22.   
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2.3 Results  
2.3.1 Direct Bactericidal Assessment of GS5  
We firstly wished to determine if GS5 was effective against bacteria in solution, prior to 
surface testing.  We hypothesised that a solution of GS5 at working concentration would 
exhibit a bactericidal effect against a suspension of bacteria.  The direct antibacterial effects 
of GS5 against S. aureus ATCC43300 was assessed using a suspension assay.  S. aureus 
ATCC43300 was challenged with increasing concentrations of GS5 to quantify bactericidal 
activity.  GS5 exhibited bactericidal actions at all concentrations after 5 min contact time 
(0.25% = 4.96 Log10 reduction; 0.5% = 5.6 Log10 reduction; 1% = 6 Log10 reduction (complete 
kill) (Figure 2.3).  Subsequent testing was completed at 5% as per manufacturer’s 
instructions.   
33 
 
Figure 2.3 – Staphylococcus aureus ATCC43300 survival following suspension test using GS5.  ~2×106 
CFU/mL of S. aureus ATCC43300 was challenged with increasing concentrations of GS5.  Data 
represents mean +/- SD of three independent experiments.  Statistical analysis by independent T-tests 
versus Untreated (0%) controls (*=p<0.05).   
 
2.3.2 Growth Calibration  
For each antimicrobial testing protocol it was important to accurately and precisely apply a 
pre-defined number of bacterial to test surfaces.  Therefore, a growth calibration to 
determine relationship between D600nm to CFU/mL was completed.  Figure 2.4 and Figure 2.5 
show the growth calibration curves for Gram negative and Gram positive bacteria 
respectively; results are summarised in Table 2.2.  This calibration was verified for each 
antimicrobial test by determining the CFU/mL of the bacterial suspension used in these tests, 
i.e. bacterial suspension applied to untreated surfaces and treated surfaces.
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Figure 2.4 – Growth calibration curves for Gram negative model HAI bacteria.  Graphs represent D600nm to CFU/mL relationship for each bacterium.  Data represents 
mean +/- SD of three independent experiments.  
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Figure 2.5 – Growth calibration curves for Gram positive model HAI bacteria.  Graphs represent D600nm to CFU/mL relationship for each bacterium.  Data represents 
mean +/- SD of three independent experiments. 
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Table 2.2 – Growth calibration to determine optical density (at 600nm) to CFU/mL relationship for 
model healthcare acquired infection bacteria.   
Bacteria y intercept  D600nm =2×108 
CFU/mL 
Acinetobacter baumannii DSM30008 y = 1.674e+009*x - 2.968e+007 0.12 
Burkholderia multivorans DSM13243 y = 1.328e+009*x - 4.340e+007 0.16 
Enterococcus faecalis DSM12956 y = 1.735e+009*x - 1.480e+008 0.13 
Escherichia coli ATCC25922 y = 1.918e+009*x - 1.102e+008 0.11 
Klebsiella pneumoniae DSM16358 y = 1.066e+009*x - 5.365e+007 0.20 
Mycobacterium smegmatis DSM43469 y = 6.166e+008*x - 0.0 0.32 
Pseudomonas aeruginosa DSM3227 y = 1.745e+009*x - 0.0 0.11 
Staphylococcus aureus (MRSA) 
ATCC43300 y = 3.772e+008*x + 2.830e+007 0.49 
Staphylococcus aureus (non-MRSA) 
DSM20231 y = 1.464e+008*x + 9.160e+006 1.29 
Staphylococcus epidermidis DSM28319 y = 2.662e+008*x - 8.339e+006 0.78 
 
2.3.3 Residual Activity of Surface Disinfectants 
GS5 is reported to form covalent bonds with surfaces, thereby leaving a nanoscale 
antimicrobial coating which kills microbes that encounter that surface. This, it is claimed, 
makes GS5 a more effective product due to its residual antimicrobial activity compared to 
other disinfectants.  We designed an experiment to test this hypothesis by determining the 
residual antimicrobial effect of GS5, Actichlor and Distel.  The bactericidal activity of the 
three surface disinfectant agents was tested against S. aureus ATCC43300 on 316l Steel 
(Aalco, UK) and residual activity was assessed over 15 days at 3 day intervals.  All three 
products exhibit bactericidal activity on day 0 (Actichlor = 3.75 Log10 reduction; Distel = 0.54 
Log10reduction; GS5 = 1.16 Log10 reduction).  Following subsequent re-challenge of treated 
surfaces with S. aureus ATCC43300 only GS5 showed significant residual bactericidal activity, 
which was evident for a total of 6 days (Day 3 GS5 =0.53 Log10 reduction; Day 6 GS5 = 0.26 
Log10 reduction; Figure 2.6).  For subsequent testing of the GS5 product, the maximum effect 
time point (day 0) was used.  
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Figure 2.6 – Comparison of residual antimicrobial effects of GS5, Actichlor and Distel on steel surface 
loaded with Staphylococcus aureus ATCC43300.  GS5 exhibited prolonged antibacterial activity (6 
days) whereas Actichlor and Distel showed no antibacterial activity after day 0.   
Results are representative of three independent experiments (n=3; mean+/- SD).  Statistical analysis 
using One way ANOVA and Dunnett’s T-test versus Untreated control (*=p<0.05, **=p<0.005, 
***=p<0.001).  ▪ = Goldshield; ● = Untreated control; ○ = Actichlor; □ = Distel.   
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2.3.4 GS5 Bactericidal Surface Testing 
Baxa et al. (2011) reported that GS5 exhibited variable effects against different bacterial 
species.  We therefore tested GS5 against a range of healthcare acquired infection 
microorganisms on 316l Steel or Formica to determine bactericidal effect.  As hypothesised, 
GS5 treated surfaces did exhibit a bactericidal effect against all ten tested microorganisms, 
and this effect was observed on both Formica and steel.  The largest bactericidal effect was 
observed with Staphylococci strains where a >1 Log10 reduction was observed on 316l Steel 
(S. aureus ATCC43300 = 1.21 Log10 reduction; S. epidermidis DSM28319 = 1.06 
Log10reduction) (Table 2.3).  On Formica, however, the GS5 product exhibited a lower 
bactericidal effect (<0.5 = Log10reduction) against both Staphylococcus organisms.  The 
average Log10 reduction on steel surfaces for all bacteria tested was 0.6 Log10reduction, 
whereas the average reduction on Formica was 0.45 Log10 reduction.   
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Table 2.3 – Log10 reductions obtained on GS5 treated surfaces challenged with a variety of microbes.   
Organism Surface Log10 Untreated ± 
SD 
Log10 Treated ± 
SD 
Log10 
change  
Acinetobacter  
baumannii DSM30008 
Steel 4.82 ±0.36 4.49 ±0.62 0.33* 
Formica 4.23 ±0.04 3.67 ±0.29 0.56* 
Burkholderia multivorans 
DSM13243 
Steel 3.89 ±0.14 3.61 ±0.17 0.28** 
Formica 3.93 ±0.05 3.40 ±0.24 0.53* 
Enterococcus faecalis 
DSM12956 
Steel 5.26 ±0.3 4.79 ±0.08 0.47 
Formica 5.15 ±0.13 4.86 ±0.03 0.29 
Escherichia coli 
ATCC25922 
Steel 5.57±0.28 5.32 ±0.33 0.25 
Formica 5.54 ±0.09 5.23 ±0.02 0.31** 
Klebsiella pneumoniae 
DSM16358 
Steel 4.28±0.27 3.53 ±0.33 0.75* 
Formica 3.93 ±0.05 3.40 ±0.24 0.53** 
Mycobacterium  
smegmatis DSM43469 
Steel 4.15 ±0.22 3.46 ±0.45 0.69* 
Formica 5.83 ±0.43 5.15 ±0.44 0.68 
Pseudomonas aeruginosa 
DSM3227 
Steel 5.09±0.04 4.66±0.29 0.43* 
Formica 5.15±0.1 4.63±0.12 0.52* 
Staphylococcus aureus 
(MRSA) ATCC43300 
Steel 4.20 ±0.13 2.96 ±0.58 1.24** 
Formica 5.00 ±0.03 4.68 ±0.08 0.32** 
Staphylococcus aureus 
(non-MRSA) DSM20231 
Steel 4.13±0.22 3.03±0.27 1.1* 
Formica 5.02±0.23 3.94±0.35 1.08 
Staphylococcus 
epidermidis DSM28319 
Steel 3.95 ±0.04 2.88 ±0.05 1.07* 
Formica 5.23 ±0.19 4.94 ±0.25 0.29* 
Results are representative of three independent experiments (n=3; mean+/- SD).  p value calculated 
using T-Test (*=p<0.05, **=p<0.005, ***=p<0.001).   
 
2.3.5 Effect of GS5 on Bacterial Biofilm Formation 
Walker et al., 2014 have demonstrated that biofilm contamination can contribute 
significantly to outbreaks of healthcare acquired infections.  Given the efficacy of GS5 against 
a range of HAI microbes, we hypothesised that a GS5-treated surface would impede the 
development of bacterial biofilms.  P. aeruginosa is a well characterised biofilm former 
(Webb et al., 2003), and therefore we pre-treated plastic microtitre plate surfaces with GS5 
and assessed the development of P. aeruginosa DSM3227 biofilms. The crystal violet staining 
method provides a quantitative measure of biofilm development/biomass and somewhat 
unexpectedly our data revealed that GS5 did not appear to inhibit the development of P. 
aeruginosa DSM3227 biofilm in plastic microtiter plates (Figure 2.7).  Having observed that 
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P. aeruginosa DSM3227 biofilm development was apparently unaffected, we assessed 
bacterial viability within the biofilms using the well-established BacLight staining method.  
This analysis suggested that a proportion of the bacterial cells were damaged or rendered 
non-viable when grown on GS5 treated surfaces, but that, critically, a sufficient number of 
viable/undamaged cells remained (Figure 2.8) which, we hypothesise are responsible for 
subsequent biofilm development. 
 
Figure 2.7 – Biofilm development following pre-treatment with GS5. Pseudomonas aeruginosa 
DSM3227 biofilm biomass was assessed by crystal violet staining at various time points and data 
presented represents mean +/- SD of three independent experiments.  Statistical analysis by 
independent T-tests versus Untreated controls (*=p<0.05).  Grey columns representative of pre-
treated samples; black bars representative of untreated controls.  
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Figure 2.8 – BacLight staining of P. aeruginosa DSM3227 biofilm at 24 h and 48 h following pre-treatment with GS5.  Live cells appear green and dead/damaged 
cells appear red.  Images A and B show development of extensive biofilm on untreated surfaces.  Image C shows biofilm development on GS5 treated surface with 
a greater proportion of dead/damaged cells.  Image D shows GS5 treated surface biofilm at 48h: biofilm development and cell viability is similar to the untreated 
control.  Images were obtained ×100 magnification (oil immersion) on a Nikon ECLIPSE E400 (Nikon) microscope utilising a dual-band emission filter (450-
490nm/510-560nm) and NIS-Elements BR (Nikon) software; composite (red/green) images generated using ImageJ software.  Scale bar = 10 µm.  
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2.3.6 Sporicidal activity of GS48 and GS48-55 
GS48 and GS48-55 sporicidal products were tested for sporicidal activity against C. difficile 
strain 630 spores (Figure 2.9).  Both agents exhibited sporicidal activity and we observed a 
marked reduction (>4 Log10) in viable C. difficile strain 630 spores.  A time-dependant 
sporicidal effect was observed with both GS48 and GS48-55 products with 4-5 Log10 
reduction of spores following 8 h exposure to the wet GS product.  An exposure time of 8-12 
h was necessary for complete spore kill.  We noted that GS48-55 exhibited a quicker kill-rate 
than the original GS48 product. 
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Figure 2.9 – Effect GS48 and GS48-55 sporicidal agents against Clostridium difficile strain 630 spores.  
Data presented is mean+/- SD of three independent experiments.  Statistical analysis by One way 
ANOVA and Dunnet T-tests versus Untreated (*=p<0.05, **=p<0.005, ***=p<0.001).  ● = Untreated 
control; ▪ = GS48; □ = GS48-55.   
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2.4 Conclusion  
Only a single published report exists (Baxa et al., 2011) which details the effects of GS5 used 
as a surface biocide.  GS5 is reported to exert its antimicrobial effect via bonding of the silane 
end of the molecule to surfaces, following which microbes are drawn onto the hydrocarbon 
chain.  The resultant puncturing of cell membranes and denaturation of proteins is proposed 
as the cause of cell death (Baxa et al., 2011; Perez et al., 2015). As a covalent bond is formed 
with the surface it is hypothesised that this mode of action is prolonged creating a 
‘bactericidal surface’. 
 
2.4.1 GS5 as a Long Lasting Surface Disinfectant 
The residual activity of GS5 exhibited bactericidal activity for 6 days (0.26 Log10 reduction) 
whereas the other surface disinfectants tested showed no activity beyond day 0 (Figure 2.6). 
In comparison with previous residual testing of the GS5 product (Baxa et al, 2011), which 
was completed on fabric swatches rather than on hard surfaces, we observed that residual 
antimicrobial activity of GS5 was lower (6 days rather than 14 days). However, the residual 
antibacterial effect decreased over time to a <1 Log10 reduction in bacterial numbers, 
suggesting that GS5 would need regular reapplication and would not be sufficient as a 
surface disinfectant alone. 
 
GS5 treated surfaces exhibited bactericidal activity which varied in effectiveness between 
surface type and bacterial species. Thus, bacterial species challenged, in addition to surface 
type/properties, appears to have a significant influence on the performance of the GS5 
product. Surface hydrophobicity, charge and roughness have all been reported as important 
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with respect to performance of biocides (Beggs et al., 2015).  Indeed, variations in the 
response of bacterial species to disinfectants is evident in the literature with disparate Log10 
reductions and widely varying minimum inhibitory concentrations (MICs); biocidal resistance 
is also evident (Baxa et al., 2011; Otter et al., 2015).  GS5 is said to not induce resistance in 
microorganisms as a result of its physical mode of action, reported as membrane disruption 
and protein denaturation.  We noted differences between the results of our current work 
and data reported by Baxa et al. (2011) who also tested S. aureus, E. coli and P. aeruginosa 
on steel and Formica. The work of Baxa et al. (2011) suggested that GS5 had greater efficacy 
against E. coli and P. aeruginosa, however this observation could be a result of differing 
surface properties across different types of Steel and Formica used.  However, like Baxa et 
al. (2011), we have shown that the performance of GS5 against different bacterial species 
varies considerably, which indicates that the specific type of microbial contaminant will be 
of greater influence on the effectiveness of GS5, than the actual surface on which it is used. 
 
Methods to assess GS technology coating capabilities were used, such as contact surface 
angle measurements, bromophenol blue indicator and scanning electron microscopy 
however results proved inconclusive.  However the antimicrobial activity of coated surfaces 
compared to control surfaces strongly indicates successful GS coating.   
 
2.4.2 GS5 Use for Prevention of Biofilm Formation 
Experiments in which plastic surfaces were pre-treated for 10 min with GS5 showed that 
there was no significant inhibitory effect against P. aeruginosa biofilm formation. It is well 
documented that biofilms exhibit increased resistance to antimicrobials and disinfectants, 
mainly due to the inability of these molecules to penetrate the biofilm (Otter et al., 2015; 
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Devlin-Mullin et al., 2017).  Given that the GS5-treated plate surfaces would be expected to 
possess antimicrobial activity, we then considered the viability of cells within developing 
biofilms. Using BacLight, we observed an initial apparent bactericidal effect on P. aeruginosa 
DSM3227 cells as evidenced by a reduction in biofilm coverage and increased numbers of 
red stained, damaged, cells at 24 h.  However, this did not result in reduced biofilm formation 
as measured by crystal violet staining, and 48 h samples showed a well-developed biofilm 
containing viable cells, similar to that observed in the untreated control.  It is likely, 
therefore, that residual viable cells maintain the ability to form biofilm and we hypothesise 
that the cells that are initially damaged by GS5 could actually promote biofilm formation: it 
has been suggested that dead bacterial cell constituents could comprise a key component of 
the biofilm or indeed even enhance adhesion and stability of cells, thereby allowing biofilm 
development (Bayles, 2007).  The data assessing the quantitative and qualitative effects of 
GS5 on P. aeruginosa biofilm suggest that GS5 treatment will not significantly inhibit biofilm 
formation. 
 
2.4.3 GS48 and GS48-55 Sporicidal Activity  
Both GS48 and GS48-55 products exhibited considerable sporicidal activity when spores 
were suspended in the product, with GS48-55 having a quicker kill rate.  Given that 3% 
hydrogen peroxide has been shown to be sporicidal against C. difficile spores (Lawley et al., 
2010) this is unsurprising as the GS48-55 contains a higher level of hydrogen peroxide than 
GS48.  A number of papers have reported use of Hydrogen peroxide vapour (HPV) systems 
for de-contamination of hospital rooms with specific interest in the efficacy of these against 
C. difficile spores (Boyce et al., 2008; Shapey et al., 2008; Passaretti et al., 2013).  While many 
of these reports have shown very effective reduction of both contamination and infection 
rates, there is however evidence of rapid re-contamination of environments post de-
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contamination (Hardy et al., 2007; Aldeyab et al., 2009).  Whilst the GS48 and GS48-55 
sporicidal agents are, in our hands, highly sporicidal in vitro, the efficacy of these in a real 
clinical setting has yet to be demonstrated.   
 
 
2.4.4 GS Technology use as a Hospital Disinfectant  
Current NHS Infection control practices require that when choosing disinfectants, a 4–5 Log10 
reduction is required in viable vegetative bacterial cells within a contact/drying time of 10 
min, in addition to a spore reduction of 3 Log10 within the same period.  When tested directly 
on a suspension of bacterial cells, GS5 achieved a more than 4 Log10 reduction with a 5 min 
contact time however the residual surface active antimicrobial activity of GS5 was much less, 
at approximately 1 Log10 reduction in bacterial numbers. The surface protective effect of GS5 
remained for a further 3–6 days without reapplication of the product, however we noted a 
diminution of the measured Log10 reductions over time to a level which was much lower than 
that required for use in infection control.  Bacteria can form biofilm on surfaces allowing 
prolonged survival and increased resistance to biocides. Considering the GS5 mode of action 
we hypothesised a regime where GS5 could be utilised to prevent biofilm formation on 
surfaces subsequently reducing risk of infection. However GS5 has been shown to possess 
limited anti-biofilm properties as biofilm production is not impeded on GS5 coated surfaces. 
 
Within the NHS, certain disinfectants (for example, DifficilS) routinely achieve 4 Log10 
reductions in both vegetative cell and spore numbers within 3–5 min however control of 
infection is only achievable in practice by using these products in intensive cleaning up to 
twice daily in a rolling programme of disinfection. Thus, on the basis of the data generated 
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in this work, it appears unlikely, despite modest reductions in bacterial cell viability and 
evidence for a short lived residual effect, that GS5 would replace current infection control 
products such as DifficilS or Actichlor in reducing the transmission of HAI pathogens within 
hospitals and care settings. 
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Chapter 3 
Assessment of the reservoir potential of healthcare workers’ 
uniforms as a source of antibiotic resistant pathogenic 
bacteria 
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`3.1 Introduction 
3.1.1 Prevalence of Healthcare Acquired Infections in Healthcare 
Settings  
HAIs are infections that occur in healthcare settings at least two days after admittance to 
hospital (Cardoso et al., 2014).  It is estimated that HAIs are responsible for 4.5 million 
infections per year in the EU (European Centre for Disease Prevention and Control, 2018).  
HAIs occur in healthcare settings for a variety of reasons: there are multiple factors that are 
unique to healthcare settings (for example, hospitals) which encourage the emergence, 
prevalence and spread of HAIs.  One such factor is increased antibiotic resistance, as over-
use, mis-use and over-dependence on antibiotics in hospitals has resulted in the emergence 
of highly virulent, difficult to treat, multi-drug resistant organisms and their persistence in 
hospitals (Cosgrove, 2006).  HAIs are predominantly opportunistic pathogens therefore the 
increased vulnerability of patients in hospitals is a contributing factor for increased 
prevalence and spread of HAIs.  However, it is not just simply these factors individually that 
can cause a problem but a combination, that increases prevalence of HAIs.  For example use 
of antibiotics can increase vulnerability of patients to opportunistic organisms.  Use of 
antibiotics can result in suppression of the normal microbiota reducing protectiveness 
against colonisation by opportunistic pathogens, and this is especially true when broad 
spectrum antibiotics are used.  As these increase the risk of patient’s developing C. difficile 
infection (CDI) – a common HAI (Bartlett, 2002; Jernberg et al., 2010, Deshpande et al., 2017).   
 
3.1.2 Contamination of Healthcare Settings  
As discussed in chapter 1, contamination of the healthcare setting is a source of spread of 
bacteria onto patients (Mitchell et al., 2013; Dancer, 2014, 2016; Lee et al., 2018).  The most 
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problematic areas tend to be so called “high-touch” points with examples including bed rails, 
door handles, table top surfaces, bed clothing (linen and mattress), staff, and staff uniforms.  
As a consequence, the CDC guidelines specifically stipulate that “close attention be paid to 
cleaning and disinfecting high touch surfaces in patient care areas” (Carling et al., 2008).  
When these inanimate surfaces become contaminated with infectious agents they then act 
as a source for spread of bacteria to patients both directly and indirectly.  Bacteria can be 
contacted by patients (direct transmission) or staff who thus indirectly spread bacteria to 
patients (via hands, uniforms or both) – ultimately direct and indirect spread could 
potentially result in infection of patients resulting in increased infection rates and associated 
costs.  The transmission routes are summarised in Figure 3.1.   
 
Figure 3.1 – Direct and indirect transmission routes for dissemination of Healthcare acquired 
infections from contaminated surfaces in healthcare settings onto patients (Kramer et al., 2006).     
Contaminated 
inanimate 
surface 
Hands of 
healthcare 
worker 
Susceptible 
patient 
Compliance in hand 
hygiene: ~50% 
Direct transmission 
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3.1.3 Contamination of Healthcare Workers Uniforms  
Healthcare workers’ uniforms can act as vectors in the indirect transmission of bacteria to 
patients (Figure 3.1) and in fact contamination of workers’ hands often results in 
contamination of uniforms and vice versa (Munoz-Price et al., 2012).  It is well documented 
that healthcare workers’ uniforms are contaminated with bacteria which could potentially 
act as an infectious agent toward patients (Abu Radwan and Ahmad, 2017; Gaspard et al., 
2009).   
 
For example, in an investigation to identify types of microorganisms present on a variety of 
healthcare professionals’ uniforms, 305 samples were tested and the investigators identified 
24 types of microorganisms including S. aureus, S. epidermidis, Bacillus spp., and 
Acinetobacter spp., amongst others (Abu Radwan and Ahmad, 2017).  In a study assessing 
MRSA contamination of uniform pockets in a long-term care facility, high levels of MRSA 
contamination were observed.  In standard non-controlled (no changes to normal practice) 
uniforms, 60% of pockets were contaminated with MRSA.  Subsequently, a range of test 
groups were set up, each with varying instructions for prevention of contamination 
(examples of instructions included wearing of aprons to zero use of pockets).  The authors 
found that only the groups with the strictest instructions – meaning disposable aprons were 
worn, hand hygiene instructions were followed and zero pocket contents – and those that 
demonstrated complete compliance with these instructions had 0% contamination (Gaspard 
et al., 2009).  This investigation elegantly highlighted how easily the hospital environment 
results in uniforms becoming contaminated.   
 
 
52 
3.1.4 Use of Antimicrobial Healthcare Workers Uniforms 
Due to the high levels of uniform contamination a number of interventions have been tested 
with the aim of reducing/removing this bioburden.  Examples of such interventions include 
the use of antimicrobial fabrics, or specialised laundry conditions.  Researchers at Denver 
Health Hospital, Colorado, USA assessed 105 workers’ uniforms with the sample groups 
being made up of 5 types of hospital workers and 3 different fabric types (standard uniforms 
and type A and type B ‘antimicrobial’ uniforms).  These were assessed for bioburden after an 
8 h working day.  All the uniforms assessed were contaminated with bacteria and no 
significant differences were seen between control groups and furthermore antimicrobial 
fabric groups (Burden et al., 2013).  Another study conducted at Antrim Area Hospital 
assessed the effects of antimicrobial impregnated fabrics and in this work all uniforms tested 
demonstrated bacterial contamination.  Again there was no difference in contamination 
levels reported between standard/control uniforms and “antimicrobial” impregnated 
uniforms.  (Johnston, 2012).   
 
3.1.5 Spread of Antibiotic Resistance by Contamination of 
Healthcare Workers Uniforms 
Contamination of healthcare workers’ uniforms poses a significant risk to patients in 
healthcare settings as this contamination has been shown to affect infection rates (Gaspard 
et al., 2009; Sanon, 2012; Burden et al., 2013; Abu Radwan and Ahmad, 2017).  However, as 
contamination of uniforms contributes to the spread of HAIs (Johnston, 2012; Deshpande et 
al., 2017) this contamination subsequently promotes the survival and resistance of these 
microorganisms within the healthcare environment (Kramer et al., 2006b; Dancer, 2014).  As 
these microorganisms continue to persist in the healthcare environment there is the 
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potential for development of increased numbers of antibiotic resistant strains (O’Neill, 
2016).  Such microorganisms could already be highly pathogenic multi-drug/antibiotic 
resistant strains, or they could adapt – for example by acquiring additional genetic material 
– to become multi-drug resistant whilst persisting in the hospital environment (Weinstein, 
2001).  In conclusion the survival/spread of HAIs via healthcare workers uniforms is a concern 
for two major reasons, [1] increased infection risk and, [2] increased antibiotic resistance.   
 
3.1.6 Aims and Hypothesis  
The main aim of this chapter was to robustly assess bacterial contamination of healthcare 
workers’ uniforms at a local hospital.  Thus, the first aim of this work was to develop a highly 
sensitive detection, recovery and enumeration protocol for recovery of bacteria from fabric 
surfaces.  This method was then implemented to enumerate S. aureus and Enterococcus spp. 
contamination on pre-shift and post-shift healthcare workers’ uniforms at Antrim Area 
Hospital, Northern Health and Social Care Trust.  A biobank was created from the bacteria 
isolated from uniforms and these bacteria were assessed for antibiotic 
resistance/susceptibility profiles against commonly used antibiotics.  It was hypothesised 
that pre-shift healthcare workers uniforms would have little or no S. aureus or Enterococcus 
spp. contamination, and that both S. aureus and Enterococcus spp. contamination levels 
would be increased significantly on post-shift healthcare workers’ uniforms.  It was also 
hypothesised that multi-drug resistant isolates would be identified in antibiotic susceptibility 
testing.   
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3.2 Materials and Methods  
3.2.1 Study Overview  
A pilot study was conducted at Antrim Area Hospital, Northern Health and Social Care Trust 
(NHSCT).  The aim of the study was to determine S. aureus and Enterococcus spp. 
contamination levels on pre-shift and post-shift healthcare workers uniforms in a 
comparative assessment.  Post-shift uniform contamination could be indicative of 
environmental contamination burdening healthcare workers uniforms.  In addition we 
assessed was the antibiotic sensitivity profiles of randomly selected S. aureus and 
Enterococcus spp. isolated from post-shift uniforms.   
 
A total of 100 pre-shift and 100 post-shift uniforms were assessed.  The domestic services 
team at Antrim Area Hospital provides freshly laundered uniforms for staff (pre-shift) and 
collects uniforms to be laundered (post shift).  Uniforms were sampled for microbial 
contamination at the pocket, abdominal area and neck equalling a total of 600 samples.   
 
This work was funded by an NHS discretionary award secured by Jason Murray (Ulster 
University), Dr Nigel Ternan (Ulster University) and Prof Michael Scott (NHSCT).  No ethical 
approval was required as no human or animal participants were involved.   
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3.2.2 Chemicals, glassware and media 
All glassware was cleaned/sterilised by soaking overnight in 1% Virkon (Antec, UK) and steam 
sterilised in an autoclave prior to use.  All culture media was prepared as per the 
manufacturer’s instructions.  For agar growth of presumptive S. aureus CHROMagarTM Staph 
aureus [CSA hereinafter] (Bioconnections, UK) was used.  CSA was prepared by suspending 
in deionised water (82.5 g/L), bringing to boil on a Bibby HB502 hot plate (Bibby Scientific, 
UK) with stirring followed by dispensing into 9 cm petri dishes (SLS, UK).    Slanetz and Bartley 
agar was prepared by suspending in deionised water (42 g/L), bringing to boil and dispensing 
into 9 cm petri dishes.  All Slanetz and Bartley plates were incubated at 45°C with colonies 
enumerated daily for a total of 5 days.  For Total Viable Counts (TVC) Tryptone Soya 
Broth/Agar (TSB/TSA) (Oxoid, UK).  TSB was prepared by suspension in deionised water (30 
g/L) and steam sterilised in an autoclave.  TSA was prepared by suspension in deionised water 
(40 g/L) and steam sterilised in an autoclave prior to dispensing in 9 cm petri dishes.  All TVC 
cultures were incubated at 37 °C.  For broth growth of presumptive S. aureus TSB plus 7.5% 
(w/v) sodium chloride (Sigma, UK) was used (Goodwin and Pobuda, 2011).  TSB plus 7.5% 
sodium chloride was prepared by suspension in deionised water (30 g/L), addition of 7.5% 
sodium chloride followed by steam sterilisation in an autoclave.  Mueller-Hinton Broth/Agar 
(MHB/MHA) (Oxoid, UK) was used for biobank creation and growth in antibiotic susceptibility 
testing.  MHB was prepared by suspension in deionised water (21 g/L) and steam sterilised 
in an autoclave.  MHA was prepared by suspension in deionised water (38 g/L) and steam 
sterilised in an autoclave prior to dispensing in 9 cm petri dishes.  All MHB and MHA were 
incubated at 37 °C.  Phosphate Buffered Saline (Oxoid, UK) was prepared in deionised water 
and steam sterilised in an autoclave prior to use. 
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3.2.3 Optimisation of recovery and enumeration of bacteria 
There is considerable dispute in the literature regarding the sensitivity and accuracy of 
techniques of direct plating of samples, or sample enrichment in the recovery, isolation and 
enumeration of microorganisms from inanimate surfaces/objects (Lesmana et al., 1997; 
Mcallister et al., 2011; Liss et al., 2013).  Moreover, direct plating versus pre-enrichment is 
particularly important in recovery from inanimate surfaces such as healthcare workers’ 
uniforms (Landers, Hoet and Wittum, 2010) as it could be argued a pre-enrichement step 
would add bias (especially true for enumeration) and selection.  If the researcher is wishing 
to detect a pathogen in a human or food sample, then it is suggested that a pre-enrichment 
step is more applicable in order to increase sensitivity of detection for low numbers (O’Brien 
et al., 2005; Liss et al., 2013).  However if the user wishes to accurately enumerate 
microorganism(s) in a sample, then direct plating is more suitable (Landers et al., 2010) as 
pre-enrichment will result in exaggerated counts which could be problematic in comparative 
studies.  In this work, we decided to test both the direct plating approach and the pre-
enrichment approach.  One pre-shift uniform and one post-shift uniform were swabbed as 
described in the ‘Uniform sampling’ section.  Briefly, from the 5 mL swab samples 0.1 mL was 
directly plated onto Tryptone Soya Agar (TSA) (Oxoid, UK) to determine total viable count 
(TVC) without pre-enrichment; and onto CSA to determine S. aureus count without pre-
enrichment.  All samples were plated out in duplicate, incubated at 37 °C overnight and 
colonies enumerated.  In addition, 50 mL of Tryptone Soya Broth (TSB) (Oxoid, UK) was 
inoculated with a 50 L (1% v/v) aliquot of the swab sample to determine TVC with 
enrichment.  Similarly a 1% inoculation was completed into 50 mL TSB plus 7.5% sodium 
chloride (Goodwin and Pobuda, 2011) to determine S. aureus count with pre-enrichment.  
Both inoculations were incubated at 37 °C for 12 h followed by serial dilution in PBS and 
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plating onto TSA and CSA as described above.  All plates were completed in duplicate, 
incubated at 37 °C overnight and colonies enumerated.   
 
3.2.4 Uniform collection 
100 pre-shift uniforms and 100 post-shift uniforms were directly collected from domestic 
services team at Antrim Area Hospital, NHSCT.  Uniforms were collected at 9 am each 
morning, corresponding to the time at which daily collection of post-shift uniforms and daily 
allocation of pre-shift uniforms occurred (Table 3.4).  Uniforms were individually packaged 
in UV-treated collection bags and transported to Ulster University, Coleraine (travel time = 
approximately 1 h).   
 
3.2.5 Uniform sampling 
Uniforms were sampled for recovery of microorganisms from their surface; individual 
samples were collected from the abdomen, neckline and pocket of the uniforms (200 
uniforms × 3 sampling sites = 600 samples).  Swabs were pre-moistened in sterile PBS (Oxoid, 
UK) followed by vortex recovery of bacteria as these conditions have been shown to result 
in higher sensitivity for bacterial recovery compared to other methods (Moore and Griffith, 
2002; Hodges et al., 2006, 2010; Landers et al., 2010).  Pre-moistened cotton swabs (Copan, 
UK) were used to swab each area by motioning the swab in a 15 up/down and 15 left/right 
motion over a 10 × 10 cm area of each sample site.  Swabs were then transferred to 5 mL 
sterile PBS and subject to vortex for 1 min.  Each sample was clearly labelled with uniform 
number and sample site.  From each sample a serial dilution range was completed and each 
dilution spread plated in duplicate (0.1 mL spread plates) onto CSA and Slanetz and Bartley 
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agar.  CSA plates were incubated at 37 °C and Slanetz and Bartley plates were incubated at 
45 °C followed by colony counting for enumeration.   
 
3.2.6 Bioburden analysis 
Following enumeration, colony forming unit (CFU) values were obtained for each sample 
point (CFU = colony count × 1/dilution factor × 1/volume plated in mL).  Values were collated 
and an average count calculated for each sample area for pre-shift and post-shift uniforms.  
For comparison purposes, the log change in bacterial numbers between pre-shift and post-
shift uniforms was determined (Log Reduction LR = log10 (Npost shift)/log10 (Npre-shift)).  Data was 
imported to Graphpad Prism 6.01 and charts constructed.  Statistical analysis (Wilcoxon test) 
was completed using SPSS v22. 
 
3.2.7 Creation of Biobank 
As we wished to determine antibiotic susceptibility profiles,  random selection of colonies 
deemed positive for S. aureus (pink/mauve on CSA) and colonies deemed positive for 
Enterococcus spp. (red/maroon on Slanetz and Bartley) were selected and isolated.  Isolates 
were only selected from post-shift uniforms.  These colonies were sub-cultured onto MHA 
and incubated overnight at 37 °C.  Biomass from each isolate was transferred into cyrovials 
(Technical services consultants LTD, UK), given identification numbers and stored at -80 °C.   
 
 
 
59 
3.2.8 Antibiotic susceptibility testing using EUCAST guidelines 
All biobank isolates were subject to antibiotic susceptibility testing using the disk diffusion 
method adhering to the European Union Committee on Antimicrobial Susceptibility Testing 
(EUCAST) guidelines (http://www.eucast.org/).  These guidelines provide information on 
procedures and analysis ensuring standardisation of antibiotic testing.  Main points from the 
guidelines include use of Mueller Hinton as growth media, a growth density of 0.5 McFarland 
standard for all test cultures, antibiotic discs used at a maximum of four disks per plate and 
a series of resistant/sensitive breakpoints for a range of bacteria and specific antibiotic.  To 
determine the antibiotic susceptibility profile each isolate was recovered from -80 °C by 
placing a bead into 5 mL of fresh MHB and incubating overnight at 37 °C.  Simultaneously a 
duplicate bead was recovered onto fresh MHA and also incubated overnight at 37 °C; this 
plate was inspected following growth to ensure no contamination, i.e. single colony type on 
plate.  From the inoculated MHB a 0.2 mL aliquot was transferred into 10 mL fresh MHB and 
incubated at 37 °C.  Growth was regularly checked using a Pharmacia Biotech Novaspec II 
(Pharmacia LKB Biotechnology, Sweden) to measure attenuance at 600nm (D600nm) using 
fresh MHB as a reference.  When culture turbidity reached 0.5 McFarland standard (see 
McFarland standard section), 0.1 mL of culture was spread onto fresh MHA (4 plates per 
isolate).  A total of 4 different antibiotic discs were then applied to the spread plates using 
an antibiotic disc dispenser (Oxoid, UK).  Plates were incubated overnight (16 h) at 37 °C 
followed by measurement of zones of inhibition for each antibiotic (measuring the diameter 
of the circle surrounding each antibiotic using a ruler, measurements in mm).  Each isolate 
was tested against each antibiotic in duplicate.   
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3.2.9 Antibiotic susceptibility testing analysis 
Zone of inhibition averages were compared against a sensitive/resistant breakpoint defined 
by EUCAST (Table 3.1).  Breakpoints are specific for bacterial genus/species against specific 
antibiotics.  In some cases, however, no breakpoint is defined due to standardisation issues.  
If no breakpoint was provided the decision was made to use either the S. aureus breakpoint 
for Enterococcus spp. or vice versa; for example no breakpoint is provided for vancomycin 
against S. aureus; therefore the Enterococcus spp.-vancomycin breakpoint was used to 
determine antibiotic profile of S. aureus isolates.  An antibiogram was then created for each 
of the sub-populations (S. aureus – abdomen, neck and pocket and, Enterococcus spp. – 
abdomen, neck and pocket).  Bionumerics software (Applied Maths) was subsequently used 
to assess the diversity of antibiotic resistant profiles, (this analysis is reported in Chapter 4).  
Multi-drug resistance (MDR) was also determined.  Collectively, EUCAST, CDC and ECDC 
define MDR as “acquired non-susceptibility to at least one agent in three or more 
antimicrobial categories” (Magiorakos et al., 2012).  The antibiotic profiles of S. aureus 
isolates were assessed to determine MDR or non-MDR classification.  MDR profiles were not 
assessed for Enterococcus spp. isolates as official EUCAST sensitive/resistant breakpoints are 
only available for two of the antibiotics tested.   
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Table 3.1 – Antibiotics used in testing biobank isolates using European Union Committee for Antibiotic Susceptibility Testing (EUCAST).   
 
Antibiotic Information 
Breakpoints (mm) 
Staphylococcus aureus Enterococcus spp. 
 Code Concentration (as defined by 
EUCAST) 
Sensitive Intermediate Resistant Sensitive Intermediate Resistant 
Cefoxitin FOX 30 µg/mL ≥22  <22 ≥22*  <22* 
Vancomycin VA 5 µg/mL ≥12*  <12* ≥12  <12 
Penicillin G P 10 units ≥26  <26 ≥26*  <26* 
Erythromycin E 15 µg/mL ≥21 18-20.9 <18 ≥21* 18.1-20.9* <18* 
Gentamicin CN 10 µg/mL ≥18  <18 ≥18*  <18* 
Fusidic acid FD 10 µg/mL ≥24  <24 ≥24*  <24* 
Clindamycin DA 2 µg/mL ≥22 19-21.9 <19 ≥22* 19-21.9* <19* 
Ciprofloxacin CIP 5 µg/mL ≥20  <20 ≥15  <15 
Table contents include antibiotic information including concentration of antibiotic disks; these concentrations were as recommended in the EUCAST guidelines.  
Also included is published EUCAST sensitive/resistant breakpoints (available: http://www.eucast.org/clinical_breakpoints/) (EUCAST 2017). 
*=no breakpoint published by EUCAST; breakpoint for other bacteria used, e.g. vancomycin breakpoint for Enterococcus spp. used for S. aureus.   
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3.2.10  McFarland standard 
Originally described in 1907, the McFarland standard is a measurement of opacity indirectly 
representing bacterial numbers that is recommended for standardisation of microbiological 
testing (McFarland, 1907).  However, more recently this method has been shown to result in 
large variation in microbial concentration between samples (Zapata and Ramirez-Arcos, 
2015).  Therefore, in an effort to standardise bacterial growth within this work, a 0.5 
McFarland standard was prepared by mixing 0.6 mL of 1% (v/v) barium chloride (BaCl2) with 
99.4 mL of 1% (v/v) sulphuric acid (H2SO4).  The attenuance of this was measured at 600 nm, 
with a value of 0.130 recorded against deionised water as a reference.  Subsequently, for 
EUCAST testing, all isolates were grown to D600nm = 0.130 before being applied to plates.  
 
3.2.11  Antibiotics  
A total of eight antibiotics were tested against the complete set of isolates in the biobank 
(Table 3.2).  Antibiotics were chosen based on the recommendation of Dr David Farren 
(Consultant and Clinical Lead, Medical Microbiology, Northern Health and Social Care Trust) 
(Personal communication; Farren, 2016).  We tested isolates against Cefoxitin (marker for 
Oxacillin and Methicillin resistance), Vancomycin, Penicillin, Erythromycin, Gentamicin, 
Ciprofloxacin and Fusidic Acid.   
63 
Table 3.2 – Overview of antibiotics used in antibiotic susceptibility testing of Staphylococcus aureus 
and Enterococcus spp. isolates recovered from hospital workers’ uniforms.   
Antibiotic Class Mode of action Resistance mechanism  
Cefoxitin* β-Lactam 
(Cephamycin) 
Inhibition of synthesis of 
bacterial walls – prevents 
crosslinking of peptidoglycan  
Prevention of drug 
uptake, enzymatic 
modification and/or 
synthesis of beta-
lactamases  
Vancomycin Glycopeptide Inhibition of synthesis of 
bacterial walls – interferes 
with alanine-alanine bonds  
Natural resistance – Gram 
negatives outer 
membranes prevents drug 
uptake.  Some Gram 
positives don’t need 
alanine-alanine bonds 
Penicillin β-Lactam 
(Penicillin) 
Inhibition of synthesis of 
bacterial walls – prevents 
crosslinking of peptidoglycan 
Prevention of drug 
uptake, enzymatic 
modification and/or 
synthesis of beta-
lactamases 
Erythromycin Macrolide Inhibition of protein synthesis 
– acts on 50S ribosomal 
subunit preventing protein 
elongation   
Changes to 50S subunit to 
prevent drug binding 
and/or production of 
macrolide-digesting 
enzymes 
Gentamicin Aminoglycoside Inhibition of protein synthesis 
– binds to 30S subunit 
causing mistranslation or loss 
of translation resulting in 
abnormal proteins  
Prevention of drug uptake 
or production of drug 
degrading enzymes  
Clindamycin Lincosamide Inhibition of protein synthesis 
– binds to 50S subunit 
prevention protein 
elongation  
Structural changes to 
prevent drug binding   
Fusidic acid  Fusidane Inhibition of protein synthesis 
– inhibition of elongation 
factor G  
Alteration of drug binding 
site and/or protection of 
drug binding site  
Ciprofloxacin Fluoroquinolone Inhibition of nucleic acid 
synthesis – inhibits DNA 
gyrase needed for DNA 
replication  
Binding site mutations 
reducing drug uptake 
Information collated from Collignon and Turnidge, 1999, Chen et al., 2010 and Bauman, 2013.   
*Cefoxitin is used as a marker of methicillin and/or oxacillin resistance (U.S. Centers for Disease 
Control and Prevention, 2014).  It is used as accurate determination of methicillin/oxacillin resistance 
rather than methicillin or oxacillin, as heteroresistance can occur in presence of methicillin or oxacillin.  
Cefoxitin is also a more effective inducer of the mecA gene (MRSA indicator), and thus leads to 
increased discrimination of results in disc diffusion assays (U.S. Centers for Disease Control and 
Prevention, 2014).   
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3.2.12   Multiple Antibiotic Resistance Indexes 
The Multiple antibiotic resistant index (MAR index) is a numerical value representative of the 
proportion of tested antibiotics an isolate is resistant to (i.e. 1 = resistance to 100% of 
antibiotics tested, 0.5 = resistance to 50% of tested antibiotics; 0 = resistance to 0% of 
antibiotics tested).  Using the antibiograms produced for uniform biobank isolates a MAR 
index was calculated for each isolate.  MAR index values were calculated (a/b, where ‘a’ 
represents the number of antibiotics the isolate was resistant to, and ‘b’ the total number of 
antibiotics the isolate was tested against) for all isolates (Blasco et al., 2008).   
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3.3 Results  
3.3.1 Protocol development/optimisation – Direct plating or 
Pre-enrichment  
In order to determine the influence pre-enrichment has on enumeration of bacteria from 
uniforms in comparison with direct plating we tested one pre-shift and one post-shift 
garment using both direct plating and pre-enrichment steps before enumeration of 
microorganisms.  Figure 3.2a shows the results of the direct plating testing and Figure 3.2b 
shows the results of the pre-enrichment testing.  Table 3.3 summarises the results.   
66 
 
 
 
 
 
 
 
 
Figure 3.2 – Enumeration of total viable count and Staphylococcus aureus contamination of healthcare workers uniforms using the (A) direct plating method and 
(B) pre-enrichment method post sampling of uniforms.  Data representative of mean per 10cm2 area.  Results are indicative of three areas (neck, abdomen and 
pocket) of one pre-shift and one post-shift uniform.  Table 3.3 compares both methods.   
 
  
A – Direct plating B – Pre-enrichment 
67 
Table 3.3 – -Comparison of   Log10 changes between pre-shift and post-shift test uniforms when direct 
plating versus pre-enrichment.   
 TVC Log10 change Staphylococcus. aureus Log10 change 
Area Direct plating Pre-
enrichment 
Area Direct plating Pre-
enrichment 
Abdomen 0.74 0 Abdomen 0.12 1.88 
Neck 2.72 5.87 Neck 2.35 0 
Pocket 3.3 6.82 Pocket 1.5 4.89 
 
This proof of concept experiment showed that bacterial contamination increased on the 
post-shift uniform on abdomen, neck and pocket areas, compared to levels determined on 
the pre-shift uniform.  It is evident that the pre-moistened swab technique used is a sensitive 
recovery technique as bacteria were detected on all direct plating samples.  Results for TVC 
and S. aureus contamination for pre-enrichment samples showed some exaggerated Log10 
values.  Log10 changes on pre-enrichment samples were up to 15-fold larger for S. aureus and 
2 to 3-fold for TVC.  Direct plating showed all samples were contaminated and demonstrated 
more modest Log10 changes.  As the swabbing and direct plating recovery technique was 
sufficient to allow detection and accurate enumeration of bacteria (without potential basis 
of enrichment) these methods were used in subsequent work  
 
3.3.2 Uniform collection 
Uniforms were collected from Antrim Area Hospital, transferred to Ulster University, 
Coleraine for testing using the moistened swab, serial dilution and direct plating approach.  
Table 3.4 shows collection records for uniforms from Antrim Area Hospital.  Uniform 
collection was documented and each uniform given a corresponding number according to 
the order in which they were sampled, for example post-shift uniform 1.   
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Table 3.4 – Collection of pre-shift and post-shift uniforms from Domestic Services at Antrim Area 
Hospital.   
Date  Pre-shift Uniforms collected 
(Uniform number) 
Post-shift Uniforms collected 
(Collection group) 
3.5.16 1-5 1-5 (1) 
4.5.16 6-10 6-10 (2) 
10.5.16 11-20 11-20 (3) 
13.5.16 21-30 21-30 (4) 
17.5.16 31-40 31-40 (5) 
23.5.16 41-50 41-50 (6) 
3.6.16 51-70 * 
17.6.16 71-90 * 
20.7.16 * 51-70 (7) 
22.7.16 91-100 71-80 (8) 
28.7.16  81-100 (9) 
Total number of Uniforms  100 100 
* = Uniforms not collected on that day.  All tested uniforms were documented and numbered 
according to the order they were sampled  
 
3.3.3 Assessment of Staphylococcus aureus and Enterococcus 
spp. Bioburden of Healthcare Workers’ Uniforms 
A total of 100 pre-shift uniforms and 100 post-shift uniforms were assessed for 
contamination.  S. aureus and Enterococcus spp. were recovered and subsequently 
enumerated from the abdomen, neck and pocket areas of each uniform resulting in a total 
of 600 samples.  Pre-shift and post-shift numbers were compared to determine Log10 
changes.  Figures 3.3 and 3.4 show uniforms positive tests for S. aureus and Enterococcus 
spp. contamination on individual uniforms.  Figure 3.5, Figure 3.6, Table 3.5 and Table 3.6 
show quantitative information on levels of contamination.  The data shows an increase in 
both S. aureus and Enterococcus spp. on post-shift uniforms compared to levels detected on 
pre-shift healthcare workers uniforms.  There were only a very small number of positive pre-
shift uniforms whereas most post-shift uniforms where contaminated.  Pre-shift uniforms 
which were contaminated showed very low levels of contamination whereas there was a 
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1.89-2.84 Log10 increase on post-shift uniforms with the largest increases seen in the 
numbers of S. aureus recovered from neck area sample group.   
70 
 
Figure 3.3 – Uniforms which tested positive for Staphylococcus aureus contamination.  Numbers 
representative of 100 uniforms tested (n=100). 
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Figure 3.4 – Uniforms which tested positive for Enterococcus spp. contamination.  Numbers 
representative of 100 uniforms tested (n=100).   
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Figure 3.5 – Staphylococcus aureus contamination of pre-shift and post-shift healthcare workers 
uniforms.  Data representative of mean CFU per 100 cm2 +/- standard deviation (SD) (n=100).  
Statistical analysis using Wilcoxon test; data not sharing common subscript = p<0.005.   
Figure 3.6 – Enterococcus spp. contamination of pre-shift and post-shift healthcare workers uniforms.  
Data representative of mean CFU per 100 cm2 +/- standard deviation (SD) (n=100).  Statistical analysis 
using Wilcoxon test; data not sharing common subscript = p<0.005.   
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Table 3.5 – Colony forming units per 100 cm2 recovered from sampling sites pre and post shits, with 
Log10 changes for Staphylococcus aureus.   
Staphylococcus aureus  
Area Pre shift Post shift Log10 change  
 Mean  Standard Deviation Mean  Standard Deviation  
Neck 8.2 28.4 5721 30803 ↑2.84 
Abdomen 32.3 93.9 8616 62817 ↑2.43 
Neck 21.2 123.8 1606 5592 ↑1.89 
Value representative of CFU calculated from testing of 100 healthcare workers uniforms (n=100).   
 
Table 3.6 – Colony forming units per 100 cm2 recovered from sampling sites pre and post shits, with 
Log10 changes for Enterococcus spp.  .   
Enterococcus spp. 
Area Pre shift Post shift Log10 change  
 Mean  Standard Deviation Mean  Standard Deviation  
Neck 0 0 264.8 440.2 ↑2.42 
Abdomen 0.4 4 189.2 833.2 ↑2.67 
Neck 0.1 1.05 244.5 424.6 ↑2.28 
Value representative of CFU calculated from testing of 100 healthcare workers uniforms (n=100). 
  
3.3.4 Antibiotic susceptibility testing of Staphylococcus aureus and 
Enterococcus spp. uniform isolates 
S. aureus and Enterococcus spp. isolates randomly selected from tested post-shift uniforms 
were subject to antibiotic susceptibility testing using the EUCAST guidelines.  Isolates were 
tested against 8 antibiotics commonly used in hospital laboratories, including Cefoxitin (a 
marker for MRSA) to determine MRSA prevalence amongst the S. aureus population and 
vancomycin to determine the VRE prevalence amongst the Enterococcus spp. population.  
Figures 3.7, 3.8, 3.9, 3.10, 3.11, 3.12 show antibiograms for these isolates.  Antibiograms are 
categorised based on bacteria and the specific area of a given uniform that the bacterium 
was isolated from.  Table 3.7 and Table 3.8 show prevalence of sensitive and resistant isolates 
against each antibiotic.  MDR was only determined for S. aureus isolates and not for 
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Enterococcus spp. isolates as EUCAST provide official breakpoints for only 2 of the 8 tested 
antibiotics.  Therefore, there was not a sufficient range of antibiotics to determine MDR for 
Enterococcus spp. isolates.  However, in cases where no breakpoint was provided for either 
S. aureus or Enterococcus spp. the breakpoint for the corresponding bacteria was used to 
determine resistance or sensitivity for individual isolates.  For example, no breakpoint is 
provided for vancomycin against S. aureus; therefore the Enterococcus spp. vancomycin 
breakpoint (12mm) was used to determine that antibiotic profile of S. aureus isolates.   
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Figure 3.7 – Antibiogram for Staphylococcus aureus isolates from abdominal areas of post-shift 
uniforms.  Blue = sensitive; grey = resistant; pink = intermediate resistance; black = Multi-drug 
resistant (MDR); white = non-MDR.  *= Enterococcus spp. breakpoint used.   
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Figure 3.8 – Antibiogram for Staphylococcus aureus isolates from neck areas of post-shift uniforms.  
Blue = sensitive; grey = resistant; pink = intermediate resistance; black = Multi-drug resistant (MDR); 
white = non-MDR.  *= Enterococcus spp. breakpoint used.  
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Figure 3.9 – Antibiogram for Staphylococcus aureus isolates from pocket areas of post-shift uniforms.  
Blue = sensitive; grey = resistant; pink = intermediate resistance; black = Multi-drug resistant (MDR); 
white = non-MDR.  *= Enterococcus spp. breakpoint used.   
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Figure 3.10 – Antibiogram for Enterococcus spp. isolates from abdominal areas of post-shift uniforms.  
Blue = sensitive; grey = resistant; pink = intermediate resistance; black = Multi-drug resistant (MDR); 
white = non-MDR.  *= Staphylococcus aureus breakpoint used. 
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Figure 3.11 – Antibiogram for Enterococcus spp. isolates from neck areas of post-shift uniforms.  Blue 
= sensitive; grey = resistant; pink = intermediate resistance; black = Multi-drug resistant (MDR); white 
= non-MDR.  *= Staphylococcus aureus breakpoint used.   
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Figure 3.12 – Antibiogram for Enterococcus spp. isolates from pocket areas of post-shift uniforms.  
Blue = sensitive; grey = resistant; pink = intermediate resistance; black = Multi-drug resistant (MDR); 
white = non-MDR.  *= Staphylococcus aureus breakpoint used 
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Table 3.7 – Summary of resistance prevalence for Staphylococcus aureus isolates recovered from hospital workers’ uniforms.   
 
Antibiotic 
Staphylococcus aureus 
Abdominal (n=84) Neck (n=95) Pocket (n=85) TOTAL (n=264) 
 S I R S I R S I R S I R 
Cefoxitin 83% - 17% 80% - 20% 78% - 22% 80% - 20% 
Vancomycin* 73% - 27% 93% - 7% 90% - 10% 85% - 15% 
Penicillin G 35% - 65% 52% - 48% 43% - 57% 43% - 57% 
Erythromycin 36% 6% 58% 53% 8% 39% 55% 4% 41% 48% 6% 46% 
Gentamicin 88% - 12% 94% - 6% 90% - 10% 91% - 9% 
Fusidic acid 39% - 61% 55% - 45% 66% - 34% 53% - 47% 
Clindamycin 38% 12% 50% 53% 8% 39% 64% 11% 25% 52% 10% 38% 
Ciprofloxacin 61% - 39% 93% - 7% 65% - 35% 73% - 27% 
Total MDR 56/84 (67%) 43/95 (45%) 35/85 (41%) 134/264 (51%) 
Numbers based on European Union Committee for Antibiotic Susceptibility Testing (EUCAST) analysis of isolates recovered from post-shift healthcare workers 
uniforms.  Antibiotic profile (sensitive, resistant or intermediate resistant) determined from zone of inhibition averages (technical duplicates) compared to pre-
defined breakpoints.  *= No S. aureus breakpoint available, Enterococcus spp. breakpoint used to determine profile.  S = sensitive; I = intermediate resistance; R = 
resistant.   
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Table 3.8 – Summary of resistance prevalence for Enterococcus spp. isolates recovered from hospital workers’ uniforms.    
 
Antibiotic  
Enterococcus spp. 
Abdominal (n=47) Neck (n=69) Pocket (n=53) TOTAL (n=169) 
 S I R S I R S I R S I R 
Cefoxitin* 66% - 34% 65% - 35% 58% - 42% 63% - 37% 
Vancomycin 89% - 11% 83% - 17% 87% - 13% 86% - 14% 
Penicillin G* 13% - 87% 20% - 80% 13% - 87% 15% - 85% 
Erythromycin* 57% 5% 38% 29% 0% 71% 30% 2% 70% 39% 2% 59% 
Gentamicin* 87% - 13% 84% - 16% 83% - 17% 85% - 15% 
Fusidic acid* 34% - 66% 30% - 70% 34% - 66% 33% - 67% 
Clindamycin* 77% 6% 17% 64% 6% 30% 58% 4% 38% 66% 5% 29% 
Ciprofloxacin 96% - 4% 90% - 10% 77% - 23% 88% - 12% 
Numbers based on EUCAST analysis of isolates recovered from post-shift healthcare workers uniforms.  Antibiotic profile (sensitive, resistant or intermediate 
resistant) determined from zone of inhibition averages (technical duplicates) compared to pre-defined breakpoints.  *= No Enterococcus spp. breakpoint available, 
S. aureus breakpoint used to determine profile.  S = sensitive; I = intermediate resistance; R = resistant.   
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3.3.5 Multiple Antibiotic Resistance Index Values for 
Staphylococcus aureus Isolates  
MAR index values were calculated for each S. aureus isolate based on the antibiotic 
susceptibility profile determined by antibiotic sensitivity testing.  This data was used to 
generate a reverse cumulative distribution plot as shown in Figure 3.13.  None of the S. 
aureus isolates had an MAR index of 1 meaning that no isolates were resistant to all the 
antibiotics tested.  Approximately 55-80% of isolates had a MAR index greater than 0 and 
approximately 20-55% of isolates had a MAR index 0.5 meaning they were resistant to half 
of the antibiotics tested.  
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Figure 3.13 – Reverse cumulative distribution plot of MAR index values for Staphylococcus aureus 
uniform isolates.  Data points representative of percentage of isolates equalling corresponding MAR 
index value or less.  Graph generated using Graphpad Prism (neck n=95; abdomen n=84; pocket n=85).   
84 
3.3.6 Multiple Antibiotic Resistance Index Values for 
Enterococcus spp. Isolates  
MAR index values were calculated for each Enterococcus spp. isolate based on antibiotic 
susceptibility profile determined by antibiotic sensitivity testing.  This data was used to 
generate a reverse cumulative distribution plot as shown in Figure 3.14.  Less than 5% (and 
only those isolated from the neck) of Enterococcus spp. neck isolates had a MAR index of 1 
meaning they were resistant to all antibiotics tested.  Approximately 90-95% of isolates had 
a MAR index greater than 0 and approximately 30-50% of isolates had a MAR index 0.5 across 
the three sampling sites meaning they were resistant to half of the antibiotics tested against.  
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Figure 3.14 - Reverse cumulative distribution plot of MAR index values for Enterococcus spp. uniform 
isolates.  Data points representative of percentage of isolates equalling corresponding MAR index 
value or less.  Graph generated using Graphpad Prism (neck n=69; abdomen n=47; pocket n=53).  
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3.4 Conclusion 
This work has shown that healthcare workers uniforms become contaminated with S. aureus 
and Enterococcus spp. during a normal working shift.  This suggests strongly that 
environmental contamination is contributing to contamination of uniforms and that this 
contamination has the potential to act as an indirect route of transmission for highly 
pathogenic bacteria to vulnerable patients.  Furthermore, it is evident that a proportion of 
these S. aureus and Enterococcus spp. isolated from post-shift healthcare workers uniforms 
are antibiotic resistant and a sub-population are classed as MDR.   
 
3.4.1 Detection, Recovery and Enumeration of Bacteria from 
Uniforms  
One of the aims of this work was “Development of a detection, recovery and enumeration 
protocol for highly sensitive recovery of bacteria from fabric surfaces”.  In the enumeration 
of bacteria from uniforms numbers as high as ~1×104 CFU were recovered for S. aureus and 
~1×103 CFU for Enterococcus spp.  These values allowed presentation in a Log10 scale which 
is important in bioburden studies as often Log10 changes are discussed to allow quantification 
of bioburden or the effects of an intervention.   
 
CSA was used for isolation of S. aureus from uniforms.  CSA is a chromogenic selective agar 
used for isolation of S. aureus, with S. aureus isolates producing pink/mauve colonies 
following incubation whereas other bacteria are inhibited or will appear blue, white or beige.  
Gaillot et al. (2000) tested the sensitivity of CSA for growth/identification of CSA in a 
comparison study with conventional methods of S. aureus isolation and found CSA to have 
significantly increased sensitivity (95.5% compared to 81.9%) (Gaillot et al., 2000).  Other 
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groups have also evaluated the sensitivity of CSA with positive outcomes; Goodwin and 
Pobuda (2009) reported as high as 99% sensitivity (Goodwin and Pobuda, 2011), and similarly 
Han et al (2007) reported 98% sensitivity (Han et al., 2007), more examples can be found 
(Carricajo et al., 2001; Perry et al., 2003).  For agar growth of presumptive Enterococcus spp., 
Slanetz and Bartley agar (Oxoid, UK) was used.  Slanetz and Bartley is described as highly 
selective for Enterococcus spp. at 44-45°C by the manufacturer/supplier.  Originally 
described by Slanetz et al. (1955) as selective for Enterococcus spp. in water samples and 
verified by the same group in 1957 (Slanetz, et al.,1955; Slanetz and Bartley, 1957), it has 
also been used more recently for selective growth and enumeration of Enterococcus spp. 
from contaminated medical devices (Messina et al., 2013) and from livestock environments 
(Agga et al., 2015). 
 
In comparison of the developed protocol with a study conducted in the same setting (Antrim 
Area Hospital) this work package demonstrates a better, more sensitive method for recovery 
of bacteria from uniforms.  Johnston (2012) assessed uniforms for the effect of antimicrobial 
technology (AMI) on bioburden.  The methods differed in sampling technique; here we used 
a swabbing method followed by recovery in diluent and subsequent serial dilutions and 
plating, whereas Johnston (2012) simply used a contact plate method where plates were 
contacted to the surface for 30 s.  Other variations in the methods includes 
transport/sampling time (this chapter = 2 h; Johnston = 14 h), media used and number of 
uniforms tested.  A direct comparison can be made between S. aureus recovery of post-shift 
uniforms (this chapter) and non-AMI uniforms (Johnston).  The method described in this 
chapter demonstrated 250-fold increase in S. aureus numbers compared to that reported by 
Johnston (2012).  In conclusion the method reported here allowed high sensitivity recovery 
and enumeration of bacteria from healthcare workers uniforms to accurately determine 
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Log10 differences between sample groups, i.e. pre-shift and post-shift.  A comparison 
between both studies conducted at Antrim Area Hospital is summarised in Table 3.9.   
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Table 3.9 – Comparison of bioburden uniform studies conducted at Antrim Area Hospital.   
 
This Work  Johnston, 2012 
Location Antrim Area Hospital Antrim Area Hospital 
Sample groups Pre-shift, Post-shift Non-Antimicrobial, 
Antimicrobial 
Area tested  Neck, Abdomen and Pocket Chest, Abdomen and Thigh  
Number of uniforms  200 257 
Number of samples  600 771 
Transport time Less than 2h of direct collection 12h storage, 2h transport 
Sampling Method Swab, serial dilutions, plating Contact plates, 30s 
Area tested  100cm2 25cm2 
Media CHROMAgar S. aureus, Slantz and 
Bartley  
Nutrient agar, Baird-Parker 
agar, Enterococcosel 
Maximum Recovery 
 
This Work   Johnston, 2012 
 
S. aureus  Enterococcus spp. S. aureus  Enterococcus spp. 
Pre-shift (Fresh uniforms)  ~10 cfu  0 0 0 
Post-shift (Standard suits) ~10,000 cfu  ~1000 cfu  ~40 cfu* 0 
*number adjusted (multiplied by 4) to normalise area tested to our work.   
89 
3.4.2 Contamination of Healthcare Workers’ Uniforms  
Pre-shift and post-shift healthcare workers uniforms’ were assessed for S. aureus and 
Enterococcus spp. contamination.  Levels of both S. aureus and Enterococcus spp. 
contamination were significantly increased in post-shift uniforms compared to pre-shift 
uniforms.  This indicates that contamination of the uniforms occurs during a working day 
within the vicinity of the hospital.  This increase in contamination levels on uniforms is 
confirmation of environmental contamination within hospital, which poses risk of direct 
transmission to patients and which could potentially cause infection.  Moreover, the 
microbial contamination found on uniforms could also be transmitted to patients (indirect 
transmission).  Our data showed considerable increases in levels of contamination on 
healthcare workers’ uniforms and indeed other studies have shown similar types of bacteria 
on healthcare workers hands and uniforms (Kramer et al. 2006); this work provides further 
evidence that healthcare workers become contaminated with potentially pathogenic 
bacteria.   
 
In comparison with similar work in the literature this work further confirms contamination 
of healthcare workers uniforms.  Some of the previously discussed studies had also shown 
bacterial contamination of uniforms.  (Gaspard et al., 2009; Johnston, 2012; Abu Radwan and 
Ahmad, 2017).  More specific examples include a study by Sanon (2012) where pre-sterilised 
uniforms were provided to a small sample group of staff and all uniforms became 
contaminated during a work shift by an average of 5,795 CFU per square inch – some of the 
bacteria isolated included MRSA, S. epidermidis, Bacillus sp. amongst others (Sanon, 2012).  
This was a much smaller sample group (11 uniforms) however traceability was included as 
the same pre-sterilised uniform was tested after use (Sanon, 2012).  Another example where 
pre-shift and post-shift uniforms were tested had shown minimal levels of contamination of 
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uniforms pre-shift however the authors had detected MRSA, VRE and C. difficile on an 
increased number of uniforms post shift (Perry et al., 2001).  Despite this, however only 
detection of bacteria was reported in contrast with the work in this chapter where we both 
detected and enumerated bacterial levels. 
 
3.4.3 Antibiotic Resistance in the Hospital Environment  
The biobank of S. aureus and Enterococcus spp. isolates collected in this work was tested for 
antibiotic susceptibility against 8 antibiotics which are used in testing with Antrim Area 
Hospital (Farren, 2016, pers comm.).  As hypothesised, antibiotic resistant and MDR bacteria 
were present.  Some 14% of Enterococcus spp. isolates were vancomycin resistant (thus VRE), 
a figure which correlates well with a study by Rengaraj et al (2016) in a teaching hospital 
where 12.9% of E. faecalis strains were identified as VRE by the disc diffusion method.  
Ireland is unique in having the highest prevalence of VRE cases in Europe.  Ryan et al., (2015) 
reported that 45% of E. faecium isolated from blood cultures was also VRE.  Thus, whilst 
numbers in this study are significantly lower (14%), we assessed total Enterococcus spp. 
rather than E. faecium specifically.   
 
An emerging issue is vancomycin resistant S. aureus (VRSA) as vancomycin is often used for 
treatment of MRSA infections however resistance has been noted.  Within the Ulster biobank 
collection of S. aureus isolates, 20% were classed as MRSA and 15% as VRSA.  However, only 
5% were both MRSA and VRSA.  Hiramatsu et al. (1997) previously reported that 1.3-20% of 
>1000 MRSA isolates to be VRSA within several hospitals (Hiramatsu et al., 1997), however 
more recently one study isolating S. aureus from burn patients reported that ~39% of MRSA 
were also VRSA (Hasan et al., 2016).  The numbers we report are lower than these seen in 
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the literature with regard to MRSA/VRSA, however some of these studies assess 
patient/blood cultures which are likely to be more resistant than those isolated from 
healthcare workers’ uniforms.   
 
Within the collection, significantly 51% of S. aureus isolates were classed MDR and 100% of 
MRSA isolates were MDR.  This is defined as being resistant to one agent in at least three 
anti-microbial groups.  The average MAR index values were 0.29 for S. aureus and 0.4 for 
Enterococcus spp.  This global representation of antibiotic resistance data indicates a high 
level of antibiotic resistance.  The presence of these highly pathogenic antibiotic resistant 
bacteria is of considerable concern as there is well documented evidence of high risk of 
infection of patients, which in turn will increase morbidity and mortality rates, leading to 
extra strain on resources including increased costs (Hardy et al., 2006; Goodwin and Pobuda, 
2011; Cheng et al., 2015; O’Neill, 2016).   
 
Additionally, the presence of these antibiotic resistant bacteria means the presence of 
antibiotic resistant genes in the hospital environment.  Therefore, there is the potential for 
increased emergence of antibiotic resistance, whether that derives from intrinsic 
development of antibiotic resistance (via antibiotic-driven selection) or by gene uptake 
mechanisms such as horizontal gene transfer of these mobile genetic elements from a 
resistant bacterium onto a sensitive bacterium (Davies, 1994).  These recurring processes are 
shown in Figure 3.15 (Davies, 1994).  Rowe et al. (2017) have shown that there are 
significantly increased levels of antibiotic resistance genes (including β-lactam resistance 
genes) from a hospital effluent in comparison with the outflow from the surrounding 
residential areas (Rowe et al., 2017).  Similarly, Rodríguez-Mozaz et al. (2015) assessed 
wastewater from a hospital and showed the presence of both antibiotics and antibiotic 
92 
resistance genes for fluoroquinolones, β-lactams, macrolides, sulphonamides and 
tetracyclines (Rodriguez-Mozaz et al., 2015).  The presence of these antibiotic resistant 
bacteria on uniforms tested at Antrim Area Hospital could therefore potentially contribute 
to an antibiotic resistance gene pool and could potentially result in increased antibiotic 
resistance.   
 
Figure 3.15 – Presence of antibiotic resistance genes in an environment could potentially result in 
sensitive bacteria acquiring antibiotic resistance by gene transfer mechanisms (taken from Davies, 
1994).   
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3.4.4 Summary of Findings  
• In this work we developed a high sensitivity protocol that allows rapid and accurate 
detection and enumeration of bacteria from fabric surfaces.   
• Large increases (2-3 Log10) in S. aureus and Enterococcus spp. contamination on post-
shift healthcare workers uniforms indicating environmental contamination leading 
to contamination of uniforms – with the possibility for direct and indirect 
transmission routes of HAIs onto patients.   
• The isolates collected during the work exhibited antibiotic resistance, and multi-drug 
resistant bacteria were detected on uniforms.  Thus, we conclude that there is: 
o Potential for transmission of highly pathogenic bacteria onto patients. 
o Increased presence of antibiotic resistance-encoding mobile genetic 
elements – could result in increased antibiotic resistance.   
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Chapter 4  
Diversity Analysis of Staphylococcus aureus and Enterococcus 
spp. isolated from Healthcare Workers’ Uniforms 
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4.1 Introduction 
4.1.1 Surveillance of Healthcare Acquired Infections  
Infection control plays a vital role in the prevention of HAIs by eradicating/minimising 
microbial contamination in the healthcare environment.  An important aspect of infection 
control practices is monitoring or surveillance of the microorganisms in hospitals (Sydnor and 
Perl, 2011).  One of the first infection control programs was the Study on The Efficacy of 
Nosocomial Infection Control (SENIC Project) authorised by the CDC (Haley et al., 1980; 
Quade et al., 1980; Hughes, 1988).   
 
Surveillance is “the ongoing and systematic collection, collation, and analysis of data, and 
the dissemination of the results to those who need to know to avoid or prevent infections or 
epidemics” (Nelson and Williams, 2014).  Surveillance is common element of infection 
control guidelines published by hospitals (Health Protection Scotland, 2014; Public Health 
England, 2017).  Researchers also commonly conduct large scale surveillance of HAIs, for 
example Li et al. (2018) monitored intensive care units in 176 hospitals in China for 
nosocomial infectious organisms consistent with presence of bacteria in the ICUs (Li et al., 
2018).  Interestingly, Li et al. (2018) concluded in multiple publications that surveillance not 
only acts as an information tool but that during surveillance periods there are reduced HAI 
rates, most likely due to better adherence to infection control practices by healthcare 
workers (Li et al., 2017, 2018).  Other recent examples of research in the surveillance of 
microorganisms include a 10-year surveillance programme for VRE in German healthcare 
settings (Remschmidt et al., 2018) and assessment of the occurrence of antibiotic resistant 
HAIs in Korean intensive care units (Choi et al., 2016).  These hospital guidelines and research 
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articles often conclude the importance of surveillance of microorganisms “in order to develop 
proper strategies for preventing and treating nosocomial infections” (Choi et al., 2016).   
 
Whist the traditional method of monitoring bacteria via direct analysis of the 
presence/absence of infectious agents (for example bioburden studies ((chapter 3) remains 
important – there is a growing role for epidemiological analysis (and typing) of HAI bacteria.  
These methods often identify, characterise or assess trends (for example antibiotic profiles) 
in HAIs (Nelson and Williams, 2014; Choi et al., 2016).   
 
4.1.2 Molecular Epidemiology for Surveillance of Healthcare 
Acquired Infections  
Riley defined molecular epidemiology as “the study of the distribution and determinants of 
infectious diseases that utilizes molecular biology methods” (Riley, 2004).  Molecular 
methods are often applied for epidemiological investigations and the surveillance of HAIs.  
This involves an experimental approach to rapidly assess the genotypic characteristics of 
bacteria to either identify or characterise a population of isolates, i.e. genotyping.  This allows 
comparisons of HAIs with a high level of discriminatory power with multiple applications 
(Foxman, 2012).  Molecular epidemiology tools can be used to distinguish microorganisms 
at a genus, species or strain level and hence may be used to determine causative agents of 
infections or outbreaks in healthcare settings, and to determine clonality or relatedness 
between populations of microorganisms of interest (Ramirez et al., 2015).  Furthermore, 
certain molecular methods could also provide information on pathogenicity, antimicrobial 
resistance, prevention and treatment options (Foxman, 2012; Ramirez et al., 2015).   
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There are many methods available for use in molecular epidemiology of microorganisms and 
some of these will be discussed in subsequent sections.  The ideal molecular tool would be 
whole genome sequencing (WGS) as this would allow the user the highest discriminatory 
power (theoretically could distinguish between a single nucleotide difference) and provide a 
wealth of information about the organism (Salipante et al., 2015).  However, alternative 
molecular tools utilise genetic variation to discriminate amongst members of a microbial 
population, i.e. to identify and determine genomic variants of a population and to conduct 
comparative analysis to determine relatedness.  Examples of outputs of these techniques 
include tracking of bacteria either within a hospital (Leong et al., 2018) or internationally (He 
et al., 2013).  For example Leong et al. (2018) used whole genome sequencing to map VRE 
movement throughout an Australian hospital, they were able to track the movement of 
specific sequence types of VRE throughout the hospital and characterise the genetic 
evolution of the bacteria as it moved through hospital departments by identifying single 
nucleotide polymorphisms.  On an larger scale, He et al. (2012) used whole genome 
sequencing to track epidemic C. difficile 027 from Canada to the UK, mainland Europe and 
Australia, furthermore they tracked the movement nationally within the UK, eventually 
tracking its way to Stoke Mandeville where a serious outbreak of C. difficile resulted in 
numerous deaths.   
 
4.1.3 Pulse-field Gel Electrophoresis (PFGE) 
Pulse field gel electrophoresis (PFGE) (first described by Schwartz et al., 1983) is a method of 
typing organisms based on “a genetic fingerprint” or banding pattern.  The fingerprint is 
generated using specific restriction enzymes which digest DNA at specific target sites 
cleaving into a number of fragments (Simner et al., 2015).  This restriction digest is purposely 
designed to result in a small number of large size fragments (Wang et al., 2015) which are 
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then subject to gel electrophoresis.  Voltage is applied using alternating directions of the 
electric field to allow the user to resolve large DNA fragments.  Various gel electrophoresis 
methods have been applied for this and the most common is referred to as contour-clamped 
homogenous electric field (CHEF) (Wang et al., 2015; Parizad et al., 2016).  The banding 
pattern produced from the gel electrophoresis is considered a genomic fingerprint for the 
organism under investigation and can be used in comparative/relatedness epidemiological 
investigations.  The process of PFGE involves suspending cells in melted agar and lyses of the 
cells for DNA release, to which a restriction digest enzyme is added.  The sample is then 
subject to pulse field gel electrophoresis and visualised under UV light with a suitable stain 
to obtain a banding pattern (Briczinski and Roberts, 2007; Parizad et al., 2016).   
 
PFGE is often considered the ‘gold standard’ molecular epidemiology tool (Goering, 2010; 
Tibayrenc, Abdelbary, et al., 2017).  Engelhart et al. (2002) used PFGE to identify 
environmental contamination of surface cleaning equipment in a haematology-oncology 
unit.  They showed that the PFGE pattern of P. aeruginosa isolated from infected patients 
matched the PFGE pattern of P. aeruginosa isolated from the cleaning equipment (Engelhart 
et al., 2002).  More recently, Kreidl et al. used PFGE to assess an outbreak of VRE and found 
identical PFGE patterns from patient isolates and from environmental contamination (Kreidl 
et al., 2018).  However, issues surrounding reproducibility and standardisation have been 
noted for PFGE, especially in regard to inter-laboratory investigations.  Murchan et al. 
reported the importance of strict standardisation of many of the parameters in the PFGE 
protocol and during their assessment of a ‘harmonised’ protocol showed that patterns from 
some samples were not reproducible when assessed in different laboratories (Murchan et 
al., 2003).  Goering also reported intra-reproducibility and inter-reproducibility issues, 
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highlighting in particular standardisation problems with DNA extraction, restriction enzyme 
digestion and electrophoresis conditions (Goering, 2010).   
 
4.1.4 Multi-Locus Sequence Typing (MLST) 
Multi-locus sequence typing (MLST) is another tool that can be implemented in molecular 
epidemiology (Pérez-Losada et al., 2011; Tibayrenc et al., 2017).  MLST was first used by 
Maiden et al. (1998) in assessment of Neisseria meningitides.  They analysed 11 
housekeeping gene sequences in a collection of 107 isolates, effectively creating the first 
MLST database (Maiden et al., 1998).  MLST analyses nucleotide sequences of 5-7 highly 
conserved housekeeping genes for an organism (Dingle and MacCannell, 2015).  The genes 
of interest are standardised for organisms and found on http://www.mlst.net or 
http://www.pubmlst.org.  As multiple sequences are analysed, the combination of alleles 
results in a sequence type (ST) for the organism of interest, STs are determined by analysis 
of sequences using the MLST database derived a ST for an organism (Chui and Li, 2015; Paris 
et al., 2015).  Within a population of bacteria, STs can be compared to determine relatedness 
of organisms based on allelic variation.  The process of MLST is carried out by conducting PCR 
for MLST genes (pre-defined per organism) followed by sequencing of PCR products and 
using this data to determine a ST (Chui and Li, 2015).  An alternative version of MLST, multi-
virulence-locus sequence typing (MVLST) can also be used for epidemiological investigations 
and is based on the same PCR-sequencing principles but specifically analyses the sequences 
of virulence genes (Chui and Li, 2015).   
 
Maiden et al. concluded that the use of MLST in epidemiological investigations was 
potentially valuable due to the high levels of standardisation as sequence data is generated 
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and used for analysis/comparisons (Maiden et al., 1998).  MLST has been used in 
epidemiological investigations, for example Yin et al. (2018) used MLST to assess 196 P. 
aeruginosa isolates from bloodstream infections and wounds of patients in a Chinese burn 
centre.  They identified 58 STs and could correlate isolates with a previous ST (ST111) known 
to have been the causative agent of an outbreak in 2014 (Yin et al., 2018).  However, the 
application of MLST for molecular epidemiology is still debated.  While the analysis of 
sequences generates standardised data, it subsequently reduces the discriminatory power 
especially in use for epidemic (local) outbreaks (Tibayrenc, et al., 2017), due to the high levels 
of sequence conservation in the genes used for analysis.  Isolates from a similar geographic 
population are thus unlikely to display great diversity in these housekeeping genes.  On the 
other hand, MLST has high discriminatory power with regard pandemic (global) outbreaks 
for the same reasons (Wang et al., 2015).  Other limitations of MLST include cost and data 
analysis time constraints (Tibayrenc et al., 2017).   
 
4.1.5 Random Amplification of Polymorphic DNA (RAPD-PCR 
[RAPD hereafter]) 
Random amplification of polymorphic DNA (RAPD) is a molecular technique that uses PCR 
for DNA amplification of arbitrary sequences.  RAPD was first described by Williams et al. 
(1990) as an alternative method for generating molecular genetic maps.  Single primers of 5-
10 bases are utilised which serve as both the forward and reverse primer in the PCR (Grody 
et al., 2010) and less stringent conditions are used than those commonly used for PCR based 
techniques.  Due to the low-stringency PCR conditions and non-specific short primers, many 
primer binding sites are available on template DNA resulting in strain-specific amplification 
of multiple fragments of varying size (Tang et al., 2015).  As only one primer is used 
amplification requires the primer to bind to opposite strands of the DNA, these binding 
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points must be in relatively close proximity to each other (100-3000bp) (Figure 4.1) for 
successful amplification (Hiett, 2011) and the distance between binding points also 
determines the PCR product length (Hata, 2010), thereby increasing the randomness of 
RAPD.  Thus, variation in location and number of binding sites, coupled with low stringency 
PCR conditions results in variation of banding patterns and in bacterial populations to be 
detected (Hata, 2010).  This is achieved by visualising amplified fragments using staining 
protocols and gel electrophoresis to generate a banding pattern/RAPD fingerprint for 
isolates.  The process of RAPD includes DNA extraction, PCR, gel electrophoresis and 
comparative analysis of banding patterns.  These banding patterns act as a ‘fingerprint’ for 
samples and can be used to determine genomic diversity in comparative analyses relatively 
easy.  Figure 4.2 highlights how RAPD can provide different fingerprints for two independent 
DNA templates using the same primer (adapted from Arif et al. 2010).   
 
RAPD has been used for molecular epidemiological investigation of infectious outbreaks in 
hospitals.  Qi et al. (2018) assessed RAPD patterns of Candida parapsilosis isolated from 
infected neonatal patients and 313 samples isolated from the environment.  Using RAPD they 
were able to determine the same RAPD pattern for environmental isolates and patient 
isolates (Qi et al., 2018).  This information was used to support an increase in infection 
control measures.  Aditi et al. (2017) used RAPD to type 87 P. aeruginosa isolates, generating 
71 RAPD fingerprints.  However the analysis showed marked similarity (85%) amongst all 
isolates (Aditi et al., 2017).  In contrast to PFGE and MLST, RAPD requires no information on 
the genomic make up of an organism of interest (Carrascosa et al., 2011) (MLST and PFGE 
requires sequence information for primer and restriction enzyme design), and is a cost 
effective, high throughput (Chifiriuc et al., 2017) method for epidemiological/diversity 
analysis of a large population of bacteria.  Despite this, reproducibility issues have been 
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highlighted with RAPD, due primarily to the randomness of the method, and also to intra-
reproducibility, inter-reproducibility and inter-laboratory-reproducibility issues that are well 
documented (Carrascosa et al., 2011; Hiett, 2011).  A potential reason for this is that the low 
stringency PCR conditions result in unstable PCR fragments that can be difficult to reproduce 
(Carrascosa et al., 2011).   
 
In order to analyse the biobank of uniform bacteria isolated in chapter 3 we performed RAPD.  
The RAPD fingerprints allowed a diversity dendrogram to be produced to assess population 
diversity of the S. aureus and Enterococcus spp. isolates recovered from healthcare workers’ 
uniforms.  Control isolates were also assessed to determine RAPD reproducibility and 
develop a robust RAPD protocol to overcome reproducibility issues.   
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Figure 4.1 – Primer binding in RAPD.  Primers must bind in the correct orientation in close proximity 
for successful amplification.  If primers are too far apart and/or in the wrong orientation amplification 
will not occur during PCR.   
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Figure 4.2 – The process of how random amplification of polymorphic DNA can result in different 
fingerprints for multiple DNA templates.  In template A there was two products amplified fragments.  
However, in template B there was an additional amplified fragment as can be seen in gel 
electrophoresis meaning a different banding pattern is seen.  This is indicative of genetic diversity 
between DNA template A and DNA template B.  Figure adapted from Arif et al. 2010.   
 
4.1.6 Aims and Hypotheses 
In this chapter the aim was to develop a robust reproducible RAPD protocol using control 
isolates of S. aureus and E. faecalis.  Using the developed protocol isolates were assessed for 
RAPD banding patterns followed by analysis using bionumerics software.  To determine 
genotypic and phenotypic diversity, dendrograms based on RAPD profiles and antibiotic 
resistance were produced.  The hypothesis was that RAPD and antibiotic resistance profile 
comparisons would show that there is genomic and phenotypic diversity. 
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4.2  Materials and Methods 
4.2.1 DNA extraction  
DNA was extracted for each biobank isolate for use in RAPD-PCR using the ‘Chelex’ method; 
a chelating agent used in combination with cell lysis (by heating) for high quality, high yield 
DNA extraction (HwangBo et al., 2010).  The protocol used was adapted from that described 
by HwangBo et al. (2010) who successfully assessed the Chelex method showing successful 
PCR using DNA extracted using Chelex 100.  Similarly, Reyes-Escogido et al. (2010) compared 
a Chelex 100 based protocol with alternative methods and again demonstrated successful 
PCR using Chelex 100 extracted DNA.  Beads (cryovials) for each isolate were recovered from 
-80 °C and aseptically streaked onto fresh MHA.  This was incubated overnight at 37 °C for 
growth.  The resulting biomass was re-suspended in 1 mL aliquots of ice cold PBS.  This was 
centrifuged at 12,000 rpm for 10 min at 4 °C using an Eppendorf centrifuge 5418R (VWR, UK).  
Supernatant was decanted, the cell pellet re-suspended in 1 mL of fresh ice-cold PBS 
centrifuged at 12,000 rpm for 10 min at 4 °C and the step repeated twice.  Finally, the 
supernatant was removed, and cell pellet re-suspended in 300 µL 5% w/v Chelex 100 (Sigma, 
UK) and incubated at 100 °C for 15 min on a Stuart block heater SBH200D (Stuart equipment, 
UK).  Samples were then centrifuged at 12,000 rpm for 10 min at 4 °C and supernatant 
transferred to a clean Eppendorf in 100 µL aliquots and stored at -20 °C until use.   
 
4.2.2 RAPD Primers 
Primers used in RAPD are short arbitrary primers with no specific target gene.  Both primers 
used are presented in Table 4.1.  For random amplification of S. aureus isolates DNA primer 
‘AP-7’ was used.  This has previously been used for successful RAPD on both MSSA and MRSA 
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isolates (named RAPD-7 rather than AP-7) and for RAPD of Klebsiella pneumonia (Ashayeri-
panah 2012).  Primer ‘R5’ was used for RAPD of Enterococcus spp. isolates.  This has 
previously been used for RAPD and showed high levels of discrimination compared to other 
RAPD primers (Martin et al., 2005) and has recently been successfully used for RAPD of E. 
faecalis strains (Cheng et al., 2017).  Primers were purchased in lyophilised form (Invitrogen), 
and were re-constituted to a stock concentration of 100 M using molecular grade water 
then diluted to a working concentration of 10 M.   
 
Table 4.1 – Primers used in Random Amplification of Polymorphic DNA of Staphylococcus aureus and 
Enterococcus spp. isolates.   
Bacteria Primer Primer Sequence (5′–3′) Reference  
S. aureus AP-7 GTGGATGCGA (Grinholc, Wegrzyn and 
Kurlenda, 2007) 
Enterococcus spp. R5 AACGCGCAAC (Martin et al., 2005) 
 
4.2.3 RAPD-PCR Protocol 
All reagents were purchased from Invitrogen unless otherwise stated and PCR reactions were 
carried out using a TC5000 PCR machine (Techne, UK).  DNA extracted from isolates was 
subject to PCR in a final individual reaction volume of 25 µL; 24 µL RAPD PCR mastermix 
(Table 4.2) and 1 μL of genomic DNA were mixed in 0.2 mL PCR tubes (VWR).  PCR was then 
completed using the cycle conditions summarised in Table 4.3.  Each isolate was subject to 
RAPD-PCR (reaction mixture volume of 25 µL) in duplicate independent runs.  Following PCR 
isolates were subject to gel electrophoresis.   
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Table 4.2 – PCR mastermix used for PCR reaction in RAPD analysis of S. aureus and Enterococcus spp. 
isolates.   
PCR reagent Volume (for 34 reactions) 
PCR buffer (10 M) 85 µL  
dNTP mix (0.2 mmol) 68 µL  
Primer (10 μM) 34 µL  
Taq DNA polymerase 17 µL  
MgCl2 (50 mM) 68 µL  
Molecular grade H2O (Sigma) 578 µL  
Total 850 µL  
 
 
Table 4.3 – PCR program used for RAPD analysis of S. aureus and Enterococcus spp. isolates.   
Temperature  Time Number of Cycles 
94 °C 5 min - 
94 °C 45 s  
35 35 °C 1 min 
72 °C 2 min 
10 °C Pause - 
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4.2.4 Gel Electrophoresis  
Following PCR, samples were subject to gel electrophoresis in a bio-rad gel electrophoresis 
tank using a PowerPac Basic battery (Bio-rad).  2% 12.5 cm agarose gels were prepared by 
dissolving (heating in microwave) 5 g of molecular biology grade agarose (Appleton, UK) in 
250 mL 1X Tris/Borate/EDTA (TBE) buffer (Invitrogen), 25 µL of Sybr® Safe DNA gel stain 
(Invitrogen) was added then the gel allowed to set in the casting tray.  Subsequently gels 
were placed in a Bio-rad gel tank and immersed in 1500 mL of 1X TBE buffer.  A 10 µL aliquot 
of PCR product was mixed with 2 µL 6X DNA gel loading dye (Invitrogen) and 10 µL of this 
mixture was loaded into an individual well on the gel.  5 µL of a 100-base pair ladder was 
loaded into the first, middle and last lanes of each gel.  Gels were then subject to 
electrophoresis at 100 V for 3h.  Gels were visualised using G:BOX F3 gel doc system (Syngene 
Europe, UK) and each gel was imaged using the default settings on the Syngene software for 
standardisation purposes.   
 
4.2.5 Validation of reproducibility of Gel Electrophoresis  
A series of validation steps were undertaken to ensure reproducibility of the gel 
electrophoresis step, i.e. will the same PCR product run multiple times on one gel result in 
the same banding pattern (RAPD profile).  For this control isolates S. aureus ATCC43300, S. 
aureus DSM20231, E. faecalis ATCC29212 and E. faecalis DSM12956 were used. The RAPD 
protocol (as described above) was used for RAPD assessment of these isolates followed by 
gel electrophoresis (as described above).  One RAPD-PCR reaction was completed for each 
isolate, in gel electrophoresis steps, independent aliquots of the same PCR reaction were 
added to individual wells of the gel.  The electrophoresis results were then assessed for 
reproducibility between replicates.   
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4.2.6 Validation of Intra-reproducibility of RAPD 
Intra-reproducibility is the replication of an observation/measurement within a single 
experiment.  In this case the intra-reproducibility is the replication of the RAPD profile of 
control isolates assessed in a single PCR reaction and on a single gel.  However, multiple 
replications of the same isolate were tested.  Therefore, this is a validation of the intra-
reproducibility of a given isolate using the RAPD system designed; i.e. will the same isolate 
tested multiple times result in the same RAPD profile.  The same procedures were completed 
as above, however the additional sample was included so reproducibility of the PCR could be 
assessed, i.e. two PCR runs of the same sample and subsequent processes.   
 
4.2.7 Validation of Inter-reproducibility of RAPD 
Inter-reproducibility is the replication of an observation/measurement between multiple 
independent experimental runs.  In this case the inter-reproducibility is the replication of the 
RAPD profile of control isolates assessed in multiple independent PCR runs.  This tests 
whether the same isolate tested in independent PCR runs of the RAPD protocol will result in 
the same RAPD profile, i.e. two separate PCR runs at different times.   
 
For this control isolates S. aureus ATCC43300, S. aureus DSM20231, E. faecalis ATCC29212 
and E. faecalis DSM12956 were used.  The RAPD protocol (as described above) was used for 
RAPD assessment of these isolates followed by gel electrophoresis (as described above).  The 
test described in ‘Validation of Intra-reproducibility of RAPD’ above was repeated 
independent of that test and both results assessed for reproducibility.   
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4.2.8 Bionumerics Analysis of RAPD  
Bionumerics is a software package commonly used for analysis of RAPD throughout the 
literature.  Following validation of the RAPD protocol, each S. aureus and Enterococcus spp. 
uniform isolate was subject to RAPD analysis in duplicate independent PCR runs.  To assess 
reproducibility of the two runs for each isolate, the band pattern was compared to each 
other for similarity using bionumerics software.  Banding patterns were analysed using 
unweighted pair grouping method with arithmetic mean.  Several comparison tests were 
then completed to produce similarity dendrograms.  Each comparison was conducted with 
three reproducibility threshold parameters; i.e. [1] all isolates, [2] isolates which displayed 
>/=95% reproducibility and [3] isolates which displayed >/=99% reproducibility.   
 
4.2.9 Bionumerics Analysis of Antibiotic Susceptibility Testing  
Bionumerics software can be also used to compare antibiotic susceptibility antibiogram data.  
Each S. aureus and Enterococcus spp. isolate tested using EUCAST methods in Chapter 3 
resulted in an antibiogram profile for each isolate.  These profiles can be compared to each 
other as a method of determining diversity between bacterial populations.  Antibiogram data 
was input to the bionumerics software and comparisons conducted.   
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4.3 Results 
4.3.1 RAPD Gel Output Example 
The output of RAPD experiments used for analysis is a banding pattern visible under UV light 
following gel electrophoresis and staining with SybrSafe.  In all RAPD assessments conducted 
duplicate gels were produced for each isolate and input to the bionumerics software for 
analysis.  Two examples of gels produced using the described protocols are shown.  Figure 
4.3 shows a gel from validation/assessment of reproducibility steps conducted – the banding 
patterns seen across this gel are of the same isolate and can be seen to be consistent 
indicating reproducibility.  Figure 4.4 shows the RAPD banding pattern for some of the 
hospital biobank isolates assessed – the differences in banding pattern between isolates is 
an indicator of genomic diversity.  Such diversity of the biobank was subsequently assessed 
using the bionumerics software.   
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Figure 4.3 – RAPD gel showing analysis of reproducibility assessment of Staphylococcus aureus 
DSM20231.  2% agarose gel stained with SybrSafe imaged under UV light.  Lanes 1 = 100bp ladder; 
lanes 2-6 = same PCR product of S. aureus DSM20232 RAPD (assessment of gel reproducibility); lanes 
7-9 = replicates of S. aureus DSM20231 RAPD (assessment of RAPD reproducibility); lane 10 = 100bp 
ladder; lanes 11-16 replicates of S. aureus DSM20231 RAPD; lane 17 = negative no DNA control; lane 
18 = 100bp ladder.   
 
Figure 4.4 –RAPD gel showing isolates from the hospital uniform biobank.  2% agarose gel stained with 
SybrSafe imaged under UV light.  Lane 1 = 100bp ladder; lane 2 = EA5; lane 3 = EA13; lane 4 = EA21; 
lane 5 = EA39; lane 6 = EA40; lane 7 = EA43; lane 8 = EA44; lane 9 = EA45; lane 10 = 100bp ladder; lane 
11 = EA46; lane 12 = EA47; lane 13 = EA49; lane 14 = EA52; lane 15 = EA53; lane 16 = EA54; lane 17 = 
EA55; lane 18 = empty; lane 19 = negative no DNA control; lane 20 = 100bp ladder.   
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4.3.2 Assessment of Reproducibility of RAPD Protocol using 
Control Isolates  
Due to the nature of RAPD assessment it is vital to ensure reproducibility of the protocol.  
Gel electrophoresis, intra-reproducibility and inter-reproducibility were all assessed and 
validated to ensure a robust RAPD method.  Control isolates were used to assess 
reproducibility as outlined in materials and methods section.  These assessments were 
conducted on the same gel (gel electrophoresis validation and intra-reproducibility check) 
then repeated independently to ensure reproducibility of the overall protocol (inter-
reproducibility).  Banding patterns from these gels were input to the bionumerics software 
and similarity comparisons conducted to quantitate reproducibility.  Example dendrograms 
for S. aureus ATCC43300 and E. faecalis ATCC29212 are shown in Figure 4.5 and Figure 4.6; 
also shown is a summary Table 4.4 detailing the results (% similarity) for various 
reproducibility tests completed for all control isolates.   
 
The dendrogram for the S. aureus ATCC43300 control isolate clearly highlights good 
reproducibility in the RAPD protocol.  Two major clades can be seen with 89.9% similarity 
(which represents similarity as it is replicates of the same sample) to each other – these 
clades represent the inter-reproducibility between RAPD profiles for replicate and replicate 
2 of the protocol for this isolate.  Intra- reproducibility can also be seen within these major 
clades (two clades represent two independent PCR runs for the same smaple); within these 
independent runs there is >95% similarilty.  The E. faecalis ATCC29212 dendrogram also 
demonstrates reproducibility with inter-reproducibility being ~95%.   
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Figure 4.5 – Dendrogram showing similarity (%) in RAPD profiles of reproducibility assessment for S. 
aureus ATCC43300.  Key: • = replicate 1; * = replicate 2; independent PCR runs denoted a-j; repeats 
of a further sub-categorised a1-a5.   
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Figure 4.6 – Dendrogram showing similarity (%) in RAPD profiles of reproducibility assessment for E. 
faecalis ATTCC29212.  Key: (1) = replicate 1; (2) = replicate 2; independent PCR runs denoted a-j; 
repeats of a further sub-categorised a1-a5.   
116 
Table 4.4 – Summary of reproducibility assessment of RAPD protocol.   
 S. aureus 
ATCC43300 
S. aureus 
DSM20231 
E. faecalis 
ATCC23212 
E. faecalis 
DSM12956 
Gel 
electrophoresis 
reproducibility 
98.3% 97.5% 98.1% 98.8% 
Intra-
reproducibility 
97.9% 92.8% 98.1% 98.8% 
Inter-
reproducibility  
89.9% 86.2% 96% 97.8% 
Numbers are representative of the lowest similarity value for each test.  Gel electrophoresis is 
similarity between isolates denoted a1-a5 in example dendrograms. Intra-reproducibility is similarity 
between one full RAPD run, i.e. denoted (1)a-j or (2)a-j in example dendrograms.  Inter-reproducibility 
is the lowest similarity value in a comparison of (1) vs (2).   
 
4.3.3 Assessment of Reproducibility of RAPD analysis of Uniform 
Isolates 
Once the protocol was optimised, validated and assessed for reproducibility (as descibed in 
section 4.3.2) analysis of S. aureus and Enterococcus spp. isolates from post-shift healthcare 
workers uniforms was undertaken.  As the assessment of reproducibility with the control 
isolates highlighted variation in the results – RAPD for each biobank isolate was performed 
in duplicate in two independent RAPD runs of the described protocol.  The two resultant 
banding patterns for each isolate were then assessed for reproducibility.  Figure 4.7 shows 
an example of a dendrogram produced for one isolate comparing independent experiment 
1 and indpendant experiment 2 (of the same isolate).  This shows how the similarity values 
were determined by an independent assessment of reproducibility using the Bionumerics 
software to produce a dendrogram for each isolate.  Table 4.5 shows the reproducibility 
similarity value between replicate 1 and replicate 2 of each isolate.   
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Figure 4.7 – Example of dendrogram produced to assess similarity (%) between replicate 1 and 
replicate 2 of a isolates SA12 (replication of full RAPD protocol).   
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Table 4.5 – Reproducibility analysis of each isolates assessed using RAPD.  Table shows percentage similarity between independent replicates of RAPD for each isolate.   
Staphylococcus aureus Enterococcus spp. 
Isolate Similarity (%) Isolate Similarity (%) Isolate Similarity (%) Isolate Similarity (%) Isolate Similarity (%) Isolate Similarity (%) 
SA1 95 SP1 99 SN1 96 EA1 97 EP1 97 EN1 99 
SA10 94 SP2 99 SN4 92 EA2 91 EP3 98 EN2 99 
SA11 93 SP3 99 SN5 94 EA3 94 EP4 99 EN3 99 
SA12 98 SP5 99 SN7 97 EA6 98 EP5 98 EN4 99 
SA13 97 SP6 96 SN8 97 EA7 97 EP6 98 EN5 100 
SA14 96 SP7 98 SN10 97 EA10 97 EP7 98 EN6 100 
SA15 95 SP8 99 SN11 96 EA11 97 EP8 100 EN9 99 
SA16 93 SP9 99 SN12 96 EA14 99 EP9 99 EN12 93 
SA17 92 SP10 94 SN14 93 EA16 95 EP13 100 EN13 98 
SA21 96 SP11 93 SN15 94 EA20 97 EP15 99 EN15 100 
SA22 100 SP12 98 SN16 95 EA22 98 EP16 98 EN16 99 
SA24 100 SP14 98 SN17 95 EA23 98 EP17 97 EN17 97 
SA25 97 SP15 90 SN20 97 EA24 99 EP18 100 EN22 100 
SA26 98 SP16 94 SN21 95 EA25 98 EP21 100 EN24 99 
SA27 98 SP18 94 SN23 97 EA26 98 EP24 98 EN29 93 
SA28 96 SP20 94 SN31 94 EA27 98 EP26 96 EN31 99 
SA29 92 SP22 98 SN32 87 EA28 98 EP27 98 EN32 98 
SA34 99 SP23 96 SN34 92 EA29 98 EP28 99 EN33 98 
SA36 96 SP25 94 SN35 97 EA30 98 EP30 99 EN36 98 
SA37 99 SP26 96 SN37 99 EA31 98 EP31 98 EN39 97 
SA38 98 SP29 95 SN38 96 EA32 98 EP32 98 EN41 97 
SA39 99 SP30 98 SN39 98 EA33 96 EP34 96 EN42 97 
SA40 99 SP32 99 SN40 89 EA34 98 EP2 99 EN45 99 
SA41 99 SP33 98 SN41 92 EA36 98 EP23 98 EN46 99 
SA42 98 SP34 98 SN42 98 EA37 93 EP59 96 EN47 100 
SA43 99 SP35 99 SN43 92 EA41 98 EP60 95 EN48 99 
SA44 99 SP36 99 SN44 92 EA42 98 
  
EN49 100 
SA45 97 SP37 99 SN22 98 EA5 96 
  
EN50 100 
SA46 97 SP38 99 SN24 97 EA13 95 
  
EN51 100 
SA47 99 SP39 95 SN26 97 EA21 96 
  
EN52 100 
SA48 94 SP41 98 SN27 94 EA39 99 
  
EN53 99 
SA49 97 SP42 99 SN46 92 EA40 99 
  
EN54 100 
SA50 99 SP43 97 SN47 94 EA43 97 
  
EN55 100 
SA51 98 SP44 98 SN48 93 EA44 98 
  
EN56 100 
SA52 97 SP45 98 SN49 95 EA45 99 
  
EN57 100 
SA57 95 SP46 97 SN50 93 EA46 94 
  
EN58 99 
SA58 92 SP47 93 SN51 98 EA47 93 
  
EN59 100 
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SA59 96 SP48 98 SN52 97 EA49 97 
  
EN63 100 
SA62 96 SP49 94 SN53 93 EA52 95 
  
EN64 97 
SA64 94 SP50 99 SN54 97 EA53 98 
  
EN69 98 
SA65 97 SP51 95 SN55 98 EA54 97 
  
EN71 98 
SA66 95 SP52 93 SN57 92 EA55 97 
  
EN73 99 
SA67 93 SP53 96 SN58 96 
    
EN76 99 
SA68 94 SP57 98 SN59 94 
    
EN80 99 
SA69 98 SP58 99 SN60 95 
    
EN81 99 
SA70 97 SP60 97 SN61 98 
    
EN82 99 
SA71 98 SP64 97 SN62 95 
      
SA72 95 SP65 99 SN63 96 
      
SA74 98 SP66 96 SN64 90 
      
SA79 97 SP69 96 SN65 90 
      
SA80 99 SP70 89 SN66 93 
      
SA84 98 SP71 99 SN67 93 
      
SA87 99 SP73 92 SN68 96 
      
SA88 98 SP74 100 SN69 89 
      
SA89 99 SP75 95 SN70 99 
      
SA91 98 SP76 97 SN72 95 
      
SA93 98 SP78 97 SN74 96 
      
SA94 98 SP79 92 SN76 98 
      
SA95 99 SP81 100 SN78 99 
      
SA96 97 SP82 95 SN79 96 
      
SA97 96 SP84 92 SN80 96 
      
SA98 94 SP85 89 SN81 96 
      
SA99 99 SP86 93 SN82 98 
      
  
SP88 93 SN83 93 
      
  
SP89 98 SN86 99 
      
  
SP90 96 SN88 96 
      
  
SP91 94 SN89 95 
      
  
SP93 97 SN90 95 
      
  
SP95 94 SN91 96 
      
  
SP96 90 SN92 95 
      
  
SP97 94 SN93 95 
      
  
SP98 93 SN94 98 
      
    
SN97 99 
      
    
SN99 98 
      
    
SN100 96 
      
Similarity (%) values representative of similarity between two independent RAPD runs for each isolate.  Bionumerics was used to determine the similarity between rep 1 and 
rep 2.  Not all isolates were recoverable from -80°C hence variable sample sizes for each sample group.    
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For all S. aureus isolates three dendrogram figures were produced, [1] all S. aureus isolates; 
[2] S. aureus isolates with 95% or higher threshold for reproducibility between replicates and 
[3] S. aureus isolates with 99% or higher threshold for reproducibility between replicates.  
These dendrograms are shown in Figure 4.8, Figure 4.9 and Figure 4.10 respectively .  The 
dendrogram displaying no reproducibility threshold (Figure 4.8) shows the most isolates and 
consequently apparent increased diversity amongst the population.  However, the lowest 
reproducibility between replicates observed was 87% (Table 4.5).  This therefore represents 
the point where any diversity shown between 87% up to 100% could in theory be a result of 
experimental irreproducibility, rather than genuine genomic diversity between isolates.  
When a 95% reproducibility threshold was included any diversity between 95% and 100% 
cannot be considered genomic diversity; however as reproducibility was directly assessed 
any diversity represented below 95% should be considered genomic diversity within the 
population; this diversity is observed in the dendrogram with some isolates showing ~91% 
similarity to each other.   
 
The same can be noted when a 99% threshold was included; however this threshold 
represents a higher level of scrutiny of experimental reproducibility resulting in a more 
robust dataset as any genomic diversity observed (i.e. <99% similarity) should be considered 
representative of genomic diversity as testing has been conducted in a robust methodical 
manner and data has been assessed and validated for quality and reproducibility.  This 
analysis set demonstrated as low as ~94% genomic similarity between some isolates.  The 
caveat of including these parameters is that the sample size is reduced meaning the 
observation of any genomic diversity is limited.  However as the aim of this work was to 
determine, as accuratley as possible, genomic diversity; subsequent analyses shown used a 
reproducibility threshold of 99%.   
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Figure 4.8 – Dendrogram including all S. aureus tested using RAPD with no reproducibility threshold.  
Dendrogram represenative of similarity (%) amongst bacterial population.   
122 
 
Figure 4.9 – Dendrogram including S. aureus isolates tested using RAPD which had a 95% or higher 
reproducibility value between experimental replicates.  Dendrogram represenative of similarity (%) 
amongst bacterial population.   
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Figure 4.10 – Dendrogram including all S. aureus isolates tested using RAPD which had a 99% or higher 
reproducibility value between experimental replicates.  Dendrogram represenative of similarity (%) 
amongst bacterial population.   
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4.3.4 Staphylococcus aureus Genomic diversity based on 
Antibiotic Profiling  
Similarity analyses were conducted of the RAPD banding patterns of S. aureus isolates 
classed MRSA and MSSA by EUCAST assessment of isolates as described in chapter 3.  Figure 
4.11, Figure 4.12, Figure 4.13 and Figure 4.14 show the similarity dendrograms for MRSA and 
MSSA, MDR and non-MDR respectively.  All S. aureus isolates (MRSA and MSSA) showed a 
minimum similarity of ~94%.  Only 2 of 6 isolates MRSA isolates showed 100% similarity to 
one another; however one isolate showed <95% similarity to all other MRSA isolates.  
Interestingly all MRSA isolates were also MDR.  Isolates deemed MSSA showed more clades 
with high levels of genomic similarity to each other.  The minimum similarity seen was ~94%.  
Throughout the dendrogram small clusters with high similarity to each other can be seen, 
often these clusters arise from the same collection day and/or MDR classification.  The S. 
aureus MDR isolates dendrogram shows a large clade of 14/18 isolates with 98% genomic 
similarity to each other, the other 4 isolates have decreasing similarity to as low as 94%.  The 
non-MDR isolates showed a high percentage of similarity to each other with a 18/21 
exhibiting 97.8% similarity to each other.  Interestingly, all non-MDR are also MSSA and both 
non-MDR and MSSA isolates have minimum similarity of ~94%.   
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Figure 4.11 – Similarity dendrogram of MRSA S. aureus isolates recovered from post-shift healthcare 
workers uniforms.  Isolates were classed MRSA by EUCAST disc diffusion testing.  Simailrity 
determined by RAPD testing and subsequent analysis using Bionumerics software.  For each isolate 
RAPD experimental protocols were completed in duplicate and reproducibility assessment conducted, 
only isolates with reproducibiliy of 99% and above (between two independent replicates) were 
included in analysis.   
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Figure 4.12 – Similarity dendrogram of MSSA S. aureus isolates recovered from post-shift healthcare 
workers uniforms.  Isolates were classed MSSA by EUCAST disc diffusion testing.  Simailrity determined 
by RAPD testing and subsequent analysis using Bionumerics software.  For each isolate RAPD 
experimental protocols were completed in duplicate and reproducibility assessment conducted, only 
isolates with reproducibiliy of 99% and above (between two independent replicates) were included in 
analysis.   
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Figure 4.13 – Similarity dendrogram of MDR S. aureus isolates recovered from post-shift healthcare 
workers uniforms.  Isolates were classed MDR by EUCAST disc diffusion testing.  Simailrity determined 
by RAPD testing and subsequent analysis using Bionumerics software.  For each isolate RAPD 
experimental protocols were completed in duplicate and reproducibility assessment conducted, only 
isolates with reproducibiliy of 99% and above (between two independent replicates) were included in 
analysis.   
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Figure 4.14 – Similarity dendrogram of non-MDR S. aureus isolates recovered from post-shift 
healthcare workers uniforms.  Isolates were classed non-MDR by EUCAST disc diffusion testing.  
Simailrity determined by RAPD testing and subsequent analysis using Bionumerics software.  For each 
isolate RAPD experimental protocols were completed in duplicate and reproducibility assessment 
conducted, only isolates with reproducibiliy of 99% and above (between two independent replicates) 
were included in analysis.   
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4.3.5 Staphylococcus aureus Genomic diversity based on Source 
of Isolation 
S. aureus isolates assessed for genomic diversity using RAPD were isolated from post-shift 
healthcare workers uniforms at three locations (abdomen, pocket and neckline).  Figure 4.15, 
Figure 4.16 and Figure 4.17 show the dendrograms for S. aureus abdomen, neckline and 
pocket isolates respectively.   
 
Within the S. aureus population recovered from abdomen area of uniforms there is high 
similarity amongst all isolates (~94-100% similarity).  However some isolates demonstrate 
increased similarity with isolates which have the same antibiotic profiling traits as each other, 
i.e. there are clades of MRSA, MSSA, MDR and non-MDR isolates with very high (99-100%) 
similarity values.  A small number (5) of neck isolates could be included in this analysis and 
they all demonstrate 98-100% similarity – a larger population of isolates would be required 
to robustly determine diversity.  Pocket isolates also display high similarity (lowest =95%) 
however, there are sub-populations present – within these sub-populations similar antibiotic 
profiles can be seen similar to that reported for the abdomen population.   
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Figure 4.15 – Similarity dendrogram of S. aureus isolates recovered from abdomen of post-shift 
healthcare workers uniforms.  Simailrity determined by RAPD testing and subsequent analysis using 
Bionumerics software.  For each isolate RAPD experimental protocols were completed in duplicate 
and reproducibility assessment conducted, only isolates with reproducibiliy of 99% and above 
(between two independent replicates) were included in analysis.   
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Figure 4.16 – Similarity dendrogram of S. aureus isolates recovered from neck of post-shift healthcare 
workers uniforms.  Simailrity determined by RAPD testing and subsequent analysis using Bionumerics 
software.  For each isolate RAPD experimental protocols were completed in duplicate and 
reproducibility assessment conducted, only isolates with reproducibiliy of 99% and above (between 
two independent replicates) were included in analysis.   
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Figure 4.17 – Similarity dendrogram of S. aureus isolates recovered from pocket of post-shift 
healthcare workers uniforms.  Simailrity determined by RAPD testing and subsequent analysis using 
Bionumerics software.  For each isolate RAPD experimental protocols were completed in duplicate 
and reproducibility assessment conducted, only isolates with reproducibiliy of 99% and above 
(between two independent replicates) were included in analysis.   
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4.3.6 Enterococcus spp. Genomic diversity  
A similarity test was conducted comparing RAPD banding patterns of all Enterococcus spp. 
isolates recovered from healthcare workers post shift uniforms (Figue 4.18).  As with S. 
aureus analysis only isolates that demonstrated 99% or above reproducibility values 
between independent RAPD runs were included.   
 
All Enterococcus spp. isolates show similarity as low as <93% with numerous sub-populations 
evident.  Some of these sub-populations have similar antibiotic susceptibility patterns with 
clades of VRE or non-VRE isolates showing increased similarity.  A small family of 9 isolates 
show the same characteristics (all VRE and same collection point) and demonstrate 100% 
similarity.  Conversely there are families of non-VRE isolates which also display 100% 
similarity.  Trends can also be seen regarding source of isolation specifically with 
Enterococcus spp. isolated from the neck having increased similarity compared to those 
isolates from abdomen or pocket areas.    
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Figure 4.18 – Similarity dendrogram of Enterococcus spp. isolates recovered from post-shift healthcare 
workers uniforms.  Similarity determined by RAPD testing and subsequent analysis using Bionumerics 
software (n=48).  For each isolate RAPD experimental protocols were completed in duplicate and 
reproducibility assessment conducted, only isolates with reproducibility of 99% and above (between 
two independent replicates) were included in analysis.   
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4.3.7 Enterococcus spp. Genomic diversity based on Antibiotic 
Profiling  
Similarity tests were conducted on Enterococcus spp. isolates recovered from healthcare 
workers uniforms instructing the software to use parameters based on antibiotic profiles 
determined by EUCAST  (chapter 3).  Similarity tests was conducted for all isolates deemed 
VRE and non-VRE, dendrograms shown in Figure 4.19 and Figure 4.20 respectively.   
 
The VRE isolates dendrogram shows two distinctive clades with 94% similarity between the 
two clades.  Within these clades there is high levels of similarity, one of them shows 100% 
similarity between four isolates – interestingly these four isolates arise from the same source 
(neck), same collection group (9) and are all classed VRE – these four isolates were recovered 
from two independent uniforms.  The non-VRE isolates show increased diversity however, 
there is also an increased number of isolates.  There is as low as 94% similarity and a range 
of sub-populations present with obvious trends where source of isolation shows increased 
similarity in certain clades.   
136 
 
Figure 4.19 – Similarity dendrogram of VRE Enterococcus spp. isolates recovered from post-shift 
healthcare workers uniforms.  Isolates were classed VRE by EUCAST disc diffusion testing.  Simailrity 
determined by RAPD testing and subsequent analysis using Bionumerics software.  For each isolate 
RAPD experimental protocols were completed in duplicate and reproducibility assessment conducted, 
only isolates with reproducibiliy of 99% and above (between two independent replicates) were 
included in analysis.   
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Figure 4.20 – Similarity dendrogram of non-VRE Enterococcus spp. isolates recovered from post-shift 
healthcare workers uniforms.  Isolates were classed non-VRE by EUCAST disc diffusion testing.  
Simailrity determined by RAPD testing and subsequent analysis using Bionumerics software.  For each 
isolate RAPD experimental protocols were completed in duplicate and reproducibility assessment 
conducted, only isolates with reproducibiliy of 99% and above (between two independent replicates) 
were included in analysis.   
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4.3.8 Enterococcus spp. Genomic diversity based on Source of 
Isolation 
Similarity tests were conducted to assess diversity of Enterococcus spp. isolates based on the 
area of the uniform they were isolated from.  Figure 4.21, Figure 4.22 and Figure 4.23 show 
dendrograms for similarity tests for abdomen, neck and pocket isolates respectively.   
 
Only five isolates could be included in the similarity test for Enterococcus spp. isolates 
recovered from the abdomen site, therefore limited diversity is seen as a larger population 
would be required; however interestingly none of the isolates demonstrate 100% similarity 
to each other.  Isolates recovered from the neck show increased diversity with lowest 
recorded similarity being ~93%, within the neck population VRE and non-VRE showed 
increased similarity with obvious clades/families of isolate present.  There is also increased 
similarity to isolates recovered from in the same collection group.  As noted with abdomen 
isolates no pocket isolates were 100% similar to each other.   
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Figure 4.21 – Similarity dendrogram of Enterococcus spp. isolates recovered from abdomen of post-
shift healthcare workers uniforms.  Simailrity determined by RAPD testing and subsequent analysis 
using Bionumerics software.  For each isolate RAPD experimental protocols were completed in 
duplicate and reproducibility assessment conducted, only isolates with reproducibiliy of 99% and 
above (between two independent replicates) were included in analysis.   
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Figure 4.22 – Similarity dendrogram of Enterococcus spp. isolates recovered from neck of post-shift 
healthcare workers uniforms.  Simailrity determined by RAPD testing and subsequent analysis using 
Bionumerics software.  For each isolate RAPD experimental protocols were completed in duplicate 
and reproducibility assessment conducted, only isolates with reproducibiliy of 99% and above 
(between two independent replicates) were included in analysis.   
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Figure 4.23 – Similarity dendrogram of Enterococcus spp. isolates recovered from pocket of post-shift 
healthcare workers uniforms.  Simailrity determined by RAPD testing and subsequent analysis using 
Bionumerics software.  For each isolate RAPD experimental protocols were completed in duplicate 
and reproducibility assessment conducted, only isolates with reproducibiliy of 99% and above 
(between two independent replicates) were included in analysis.   
  
142 
4.3.9 Diversity Analysis Using Antibiotic Susceptibility Patterns  
For each isolate an antibiogram was produced in Chapter 3 outlining susceptibility to eight 
antibiotics.  This data represents phenotypic characteristics of each isolate and variation in 
collective response to the antibiotics can be compared for multiple isolates to determine 
diversity amongst a bacterial population; i.e. isolates may have different antibiotic 
susceptibility patterns.  Using bionumerics software antibiotic suscpectibility data was used 
to conduct similarity tests and produce similarity dendrograms.  Figure 4.24 and Figure 4.25 
show similarity dendrograms for S. aureus and Enterococcus spp. antibiotic susceptibility 
data respectively.   
 
For both S. aureus and Enterococcus spp. isolates, the antibiotic profiles (phenotypic 
characteristic) show increased diversity amongst isolates when compared to the RAPD 
profiles (genomic characteristic).  S. aureus isolates show similarity ranging between <35% 
and 100% whereas Enterococcus spp. isolates show similarity ranging from <40%-100%.  
There is a large variation in antibiotic profiles in response to the eight antibiotics tested 
against however there is clear trends with regard susceptibility to a single antibiotic (i.e. 
clades of isolates all resistant to cefoxitin with an overall similarity).  Similarly there is clades 
of higher similarity based on MDR classification and the source of isolation. 
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Figure 4.24 – Similarity dendrogram of Staphylococcus aureus isolates recovered from post-shift 
healthcare workers uniforms.  Similarity determined by antibiotic susceptibility testsing and 
subsequent analysis of antibiotic susceptibility profile using Bionumerics software (n=264).  Green = 
susceptible; Red = resistant; Black = Multi-Drug Resistant; Grey = non-Multi-Drug Resistant.   
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Figure 4.25 – Similarity dendrogram of Enterococcus isolates recovered from post-shift healthcare 
workers uniforms.  Similarity determined by antibiotic susceptibility testsing and subsequent analysis 
of antibiotic susceptibility profile using Bionumerics software (n=169).  Green = susceptible; Red = 
resistant.  
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4.4 Conclusion  
The diversity analysis of S. aureus and Enterococcus spp. isolated from post-shift healthcare 
workers uniforms shows that there is variation in phenotypic characteristics and genomic 
variation at a species/genus level.   
 
4.4.1 RAPD Protocol Development  
One of the aims of this work was to develop a protocol/workflow using RAPD to assess 
genomic diversity amongst a bacterial population.  The major issue to overcome is 
reproducibility of banding patterns produced for each isolate.  S. aureus ATCC43300, S. 
aureus DSM20231, E. faecalis ATCC29212 and E. faecalis DSM12956 control isolates were 
tested for reproducibility using a pre-defined RAPD protocol.  Gel electrophoresis 
reproducibility was 97.5-98.8%, intra-reproducibility was 92.8-98.8% and inter-
reproducibility was 86.2-97.8%.  The conclusion of these assays is that RAPD is not 
reproducible.  Between 2 independent runs of the same – isolate similarity/reproducibility is 
as low as 86.2%.  This means that due to protocol variability two isolates with the same 
genome (100% similarity to each other) could be assessed as only 86.2% like each other; i.e. 
assay does not allow genomic diversity to be assessed accurately.   
 
As RAPD was shown to be variable, additional steps were added to the analysis to allow the 
user to quantify/quality check the reproducibility of the assay.  Duplicate runs of the RAPD 
protocol were completed for each isolate, the two independent RAPD profiles were used to 
run a quality check of the data.  Each isolate was tested in two independent RAPD runs, the 
RAPD banding pattern for replicate 1 and replicate 2 were input to bionumerics and a direct 
comparison for similarity between replicate 1 and replicate 2 was completed.  If data was 
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fully reproducible the software deemed similarity between replicate 1 and 2 (of the same 
isolate) to be 100%; any protocol variability would be output as diversity between replicate 
1 and replicate 2.  Based on this data quality control step a reproducible threshold is included 
to ensure that any diversity seen is representative of genomic diversity rather than 
variability.  Evidence of the importance of including this step to overcome RAPD 
reproducibility issue is that when no reproducibility threshold is included the dendrogram 
produced suggests 87% similarity in a large population, however when a threshold of a 
minimum 95% threshold of reproducibility is included 91% similarity is observed.  Further 
evidence is when a strict 99% reproducibility threshold is included similarity is deemed to be 
94%.  This trend shows that when reproducibility of a RAPD dataset is included, less variation 
is observed indicating that if no quality check/reproducibility threshold is included RAPD 
variation is most likely not representative of diversity between isolates but rather 
irreproducibility of the protocol.   
 
This data leads to the conclusion that when conducting RAPD assessment [1] independent 
replicates of samples should be completed, [2] reproducibility between replicates should be 
assessed/quality checked and [3] only isolates which were shown to be reproducible should 
be included in data analysis.  Only by including these checks can any diversity presented in a 
dendrogram based on RAPD profiles be considered representative of genomic diversity 
between isolates.  Figure 4.26 shows a data analysis workflow for a single isolate.  This 
workflow is recommended to be included in all RAPD analysis.   
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Figure 4.26 – Data analysis workflow for quality check of RAPD data to determine reproducibility.  
Schematic representative of one isolate – two independent replicates of isolate undergo RAPD 
protocol producing two RAPD banding patterns/profiles.  These profiles are compared in a similarity 
test to determine reproducibility between replicates.  If reproducibility is less than 99% this isolate is 
not included in the overall data set.  If reproducibility is 99% or higher this profile is included in the 
overall data set.   
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4.4.2 RAPD Assessment of Diversity of Healthcare Worker 
Uniform Isolates  
RAPD was used to determine genomic diversity amongst S. aureus and Enterococcus spp. 
populations.  From the bacterial populations and various sub- population (i.e. antibiotic/MDR 
profile and source of isolation characteristics) it is evident that genomic diversity is present.  
There is a high level of similarity amongst isolates with many demonstrating >99%-100% 
similarity to one another.  Alternatively, the dendrograms show up to 7% diversity (93-100% 
similarity) between some isolates of the same species/genus.  The dendrograms also display 
multiple clustering of clades or families within the S. aureus and Enterococcus spp. 
populations.  Within these clusters there is obvious increased similarity amongst various sub-
groups, for example, clustering of all MRSA and non-MRSA isolates – isolates found to be 
MRSA had increased similarity as a sub-group, this was also the case with non-MRSA, MDR, 
non-MDR, VRE and non-VRE isolates.  Additionally there is increased similarity amongst 
bacteria isolated in the same collection group.  In conclusion, RAPD diversity analysis 
demonstrates a high level of relatedness amongst S. aureus and Enterococcus spp. 
populations isolated from healthcare workers uniforms.  Furthermore, there is increased 
similarity amongst sub-populations based on antibiotic susceptibility and collection points.   
 
The data shows high similarity (93-100%) amongst S. aureus bacterial populations.  In other 
published works using RAPD analysis Nikbakht et al. (2008) conducted RAPD analysis of 
MRSA isolated from staff and patients of an Iranian hospital; they found limited cluster 
groups and 95-100% similarity amongst the population, however it should be noted different 
RAPD primer sets were used (Nikbakht et al., 2008).  Kurlenda et al. (2007) assessed 234 
MRSA isolates (collected from a Polish hospital over a 7 year period) using the same primer 
as this work (AP-7) and found only 10 banding patterns, furthermore 84% of isolates 
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demonstrating the same pattern suggesting a high level of similarity (Kurlenda et al., 2007).  
Kurlenda et al. also suggest primer AP-7 is a low discriminatory RAPD primer.  This 
information supports our findings of high similarity amongst the S. aureus isolated from 
healthcare workers’ uniforms.  However, theoretically any diversity determined is indicative 
of genetic diversity and heterogeneity, meaning multiple clones/isolate types are present in 
the population.   
 
RAPD analysis of Enterococcus spp. isolated from healthcare workers’ uniforms 
demonstrated heterogeneity with multiple RAPD profiles present.  However, there is a high 
level of similarity between RAPD banding patterns.  A study conducted in a Cork hospital 
used RAPD to assess VRE isolated from faecal samples, this study also found heterogeneity 
amongst the population.  From a total of 67 samples, 18 distinct RAPD profiles were 
identified despite other molecular characteristics (virulence gene presence) testing positive 
for all isolates (Whelton et al., 2016).  Lucet et al. (2007) used RAPD for assessment of VRE 
isolated from 39 patients at French university hospital during an outbreak.  All isolates 
demonstrated the same RAPD banding pattern, an expected result from an outbreak.  
However, in a comparison with VRE isolated from different hospital heterogeneity was 
evident (assessed by RAPD) amongst isolates from different sources/hospitals – suggesting 
variation based on source of isolation (Lucet et al., 2007).  These data sets identified in the 
literature support the data from Antrim area hospital with high similarity amongst 
Enterococcus spp. isolates.  However, as seen with S. aureus isolates with low levels of 
diversity were detected suggesting multiple isolate types with high similarity amongst the 
Enterococcus spp. population.    
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4.4.3 Antibiotic Susceptibility Profile Diversity of Healthcare 
Worker Uniform Isolates  
Each isolate was tested against 8 antibiotics using the disc diffusion method following 
EUCAST guidelines.  For a single isolate the result for 8 antibiotics generates an antibiogram 
profile based on sensitive/resistance patterns.  A similarity test of antibiogram profiles was 
compared using Bionumerics software to produce a dendrogram for S. aureus and 
Enterococcus spp. isolates.  Giacca et al. (1987) first reported using antibiotic profile patterns 
to produce dendrograms for cluster and diversity comparisons for inexpensive 
epidemiological analysis of cross-infections in healthcare settings (Giacca et al., 1987).   
 
The antibiogram similarity dendrograms show increased diversity amongst bacterial 
populations compared to RAPD diversity.  S. aureus antibiotic profile pattern similarity 
ranged from 35-100% and Enterococcus spp. antibiotic profile pattern similarity ranged from 
40-100%.  For S. aureus isolates classed MDR and/or MRSA demonstrated increased 
similarity.  Similarly VRE and non-VRE isolates had increased similarity in the Enterococcus 
spp. population.  Varela et al. (2013) also reported multiple antibiotic profiles (7 antibiotics 
tested) of enterococci from hospital effluent and reported similarity values of 25-100% for 
65 isolates, this publication also reported increased diversity between VRE and non-VRE 
isolates (Varela et al., 2013).  Reem et al. (2014) also assessed antibiotic profiles for diversity 
in S. aureus (MRSA and MSSA) isolated from high touch surfaces of ophthalmology clinic over 
a 1-year surveillance study.  They also reported diversity by assessing phenotypic antibiotic 
susceptibility profile along with genotypic diversity (however this was assessed with PFGE 
rather than RAPD) (Reem et al., 2014).  Similarly to the analysis of the Antrim area hospital 
isolates MRSA and MSSA populations had increased similarity for both phenotypic and 
genotypic characteristics.   
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In conclusion the antibiotic profile pattern comparisons suggest bacterial phenotypic 
diversity suggesting multiple isolate types present in both S. aureus and Enterococcus spp. 
populations.  This diversity (40-100% similarity) is increased in comparison to diversity 
determined by RAPD (93-100% similarity).  This is an expected result, the RAPD analysis 
determines genomic diversity based on one primer (i.e. one variable) whereas in the 
antibiotic profiling the phenotypic response of isolates when challenged with eight 
antibiotics was used (i.e. eight variables).  This would suggest RAPD (using these primers and 
conditions) does not allow sufficient discriminatory power to effectively assess diversity 
amongst a large bacterial population.  Further evidence of this is different antibiogram 
profile could have the same or different RAPD profile – therefore not discriminating between 
clinically different bacteria with regard antibiotic susceptibility.  However the antibiogram 
profiles allows sufficient discriminatory power (evident by high levels of diversity).  
Furthermore the antibiogram data would be a clinically significant information set, this [A] 
allows discrimination of isolate types based phenotypic response, and [B] reveals 
information based on antibiotic resistances and therefore potential treatment options.   
 
However, both RAPD analysis and antibiogram profile comparisons suggest multiple isolate 
types present in S. aureus and Enterococcus spp. bacterial populations recovered from 
healthcare workers uniforms at Antrim Area Hospital (NHSCT).   
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4.4.4 Clinical Relevance of Bacterial Diversity  
Multiple isolates of S. aureus and Enterococcus spp. presence on healthcare workers 
uniforms has clinical significance for various reasons.  Bacterial diversity at a species/genus 
level suggests multiple contaminants increasing the bacterial types which could infect 
patients.  Multiple isolate types is also evidence of multiple sources of environmental 
contamination, leading to healthcare workers uniforms contamination which subsequently 
act as a potential transmission route of infection to patients.  The same RAPD and/or 
antibiogram profile (i.e. same isolate type) isolated on multiple uniforms, collected on 
different days is evident in one contaminant/contamination point resulting is subsequent 
contamination of multiple uniforms over a prolonged timescale (consistent contamination) 
which could act as vectors of transmission onto patients.  An example of this is seen in Figure 
4.19 where the same RAPD profile has been isolated from multiple independent uniforms.  
However, similarity between isolates is increased when isolated from the same collection 
group which suggests on different days different contaminants are introduced to the hospital 
environment.  In conclusion this suggests continuous contamination of the healthcare 
environment with multiple isolate types of S. aureus and Enterococcus spp.   
 
Multple isolate types are present in the bacterial populations therefore the bacteria are 
different which could translate to differences in phenotype.  Pathogenicity variation could 
be tested by assessing the presence/absence of related virulence genes.  Likewise antibiotic 
resistance could be tested by assessing the presence/absence of relevant antibiotic 
resistance genes, however the antibiograms represent phenotypic evidence of this variation.  
With regard infection control practices multiple isolate types potentially could represent 
variation in bacterial survival mechanisms and resistance to biocides.  This would require 
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testing of disinfection practices and technologies against an array of bacterial and isolate 
types to accurately determine their potential uses in an infection control practice.   
 
4.4.5 Summary of Findings 
• When using RAPD, reproducibility should be assessed to ensure accurate genomic 
diversity is determined.  This can be achieved by including ‘quality control’ steps of 
multiple replicates to quantify reproducibility.   
• RAPD suggests the biobank of S. aureus and Enterococcus spp. isolated from 
healthcare workers’ uniforms’ at Antrim Area Hospital (NHSCT) contain multiple 
isolate types.   
• Comparison of antibiogram profiles suggests the biobank of S. aureus and 
Enterococcus spp. isolated from healthcare workers’ uniforms’ at Antrim Area 
Hospital (NHSCT) contain multiple isolate types.   
• Multiple isolate types represent consistent contamination of the healthcare 
environment with an array of contaminants.   
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Chapter 5  
General Discussion 
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The overall theme of this work was focused on HAIs, the role of contamination on healthcare 
workers uniforms in the dissemination of HAIs and novel approaches to tackle HAI 
contamination in the healthcare environment.  The presence, survival and persistence of 
HAIs in the healthcare environment has detrimental implications for public health (mortality 
and morbidity rates increase) (Magill et al., 2014; Zingg et al., 2015), finance sectors 
(increased hospital resource use and associated costs) (Lamarsalle et al., 2013) and 
antimicrobial resistance (Holmes et al., 2016) (increased levels of antimicrobial resistant 
pathogens and antimicrobial resistance drivers contributing to increased antimicrobial 
resistance).   
 
In this work we set out to assess levels of bacterial contamination within a real-life setting 
(Antrim area Hospital) and characterised a proportion of the bacteria recovered.  We 
assessed antibiotic resistance patterns from S. aureus and Enterococcus spp. recovered from 
healthcare workers uniforms.  We also assessed the efficacy of a novel mode of action 
disinfectant (GS) in order to determine if it had any utility in an infection control system to 
prevent surface contamination.  The aims of the work can be summarised as follows: 
• To assess a novel disinfectant for direct and residual antimicrobial activity against 
bacteria, biofilm and spores.   
• To measure bacterial bioburden contamination on healthcare workers’ uniforms as 
a proxy for environmental contamination, and likely routes of transmission to 
patients.   
• To assess the antimicrobial resistance profiles and population diversity levels of 
bacteria directly recovered from a healthcare setting.   
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5.1 Disinfectant Assessment Standards  
As discussed in chapter 1, in hospitals disinfection of the hospital environment is a means to 
reduce bacterial contamination, this has been shown to reduce HAI incidence (White et al., 
2008; Simmons et al., 2013).  Hospitals use a variety of disinfectants for cleaning of the 
healthcare environment (Pratt et al., 2007; Lawley et al., 2010; Boyce et al., 2014; Boyce, 
2016; Rutala and Weber, 2017).  Disinfection conventionally involves physical cleaning 
purpose and biological cleaning purpose of the environment and microbiological cleaning 
(removal of microorganisms) (Loveday et al., 2014).  Performance of disinfectant (based on 
efficacy) is the primary consideration in disinfection (Humphreys, 2011) (other contributors 
include social factors with regard staff compliance to protocols).  The European Committee 
for Standardization (CEN) provides guidelines for validation of disinfection performance – 
these guidelines are made up of standards with specific pass/fail criteria for 
performance/effectiveness.  For disinfectant performance these guidelines comprises of a 3 
phase tiered approach for assessment and validation of a disinfection for use in hospital 
infection control practices (Hiom et al., 2015).  These phases and standards are summarised 
in Figure 5.1 and Table 5.1.  It is important to note that these standards are continually 
reviewed and updated (Fraise, 2008).  The recommended USA system outlined in the United 
States Pharmacopoeia uses a very similar three tiered approach – this standard is referred 
to as Section 1072 USP 2015 (Hiom et al., 2015).   
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Figure 5.1 – European disinfection testing framework.  Overview of processes for assessing the 
efficacy of disinfectants.  Phase 1 and phase 2 assessment are conducted in a laboratory with specific 
end-point assessment of suspension antimicrobial testing (phase 1) and surface or “intended use” 
antimicrobial testing (phase 2).  Phase 3 testing is conducted on-site of intended use (Humphreys, 
2011; European Committee for Standardization, 2015).   
 
Table 5.1 – Overview of tiered testing criteria used to assess performance of disinfectants for use in 
NHS infection control practices.   
Phase Test Setting Standard Criteria 
1 Quantitative suspension 
test to determine basic 
biocidal activity.   
Laboratory  EN 1040 5 log reduction in ≤5 
minutes 
2 Quantitative surface test 
to determine intended use 
biocidal activity  
Laboratory  EN 13697 4 log reduction in ≤5 
minutes 
3 Intervention study in real 
life setting to determine 
before and after benefits 
Place of 
intended use 
(Hospital) 
None None 
Information collated from EN 1040 and EN 13697.   
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Phase 1 is the assessment of basic biocidal activity in a laboratory by quantitative suspension 
tests – For bacteria a 5 Log10 reduction in 5 min is required (EN 1040) (The European 
Committee for Standardization, 2005).  For fungi a 4 Log10 reduction in 15 min is required (EN 
1275) (The European Committee for Standardization, 2006).   
 
In Phase 2 testing, disinfectants are assessed in vitro, however tests are designed to assess 
efficacy under “as intended use” conditions, for example surface tests.  These surface tests 
can vary in design depending on disinfectant characteristics, however normal practice is to 
assess reduction in viable numbers of microbes following addition of disinfectant on surfaces 
is determined.  To achieve this standard, 4 Log10 bacterial reduction in 5 min is required (EN 
13697) (Fraise, 2008; The European Committee for Standardization, 2015), 4 Log10 fungal 
reduction in 15 min (EN 1650) (The European Committee for Standardization, 2013) and 3 
Log10 spore reduction in 60 min (EN 13704) (The European Committee for Standardization).  
The standards associated with phase 2 do not provide criteria for assessment of novel mode 
of action disinfectants, such as residual disinfectants or surface acting disinfectants (Hiom et 
al., 2015).   
 
Phase 3 testing is performed in the actual place of intended use, for example hospitals or 
care homes.  A study in which the product is used in a “real life” scenario is conducted with 
appropriate controls to assess performance of the disinfectant (Hiom et al., 2015).  This 
ideally provides information on the potential benefits of a given product, however issues 
include no specific protocol requirements, no standardisation of tests and most importantly 
there is no end point measurement to effectively assess the performance of products is this 
scenario.  Detailed standards are published by CEN for laboratory testing but no standards 
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are available for “real-life” testing – each case is primarily judged on a “before” and “after” 
set of results specific to that setting (Hiom et al., 2015).   
 
 5.1.1 Recommendations for New Standard for Phase 3 Testing 
Disinfection of the healthcare environment is important to reduce environmental 
contamination and subsequently reduce infection rates (and associated costs and antibiotic 
use) (Pratt et al., 2007; Loveday et al., 2014).  Whilst testing disinfectant efficacy in the 
laboratory is important – the absence of standards for assessment in real life settings makes 
it impossible for the performance of novel, potentially more effective disinfectants to be 
accurately assessed and subsequently implemented for use in hospital infection control 
systems (Dancer, 2016; Holmes et al., 2016).   
 
Currently, there is no method of applying information gathered in laboratories to real life 
settings, for example the question could be asked “does a ~1 Log10 reduction in bacteria 
correlate to a significant reduction in hospital contamination levels and subsequent infection 
rates?”  In order to answer this question the previously discussed standards would require 
updating to bridge the gap between laboratory and practice.  Suggestions would include 
defining levels of contamination in hospitals (Reynolds et al., 2018) and conducting in place 
assessments of novel disinfectants to develop an information base.  Information required 
includes current levels of contamination, performance of current disinfectant(s) and 
performance of novel disinfectants.  In addition, monitoring impact of interventions on 
contamination levels and subsequent impact on infection rates.  Such information, if it were 
generated/available, would lead to accurate efficacy standards required of disinfectants to 
have a significant impact on contamination levels and infection rates in hospitals; for 
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example “a 4 Log10 reduction of bacteria by a disinfection is a minimum requirement for 
significant impact in hospitals” – this output is hypothetical but represents an example of 
potential output to bridge the gap between research and practice.  Furthermore, as this 
information bank grows, such information could be used to create standards for phase 3 
testing in the current model (Figure 5.1 and Table 5.1).   
 
 5.1.2 Does Goldshield Comply with Current Standards? 
Chapter 2 primarily details the testing of GS technologies as an alternative, modern 
technology disinfectant for use in hospital infection control systems.  GS technologies was 
robustly tested and was shown to be an effective bactericidal product.  GS is marketed as a 
long-lasting disinfectant to prevent contamination.  Whilst prolonged activity was evident, 
this residual bactericidal activity was of low effect (~1 Log10 reduction) and the efficacy of the 
product reduced over time.  
 
In basic antimicrobial suspension tests GS5 achieved 6 Log10 reduction of S. aureus 
ATCC43300 in 5 min, thus demonstrating compliance with EN 1040.  The current 
requirements outlined in EN 13697 (surface tests) are a 4 Log10 reductions in 5 min.  GS5 was 
tested in surface tests but the results were below the criteria required – Baxa et al. (2011) 
used similar surface tests of GS, and also did not meet the requirements (Baxa et al., 2011).  
However, GS5 was tested as a residual surface disinfectant, meaning bacteria were applied 
to clean surfaces post disinfection to assess residual activity of GS.  In our testing, the residual 
activity of GS was up 1 Log10 reduction of bacteria.  In accordance to the EN 13697 standard 
GS would not pass and therefore be not suitable for disinfection systems – however, the 
current standards do not consider novel mode of action disinfectants (such as residual 
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activity) (Hiom et al., 2015).  As standards do not include specifications or considerations for 
novel/modern technologies it could be argued that they are outdated.  For these reasons it 
is difficult to accurately conclude the potential benefits of 1 Log10 residual antibacterial 
activity (i.e. GS technology).  To determine the potential use of GS in infection control 
systems an intervention study would be required, i.e. phase 3 of EN standards – (see future 
directions).  However, no official standards are available for assessment of phase 3 testing 
(Reynolds et al., 2018).     
 
5.2 Infection Control Implications on Antimicrobial Resistance: An 
 Alternative Approach to Reduce Antimicrobial Resistance  
As discussed in detail in chapter 1, multiple factors contribute to increased infection rates 
within healthcare settings, one of these factors is microbial contamination of the healthcare 
environment by potentially pathogenic organisms (Kramer et al., 2006).  Many 
microorganisms can persist on inanimate surfaces for long time periods, and whilst present 
they pose a risk of (direct or indirect) transmission to susceptible individuals (Ploegmakers 
et al., 2017).  This transmission subsequently results in increased infection rates, increased 
costs (associated with infections) and increased pressure on antibiotic use – furthermore, 
increased usage of antibiotics results in increased antimicrobial resistance (Nicolle, 2001; 
Pratt et al., 2007; Loveday et al., 2014; O’Neill, 2016).   
 
As antibiotic resistance is on the rise, pressure is increasing on alternative approaches to 
tackle infections (O’Neill, 2016).  One approach to the problem is to reduce contamination 
levels resulting in infection prevention by infection control – the importance of infection 
control was discussed in chapter 1 (Ploegmakers et al., 2017).  This includes methods to 
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prevent transmission of infectious agents onto susceptible individuals – this is particularly 
evident in healthcare settings where there is high bacterial contamination levels and 
transmission routes of these contaminants onto patients (Kramer et al., 2006).  Theoretically, 
reducing the contamination levels in hospitals would reduce HAIs and subsequently reduce 
pressures on antibiotic use, this in turn would potentially reduce rates of antimicrobial 
resistance (O’Neill, 2016).   
 
Filice et al. (2010) assessed the financial aspects of poor infection control programs in USA 
and the increased expense resulting by the presence and infection of antibiotic resistance 
organisms.  Infections due to non-resistant S. aureus cost $15,923 whereas infections by 
antibiotic-resistant S. aureus (MRSA) cost $34,657 in a USA hospital over a 6 month period.  
Additional costs were primarily due to increased diagnostic and treatment expenses.  The 
authors concluded that better infection control would reduce the infection rates of MRSA, 
and thus associated costs and antibiotic use (Filice et al., 2010; O’Neill, 2016).   
 
Infection control is a viable approach to prevent infection.  Ignaz Semmelweis, known as the 
“father of infection control,” first implemented infection control measures by 
recommending healthcare workers clean their hands with chlorine before working with 
pregnant women susceptible to childbed fever – this is often described as the birth of 
infection control and was an effective measure to reduce infection rates pre-antibiotics (Best 
and Neuhauser, 2004; Ploegmakers et al., 2017).  Prior antibiotic discovery, infection control 
was the main objective for infection prevention.  Sadly, however antibiotics provided an easy 
treatment option and due to decades of overuse and misuse, there is now a need for 
alternative approaches to treat/prevent infections (Landelle et al., 2014; Filice et al., 2010).   
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The World Health Organisation (WHO) have published a report entitled ‘Infection control 
programmes to contain antimicrobial resistance’ in which they state “assumption would be 
that such a programme would decrease antimicrobial-resistant infections proportional to the 
overall decrease in nosocomial infections” (Nicolle, 2001).  Public Health England regularly 
publish ‘epic: National Evidence-Based Guidelines for Preventing Healthcare-Associated 
Infections in NHS Hospitals in England’ outlining the importance and key aspects to reduce 
HAIs and the subsequent reduction on antibiotic use (Pratt et al., 2007; Loveday et al., 2014).  
Jim O’Neill has also published ‘Infection Prevention, Control and Surveillance: Limiting the 
Development and Spread of Drug Resistance’ as part of his review on antimicrobial resistance 
(O’Neill, 2016).  In this report O’Neill states “The availability of antimicrobials has shifted the 
focus from prevention towards treatment” and “The only sustainable, long-term solution to 
the global problems of AMR lies in action to address the 'demand side'” (O’Neill, 2016) – both 
points clearly support the alternative approach of preventing infection  
 
In chapter 3 we set out to determine contamination levels of S. aureus and Enterococcus spp. 
on healthcare workers’ uniforms.  S. aureus and Enterococcus spp. isolated from uniforms 
were assessed for antibiotic susceptibility.  We showed that healthcare workers uniforms 
become contaminated with highly resistant bacteria during a working shift in a hospital.  This 
contamination confirms environmental contamination (source) and contamination of the 
uniforms.  These contaminants represent potential direct and indirect transmission routes 
of bacteria to susceptible patients.  Furthermore, infections could prove difficult to treat with 
antibiotics as high levels of antibiotic resistance was evident toward first line antibiotics 
amongst isolated bacteria.  This pressure on antibiotic use could result in increased 
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antimicrobial resistance.  Therefore reducing these contamination levels would theoretically 
reduce the need for antibiotic use and antimicrobial resistance.   
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5.3 Concluding Remarks  
The work described in this thesis assesses levels of bacterial contamination on healthcare 
workers uniforms (potential transmission route to patients) and assesses a novel disinfectant 
to prevent this contamination, i.e. assessed a problem and preliminary assessed possible 
solution.  If GS technology could be shown in practice to reduce contamination levels – this 
could subsequently lead to reduced HAIs and associated costs.  Furthermore if successful, 
could be considered an alternative to antibiotic use.   
 
In conclusion better infection control reduces [1] infection rates, [2] associated costs, and [3] 
antibiotic use and [4] antimicrobial resistance.   
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5.4 Future Directions  
The work presented in this thesis highlights a contamination problem of healthcare workers’ 
uniforms in a local hospital which potentially could act as transmission routes onto patients 
resulting in infection and related issues.  Other work assessed a novel approach to prevent 
this contamination problem occurring – however, this work was conducted in the laboratory.  
Due to the outdated standards for assessing efficacy of novel disinfectants there are 
difficulties in applying the information collated in the laboratory to assess potential benefits 
of GS technology in an infection control practice within a hospital.  Therefore, the logical 
future direction would be to test GS technology in a hospital setting, specifically on uniforms.  
GS technology has previously been used in a hospital intervention study, by application on 
high-touch contact surfaces of 18 patient rooms, it was concluded that GS technology could 
prevent 5-10% of HAI cases compared to the normal infection control practices (Perez et al., 
2015).  The proposed study would differ in that uniforms would be treated with GS during 
the laundry processes to coat the uniforms with GS with the aim of preventing contamination 
rather than surfaces – this is relevant as uniforms are a common indirect transmission route 
onto patients.  A uniform treatment study was described in chapter 3 (Johnston, 2012) 
however as previously discussed, due to the lacking of sensitivity in recovery of bacteria 
Johnston (2012) was unable to accurately determine an effect.  The protocol described in 
chapter 3 of this thesis demonstrated high sensitivity of recovery of bacteria therefore would 
be suitable to accurately quantify any reduction of bacteria numbers.   
 
A proposed intervention would involve enumeration of bacterial contamination on GS-
coated healthcare workers uniforms pre-shift and post-shift.  The protocols used would 
mimic those described in chapter 3 where S. aureus and Enterococcus spp. contamination 
was assessed on 200 uniforms.  The difference would be the inclusion of GS technology in 
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the laundry of uniforms to allow a “before and after” comparative of the healthcare workers’ 
uniforms bacterial bioburden in Antrim area hospital.  As GS coats all surfaces uniforms 
material would be coated with the nano-scale ‘bed of nails’ which theoretically prevents 
contamination.  The aims of this study would be to assess contamination levels on healthcare 
workers uniforms coated with GS and to assess infection rates and antibiotic usage during 
the testing period.   
 
It would be hypothesised (based on data from this thesis) that contamination levels would 
be reduced in comparison to the uniforms tested in chapter 3 (i.e. uniforms without GS).  
Furthermore, it is hypothesised infection rates would reduce and subsequently antibiotic 
prescribing.  Additionally, information gathered from such a study would allow assessment 
of the value of laboratory testing versus real life testing; i.e. does the laboratory testing 
presented in this thesis correlate to significant reduction in a real life infection control 
program.   
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Abstract
Healthcare acquired infections (HAI) pose a great threat in hospital settings and environ-
mental contamination can be attributed to the spread of these. De-contamination and, signif-
icantly, prevention of re-contamination of the environment could help in preventing/reducing
this threat. Goldshield (GS5) is a novel organosilane biocide marketed as a single applica-
tion product with residual biocidal activity. We tested the hypothesis that GS5 could provide
longer-term residual antimicrobial activity than existing disinfectants once applied to sur-
faces. Thus, the residual bactericidal properties of GS5, Actichlor and Distel against
repeated challenge with Staphylococcus aureus ATCC43300 were tested, and showed that
GS5 alone exhibited longer-term bactericidal activity for up to 6 days on 316I stainless steel
surfaces. Having established efficacy against S. aureus, we tested GS5 against common
healthcare acquired pathogens, and demonstrated that, on average, a 1 log10 bactericidal
effect was exhibited by GS5 treated surfaces, although biocidal activity varied depending
upon the surface type and the species of bacteria. The ability of GS5 to prevent Pseudomo-
nas aeruginosa biofilm formation was measured in standard microtitre plate assays, where
it had no significant effect on either biofilm formation or development. Taken together the
data suggests that GS5 treatment of surfaces may be a useful means to reducing bacterial
contamination in the context of infection control practices.
Introduction
Healthcare acquired infections (HAIs) are directly and indirectly responsible for increased
morbidity and mortality rates in hospitals worldwide. In Europe alone there are >4.5 million
PLOS ONE | https://doi.org/10.1371/journal.pone.0182624 August 7, 2017 1 / 13
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: Murray J, Muruko T, Gill CIR, Kearney
MP, Farren D, Scott MG, et al. (2017) Evaluation of
bactericidal and anti-biofilm properties of a novel
surface-active organosilane biocide against
healthcare associated pathogens and
Pseudomonas aeruginosa biolfilm. PLoS ONE 12
(8): e0182624. https://doi.org/10.1371/journal.
pone.0182624
Editor: Peter Setlow, University of Connecticut,
UNITED STATES
Received: October 27, 2016
Accepted: July 21, 2017
Published: August 7, 2017
Copyright: © 2017 Murray et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: JM was supported by a postgraduate
research studentship from the Department of
Employment and Learning (N Ireland).
Competing interests: I have read the journal’s
policy and the authors of this manuscript have the
following competing interests: Goldshield products
cases annually, which result in>37,000 deaths [1]. A further consequence is the financial bur-
den associated with these infections, measured in terms of increased length of patient stay,
decreased bed availability as a result and the extra cost of antibiotic therapy to treat the infec-
tion. In the USA alone the total annual expenditure on HAI is estimated to be in excess of $9.8
billion (£6–7 billion) [2], while in Europe a figure of over €7 billion (~£5.5 billion) has been
proposed [3]. As a consequence, there is increasing interest from industrial, research and
development and healthcare sectors in the development of viable and cost-effective alternative
methods of reducing HAI.
Common healthcare associated pathogens include Staphylococcus aureus (and predomi-
nantly Methicillin resistant Staphylococcus aureus (MRSA)), Vancomycin-resistant Enterococci
(VRE), Clostridium difficile, and Pseudomonas aeruginosa. Such microorganisms have been
shown to survive on inanimate surfaces for extended periods of time—for example S. aureus
has been shown to survive as long as 6 months [4,5] while Enterococci can survive as long as 4
months [6]. Clostridium difficile infections (CDI), the most common HAI type in Europe [7]
are attributed in part to the persistence of infectious spores on hospital surfaces for up to 5
months [5]. Bacteria capable of forming biofilms, such as P. aeruginosa and S. aureus, also sur-
vive and persist in the environment due to this ability, on top of any intrinsic resistance to anti-
microbials [8]. Thus vegetative cells, spores, or biofilms present a threat of infection and
indeed a recent report identified biofilm within water taps as the cause of a series of neonatal
P. aeruginosa infections [9].
Evidence of a direct correlation between environmental contamination and infection rates
exists [5,10,11,12] and microbial contamination of the environment has been shown to act as a
source of infection that is directly responsible for transmission of organisms to patients [12].
The most problematic areas tend to be high-touch points such as bed rails, door handles, table
top surfaces, bedding (mattress), television controls and staff uniforms [13]. Such contami-
nated surfaces act as a source of direct to patient, and indirect—via healthcare workers/instru-
ments—spread to patients [5,14]. As long as these organisms persist in a hospital or healthcare
facility environment they remain a source of infection and therefore, hospitals have imple-
mented revised and improved infection control practices in order to reduce and ideally eradi-
cate environmental microbial contamination. This is achieved primarily by the use of
disinfectants and detergents, although the precise disinfectant used will be dependent on mul-
tiple factors. For example, areas of high risk such as operating theatres will require multiple
cleans per day, whereas patient waiting rooms may be cleaned only once per day. The choice
of disinfectant agent is also multifactorial: body fluid spillages will normally require higher
level disinfectants than those used in routine cleaning. As a result, hospitals will use a variety
of products including ethyl alcohol in hand rubs and gels, Quaternary ammonium compounds
(QACs), chlorine-releasing agents and peroxygen sterilants [15]. Nonetheless, current cleaning
methods have in several instances been shown to be ineffective. Work by French et al. [11]
showed that 74% of sites in a London hospital were MRSA positive and when these same sites
were retested post-cleaning, all were still contaminated [11]. Recurrence of contamination on
surfaces, post disinfection, is therefore a significant issue and this is especially true of high-
touch surfaces [16]. Given the available evidence for the ineffectiveness of cleaning and rapid
recontamination of surfaces, there is currently much interest in alternative approaches to the
problem. The development of intrinsically anti-microbial surfaces that incorporate a variety of
agents to kill microbes may be considered a useful strategy. Alternatively, the use of specialised
agents that are capable of preventing surface contamination, or that exhibit a residual antimi-
crobial activity post-disinfection, could be employed, and such products have recently been
highlighted as of potential utility in the healthcare setting [17].
Evaluation of a novel biocide against healthcare acquired pathogens and P. aeruginosa biofilm
PLOS ONE | https://doi.org/10.1371/journal.pone.0182624 August 7, 2017 2 / 13
and technical information were obtained free of
charge from Goldshield Industries (Europe) Ltd,
Unit C, Lincoln Lodge Farm, Castlethorpe, MK19
7HJ. Goldshield Industries were not involved in the
experimental design, collection, analysis or
interpretation of data or in writing the manuscript
or decision to publish.
One such antimicrobial product is Goldshield, distributed by Goldshield Technologies Ltd.
[GS hereinafter]. This is a patented, water soluble organosilane, coupled with a quaternary
ammonium compound that is designed to coat surfaces with a protective antimicrobial layer
to prevent microbial contamination. The product was originally designed at Emory University,
USA and is the subject of three US patents (patent nos. US5,959,014, US6,221,944, and
US6,632,805). In this paper we report the bactericidal and anti-biofilm of GS5 technology
against 11 common healthcare associated pathogens.
Materials and methods
Chemicals, glassware and media
All glassware was sterilised by soaking overnight in 1% Virkon (Antec, UK) and steam steri-
lised in an autoclave prior to use. All culture media (Oxoid, UK) was prepared as per the man-
ufacturer’s instructions. Phosphate Buffered Saline (Oxoid, UK) was prepared in deionised
water and steam sterilised in an autoclave prior to use. Two model surfaces were used. 316l
Steel (Aalco, UK) or Formica were cut into 2cm×2cm samples, autoclaved (121˚C for 15 min)
and stored in a sealed sterile container prior to use.
Microorganisms
Ten bacterial species were obtained from either the American Type Culture Collection
(ATCC) or the Leibniz-Institute DSMZ German Collection of Microorganisms and Cell Cul-
tures (DSMZ). Bacteria included Escherichia coli ATCC25922, Klebsiella pneumoniae
DSM16358, Mycobacterium smegmatis DSM43469, Pseudomonas aeruginosa DSM3227, Staph-
ylococcus aureus (MRSA) ATCC43300, Staphylococcus aureus (non-MRSA) DSM20231, Staph-
ylococcus epidermidis DSM28319 (all cultured at 37˚C using Nutrient broth/agar),
Enterococcus faecalis DSM12956 (37˚C using Tryptone soya broth/agar), Burkholderia multi-
vorans DSM13243 (28˚C using Nutrient broth/agar) and Acinetobacter baumannii DSM30008
(30˚C using Nutrient broth and agar). These were chosen as representative organisms of the
type causing HAIs commonly seen in hospitals [18] and included Gram positive organisms,
Gram negative organisms and Mycobacteria. Mycobacterium smegmatis was used as it is a fast-
ing-growing model Mycobacterium species [19]. Organisms were stored on Cryobeads (Tech-
nical Service Consultants Ltd, UK) at -80˚C and recovered in suitable media when required.
Disinfectant agents
Three disinfectant agents used (GS5, Actichlor and Distel) are classed bactericidal surface dis-
infectants. The characteristics of these antimicrobial agents are summarised in Table 1. Agents
were acquired as full strength concentrate and working stock concentrations were prepared by
dilution with deionised water as per the respective manufacturer’s instructions.
Direct bactericidal assessment of GS5
To determine directly the bactericidal activity of GS5, a suspension contact time assay was
completed; varying concentrations of GS5 were mixed with S. aureus ATCC43300, followed by
recovery and enumeration of viable cells to determine Log10 reduction. 0% (sterile water),
0.25% (v/v), 0.5% (v/v) and 1% (v/v) GS5 dilutions were prepared using sterile water as diluent.
A 10 μl aliquot of mid-log S. aureus ATCC43300 was mixed with each of the GS5 concentra-
tions and left to stand at room temperature for 5 min. Bacteria were enumerated by dilution
plating 0.1ml aliquots onto Nutrient agar in duplicates and incubating at 37˚C for 24 h fol-
lowed by direct colony counts. Three biologically independent experiments were performed.
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Residual surface activity of disinfectants
To investigate the residual activity of surface disinfectants a protocol was developed from the
EN13697 standard and the work of Baxa et al. [20]. Staphylococcus aureus ATCC43300
(MRSA) and 316l Steel were used. The 316l Steel surface samples were sprayed with either
GS5, Actichlor, Distel or sterile water (no treatment control) using a hand spray. The test sur-
faces were left to dry in the sterile environment of a category 2 cabinet (Biomat). S. aureus
ATCC43300 was grown to mid log phase of growth (OD600 = ~0.48) and diluted 1/100 using
sterile PBS (Oxoid, UK). A total of 100 μl of this was added (in 10 μl droplets) to technical trip-
licate examples of each surface. Bacteria were left on the surfaces for 45 min, and then viable
cells recovered in 10 ml of sterile PBS by vortexing for 2 min. Bacteria were enumerated by
plating dilution series in duplicate on Nutrient Agar and incubating at 37˚C for 24 h followed
by direct colony counts [20]. Following recovery of bacteria from the surfaces each surface was
individually washed using sterile PBS, air dried and stored in a sterile storage box. These sur-
faces were then re-challenged with S. aureus ATCC43300 as above. This re-challenge was
repeated at 3-day intervals over 15 days. Three biologically independent experiments were
performed.
GS5 bactericidal surface testing
A selection of 10 different bacteria, representative of important HAI, were individually tested
on 316l Steel and Formica. Testing was performed once to determine the maximum antimi-
crobial effect for a freshly treated surface. The protocol was as described above, but without re-
challenge and only the activity of GS5 was assessed.
Assessment of GS5 efficacy against biofilms
Pseudomonas aeruginosa DSM3227 biofilms were grown in 24-well microtiter plates (4 wells
per treatment) and these were stained with 0.1% crystal violet to assess the extent of biofilm
growth according to established methods [21,22,23]. To determine efficacy of GS5 against bio-
film, Thermo Scientific™ Nunc™ Cell-Culture Treated Multidishes, (Thermo Scientific, UK)
were pre-treated with either 5% GS5 or sterile water (untreated): wells were soaked with 1 ml
of agent for 10 min following which treatment agents were aspirated and plates left to dry in a
sterile environment (Biomat category 2 cabinet). An overnight culture of P. aeruginosa
DSM3227 was diluted 1/100 (using sterile nutrient broth) and microtitre plate wells inoculated
with a 1 ml aliquot following which the plates were incubated aerobically at 37˚C. At defined
time points (8 h, 12 h, 24 h, 48 h, 72 h and 96 h) biofilm production was assessed. The medium
containing planktonic cells was removed and wells stained with 1.5 ml of 0.1% Crystal Violet
(Sigma-Aldrich, UK) for 10 min at room temperature. Unbound crystal violet (Sigma-Aldrich,
Table 1. Antimicrobial products tested.
Agent Type Active ingredient Concentration
used*
Goldshield5 Organosilane coupled with Quaternary Ammonium
Compound (siQAC)
Trihydroxysilylpropyldimethyloctadecyl ammonium
chloride
1:20 dilution
Actichlor Chlorine-based disinfectant Sodium dichloroisocyanurate 1:10 dilution
Distel Quaternary Ammonium Compound Tertiary alylamine and quaternary ammonium
compounds
1:100 dilution
* as per manufacturer’s instructions.
https://doi.org/10.1371/journal.pone.0182624.t001
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UK) was removed and stained wells washed twice with 2ml sterile PBS following which bound
crystal violet was solubilised using 1.5 ml of 30% Acetic Acid (Thermo Scientific, UK) for 30
min at room temperature. A 1 ml aliquot from each well was transferred to a fresh 24-well
microtiter plate and the absorbance of the crystal violet measured at 570nm using a FLUROs-
tar Omega plate reader (BMG LABTECH, Europe). Each experiment was repeated on three
separate occasions.
Assessment of GS5 effects on bacterial viability in biofilm
Bacterial viability in biofilms was assessed using the BacLight Live/Dead bacterial viability kit
(L-7007; Molecular Probes, Eugene, OR) [24,25]. With Baclight, live cells stain green and
dead/damaged cells stain red. A stock solution was prepared by mixing 4 μl of component A
(1.67 mM Syto9 plus 1.67 mM propidium iodide), 6 μl of component B (1.67 mM syto9 plus
18.3 mM propidium iodide) and 1ml of sterile water as described by Bauer et al. [25]. P. aerugi-
nosa DSM3227 biofilm was grown in 4-well Nunc™ Lab-Tek™ II Chamber Slide™ Systems
(Thermo Scientific, UK) pre-treated with either 5% GS5 or sterile deionised water. Slides were
inoculated with 1 ml of a 1/100 dilution of overnight culture of P. aeruginosa and incubated
aerobically for 24 h and 48 h at 37˚C. At each time point excess media and planktonic cells
were removed and the wells washed with sterile PBS followed by staining with 200 μl BacLight
mix and 100 μl of sterile water. Stained slides were incubated in the dark at room temperature
for 30 min following which the wells were then washed with sterile PBS and viewed using ×100
oil immersion on a Nikon ECLIPSE E400 (Nikon) microscope utilising a dual-band emission
filter (450–490 nm/510–560 nm). Images were generated using NIS-Elements BR (Nikon) soft-
ware version 3.22.09. Image J software was used to generate composite (red/green) images of
the baclight stained biofilms.
Statistical analysis
For bactericidal testing, log10 changes in viable bacterial numbers, compared to untreated con-
trols was determined. The equation Log Reduction LR = log10 (Ncontrol)–log10 (Ntreated) was
used where Ncontrol is total recovery of untreated bacteria and Ntreated is total recovery of treated
bacteria. Data was imported to Graphpad Prism 6.01 and charts constructed. Statistical analy-
sis was completed using SPSS v22.
Results
Direct bactericidal assessment of GS5
We firstly wished to determine if GS5 was effective against bacteria in solution, prior to surface
testing. We hypothesised that a solution of GS5 at working concentration would exhibit a bac-
tericidal effect against a suspension of bacteria. The direct antibacterial effects of GS5 against
S. aureus ATCC43300 was assessed using a suspension assay. S. aureus ATCC43300 was chal-
lenged with increasing concentrations of GS5 to quantify bactericidal activity. GS5 exhibited
bactericidal actions at all concentrations after 5min contact time as shown in Fig 1 (0.25% =
4.96 Log10 reduction; 0.5% = 5.6 Log10 reduction; 1% = 6 Log10 reduction (complete kill). Sub-
sequent testing was completed at 5% as per manufacturer’s instructions.
Residual activity of surface disinfectants
GS5 is reported to form covalent bonds with surfaces, thereby leaving a nanoscale antimicro-
bial coating which kills microbes that encounter that surface. This, it is claimed, makes GS5 a
more effective product due to its residual antimicrobial activity compared to other
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disinfectants. We designed an experiment to test this hypothesis by determining the residual
antimicrobial effect of GS5, Actichlor and Distel. The bactericidal activity of the three surface
disinfectant agents was tested against S. aureus ATCC43300 on 316l Steel (Aalco, UK) and
residual activity was assessed over 15 days at 3 day intervals. All three products exhibit bacteri-
cidal activity on day 0 (Actichlor = 3.75Log10 reduction; Distel = 0.54 Log10reduction;
GS5 = 1.16 Log10 reduction). Following subsequent re-challenge of treated surfaces with S.
aureus ATCC43300 only GS5 showed significant residual bactericidal activity; this residual
activity exerted by GS5 was evident for 6 days (Day 3 GS5 = 0.53 Log10 reduction; Day 6
GS5 = 0.26 Log10 reduction; Fig 2). For subsequent testing of the GS5 product, the maximum
effect time point (day 0) was used.
GS5 bactericidal surface testing
Baxa et al. [20] suggested that GS5 exhibited variable effect against different bacterial species.
We therefore tested GS5 against a range of healthcare acquired infection microorganisms on
316l Steel or Formica to determine bactericidal effect. As hypothesised, GS5 treated surfaces
did indeed exhibit a bactericidal effect against all ten tested microorganisms, and this effect
was observed on both Formica and steel. The largest bactericidal effect was observed with
Staphylococcus strains where a>1 log10 reduction was observed on 316l Steel (S. aureus
ATCC43300 = 1.21 Log10 reduction; S. epidermidis DSM28319 = 1.06 Log10reduction)
(Table 2). On Formica, however, the GS5 product exhibited a lower bactericidal effect
(<0.5 = Log10reduction) against both Staphylococcus organisms. The average Log10 reduction
Fig 1. S. aureus ATCC43300 survival following suspension test using GS5. ~2×106 cfu/ml of S. aureus
ATCC43300 was challenged with increasing concentrations of GS5. Data represents mean +/- SD of three
independent experiments. Statistical analysis by independent T-tests versus Untreated (0%) controls (* =
p<0.05, ** = p<0.005, *** = p<0.001).
https://doi.org/10.1371/journal.pone.0182624.g001
Evaluation of a novel biocide against healthcare acquired pathogens and P. aeruginosa biofilm
PLOS ONE | https://doi.org/10.1371/journal.pone.0182624 August 7, 2017 6 / 13
on steel surfaces for all bacteria tested was 0.6, whereas the average Log10 reduction on For-
mica was 0.45.
Effect of GS5 on bacterial biofilm formation
Walker et al. [9] have demonstrated that biofilm contamination can contribute significantly to
outbreaks of healthcare acquired infections. Given the efficacy of GS5 against a range of HAI
microbes, we hypothesised that a GS5-treated surface would impede the development of bacte-
rial biofilms. P. aeruginosa is a well characterised biofilm former [26], and therefore we pre-
treated plastic microtitre plate surfaces with GS5 and assessed the development of P. aerugi-
nosa DSM3227 biofilms. The crystal violet staining method provides a quantitative measure of
biofilm development/biomass and somewhat unexpectedly our data revealed that GS5 did not
appear to inhibit the development of P. aeruginosa DSM3227 biofilm in plastic microtiter
plates (Fig 3). Having observed that P. aeruginosa DSM3227 biofilm development was
Fig 2. Comparison of residual antimicrobial effects of GS5, Actichlor and Distel on steel surface
loaded with Staphylococcus aureus ATCC43300. GS5 exhibited prolonged antibacterial activity (6 days)
whereas Actichlor and Distel showed no antibacterial activity after day 0. Results are representative of three
independent experiments (n = 3; mean+/- SD plotted). Statistical analysis using One way ANOVA and
Dunnett’s T-test versus Untreated control (* = p<0.05, ** = p<0.005, *** = p<0.001).■ = Goldshield;● =
Untreated control;  = Actichlor; □ = Distel.
https://doi.org/10.1371/journal.pone.0182624.g002
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apparently unaffected, we assessed bacterial viability within the biofilms using the well-estab-
lished BacLight staining method. This analysis suggested that a proportion of the bacterial cells
were damaged or rendered non-viable when grown on GS5 treated surfaces, but that, critically,
a sufficient number of viable/undamaged cells remained (Fig 4) which, we hypothesise are
responsible for subsequent biofilm development.
Discussion
Only a single published report exists which details the effects of GS5 used as a surface biocide.
GS5 is reported to exert its antimicrobial effect via bonding of the silane end of the molecule to
surfaces, following which microbes are drawn onto the hydrocarbon chain. The resultant
puncturing of cell membranes and denaturation of proteins is proposed as the cause of cell
death [20]. As a covalent bond is formed with the surface it is hypothesised that this mode of
action is prolonged creating a ‘bactericidal surface’.
When we tested the prolonged activity GS5 exhibited bactericidal activity for 6 days (0.26
log10 reduction) whereas the other surface disinfectants tested showed no activity beyond day
0 (Fig 1). In comparison with previous residual testing of the GS5 product by Baxa et al. [20],
which was completed on fabric swatches rather than on hard surfaces, we observed that resid-
ual antimicrobial activity of GS5 was lower (6 days rather than 14 days) [20]. However, the
residual antibacterial effect decreased over time to a<1 log10 reduction in bacterial numbers,
suggesting that GS5 would need regular reapplication and would not be sufficient as a surface
disinfectant alone.
Table 2. Log10 reductions obtained on GS5 treated surfaces challenged with a variety of microbes.
Organism Surface Log10 Untreated ± SD Log10 Treated ± SD Log10 change p-value
Acinetobacter baumannii DSM30008 Steel 4.82 ±0.36 4.49 ±0.62 0.33* 0.0138
Formica 4.25 ±0.04 3.67 ±0.29 0.58*** <0.001
Burkholderia multivorans DSM13243 Steel 3.90 ±0.14 3.62 ±0.17 0.28*** <0.001
Formica 3.94 ±0.05 3.41 ±0.24 0.53** 0.0011
Enterococcus faecalis DSM12956 Steel 5.27 ±0.3 4.8 ±0.08 0.47 0.0623
Formica 5.15 ±0.13 4.86 ±0.03 0.29** 0.0016
Escherichia coli ATCC25922 Steel 5.57±0.28 5.32 ±0.33 0.25** 0.0018
Formica 5.54 ±0.09 5.22 ±0.02 0.32*** <0.001
Klebsiella pneumoniae DSM16358 Steel 4.30±0.27 3.54 ±0.33 0.76* 0.0135
Formica 3.94 ±0.05 3.41 ±0.24 0.53** 0.0011
Mycobacterium smegmatis DSM43469 Steel 4.06 ±0.22 3.46 ±0.45 0.6*** <0.001
Formica 5.83 ±0.43 5.16 ±0.44 0.67** 0.0026
Pseudomonas aeruginosa DSM3227 Steel 5.09±0.04 4.66±0.29 0.43** 0.0017
Formica 5.15±0.1 4.63±0.12 0.52*** <0.001
Staphylococcus aureus (MRSA) ATCC43300 Steel 4.19 ±0.13 2.99 ±0.58 1.2*** <0.001
Formica 5.04 ±0.03 4.68 ±0.08 0.36*** <0.001
Staphylococcus aureus (non-MRSA) DSM20231 Steel 4.57±0.22 3.48±0.27 1.09*** <0.001
Formica 5.02±0.23 3.94±0.35 1.08* 0.0089
Staphylococcus epidermidis DSM28319 Steel 3.95 ±0.04 2.88 ±0.05 1.07** 0.0047
Formica 5.25 ±0.19 4.94 ±0.25 0.31*** <0.001
Results are representative of three independent experiments (n = 3; mean+/- SD). p value calculated using paired T-Test (* = p<0.05, ** = p<0.005, *** =
p<0.001).
https://doi.org/10.1371/journal.pone.0182624.t002
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GS5 treated surfaces exhibited bactericidal activity which varied in effectiveness between
surface type and bacterial species (Table 1). Thus, bacterial species challenged, in addition to
surface type/properties, appears to have a significant influence on the performance of the GS5
product. Surface hydrophobicity, charge and roughness have all been reported as important
with respect to performance of biocides [12]. Indeed, variations in the response of bacterial
species to disinfectants is evident in the literature with disparate log10 reductions and widely
varying minimum inhibitory concentrations (MICs); biocidal resistance is also evident
[20,27]. GS5 is said to not induce resistance in microorganisms as a result of its physical mode
of action, reported as membrane disruption and protein denaturation. We noted differences
between the results of our current work and data reported by Baxa et al. [20] who also tested S.
aureus, E. coli and P. aeruginosa on steel and Formica. The work of Baxa et al. [20] suggested
Fig 3. Biofilm development following pre-treatment with GS5. Pseudomonas aeruginosa DSM3227
biofilm biomass was assessed by crystal violet staining at various time points and data presented represents
mean +/- SD of three independent experiments. Statistical analysis by independent T-tests versus Untreated
controls (* = p<0.05, ** = p<0.005, *** = p<0.001). Grey columns representative of pre-treated samples;
black bars representative of untreated controls.
https://doi.org/10.1371/journal.pone.0182624.g003
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that GS5 had greater efficacy against E. coli and P. aeruginosa, however this observation could
be a result of differing surface properties across different types of Steel and Formica used.
However, like Baxa et al. [20], we have shown that the performance of GS5 against different
bacterial species varies considerably, which indicates that the specific type of microbial con-
taminant will be of greater influence on the effectiveness of GS5, than the actual surface on
which it is used.
The ability of HCAI pathogens to adhere, via specific surface proteins to a range of sub-
strates likely to be found in healthcare settings, including polystyrene, has been reported [28].
While biofilms that develop on medical devices such as catheters, chest tubes, prosthetic joints
etc. are of concern [29], such medical devices were not the focus of our work. Beyond medical
devices, on which biofilms most certainly develop, the contamination of any surface with bac-
teria in a matrix containing nutrients, will potentially enable development of biofilm. Hospital
water systems, from storage to taps, allow biofilm formation and such contamination has been
directly linked to adverse health outcomes [9].
Experiments in which plastic surfaces were pre-treated for 10 min with GS5 showed that
there was no significant inhibitory effect against P. aeruginosa biofilm formation (Fig 3). It is
well documented that biofilms exhibit increased resistance to antimicrobials and disinfectants,
mainly due to the inability of these molecules to penetrate the biofilm [27]. Given that the
GS5-treated plate surfaces would be expected to possess antimicrobial activity, we then consid-
ered the viability of cells within developing biofilms. Using BacLight, we observed an initial
apparent bactericidal effect on P. aeruginosa DSM3227 cells (Fig 4c) as evidenced by a
Fig 4. BacLight staining of P. aeruginosa DSM3227 biofilm at 24 h and 48 h. Live cells appear green and dead/damaged cells appear
red. Images A and B show development of extensive biofilm on untreated surfaces. Image C shows biofilm development on GS5 treated
surface with a greater proportion of dead/damaged cells. Image D shows GS5 treated surface biofilm at 48 h: biofilm development and cell
viability is similar to the untreated control. Images were obtained ×100 magnification (oil immersion) on a Nikon ECLIPSE E400 (Nikon)
microscope utilising a dual-band emission filter (450–490 nm/510–560 nm) and NIS-Elements BR (Nikon) software; composite (red/green)
images generated using Image J software. Scale bar = 10 μm. Brightness values were generated for each panel (fig 4 a/b/c/d) using ‘imageJ
colour histogram analysis’ software which converts RBG pixels to brightness values (V = (R+G+B)/3). These red/green brightness values
are presented as bar charts to the right of the micrographs.
https://doi.org/10.1371/journal.pone.0182624.g004
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reduction in biofilm coverage and increased numbers of red stained, damaged, cells at 24 h.
This did not translate however, into reduced biofilm formation as measured by crystal violet
staining, and indeed later 48 h samples (Fig 4D) showed a well-developed biofilm containing
viable cells, similar to that observed in the untreated control (Fig 4B) It is likely, therefore, that
residual viable cells maintain the ability to form biofilm and we hypothesise that the cells that
are initially damaged by GS5 could actually promote biofilm formation: it has been suggested
that dead bacterial cell constituents could comprise a key component of the biofilm or indeed
even enhance adhesion and stability of cells, thereby allowing biofilm development [30]. Our
data, taken together suggest that GS5 treatment will not significantly inhibit biofilm
formation.
Conclusion
Current NHS Infection control practices require that when choosing disinfectants, a 4–5 Log10
reduction is required in viable vegetative bacterial cells within a contact/drying time of 10 min,
in addition to a spore reduction of 3 Log10 within the same period. When tested directly on a
suspension of bacterial cells, GS5 achieved a more than 4 Log10 reduction with a 5 min contact
time however the residual surface active antimicrobial activity of GS5 was much less, at
approximately 1 Log10 reduction in bacterial numbers. The surface protective effect of GS5
remained for a further 3–6 days without reapplication of the product, however we noted a
diminution of the measured Log10 reductions over time to a level which was much lower than
that required for use in infection control.
Bacteria can form biofilm on surfaces allowing prolonged survival and increased resistance
to biocides. Considering the GS5 mode of action we hypothesised a regime where GS5 could
be utilised to prevent biofilm formation on surfaces subsequently reducing risk of infection.
However GS5 has been shown to possess limited anti-biofilm properties as biofilm production
is not impeded on GS5 coated surfaces.
Within the NHS, certain disinfectants (for example, DifficilS) routinely achieve 4 Log10
reductions in both vegetative cell and spore numbers within 3–5 min however control of infec-
tion is only achievable in practice by using these products in intensive cleaning up to twice daily
in a rolling programme of disinfection. Thus, on the basis of the data generated in this work, it
appears unlikely, despite modest reductions in bacterial cell viability and evidence for a short
lived residual effect, that GS5 would replace current infection control products such as DifficilS
or Actichlor in reducing the transmission of HAI pathogens within hospitals and care settings.
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